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Abstract  
Flavin-containing monooxygenase 2 (FMO2) is involved in the metabolism of 
xenobiotics, including therapeutic drugs. FMO2 exists in two forms: a functional 
and a non-functional form. The functional allele is found only in Africa and 
individuals of recent African origin.  The aims of the project were to determine 
the frequency of functional FMO2 in Africa and obtain insights into the 
evolutionary history of the FMO2 gene.                                   
Six hundred and eighty nine samples from nine African population groups 
were genotyped for six high-frequency SNPs, and the genetic diversity within 
FMO2 was characterized by sequencing 3.44 kb of genomic DNA, encompassing 
the entire coding sequence and some flanking intronic sequences in 48 African 
individuals. Haplotypes were inferred using Phase and the relationship between 
mutations was revealed using reduced-median and median-joining Network. Test 
statistics were used to determine whether the genetic variation is compatible with 
neutral evolution. 
Genotyping indicated that deleterious SNPs occur mostly on a non-functional 
allele and that the frequencies of three were significantly different (P<0.05) 
among populations. Resequencing identified 32 variants. Genetree was used to 
estimate the time to the most recent common ancestral sequence (~0.928 million 
years) and the ages of some of the mutations.  
Results indicate that the frequency of full-length 23238C alleles is relatively 
uniform across sub-Saharan Africa. Interestingly, this is not the case for the 
inferred potentially functional 23238C alleles, which frequency differed 
significantly (P<0.05) across sub-Saharan Africa.  
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The results also provide evidence that the frequency of functional FMO2 in 
east and west-Africa is high (≥0.54), which has important implications for therapy 
with drugs that are substrates for FMO2.  
A Ka/Ks > 1, and low nucleotide sequence diversity of intronic regions of 
23238C alleles indicate a possible selective sweep.  
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1. Introduction 
1.1  FMOs 
Flavin-containing monooxygenases (FMOs; EC 1.14.13.8) were first described 
by Dr Daniel Ziegler and colleagues in 1964 (reviewed in [Ziegler 1988; Ziegler 
1993; Poulsen and Ziegler 1995; Ziegler 2002]). In 1972 an FMO enzyme was 
isolated from pig liver and characterized by Carolyn Mitchell. The enzyme was 
first termed “dimethylaniline N-oxidase”, or “mixed-function amine oxidase” but, 
with the realization that it could catalyze the oxygenation of a range of substrates, 
it becomes known as “multisubstrate FMO”. FMOs have recently been recognized 
as belonging to the larger family of Baeyer-Villiger monooxygenases (Krueger 
and Williams 2005). 
FMOs catalyze the oxygenation of drugs and other non-nutritive compounds, 
including tranquilizers, analgesics and antidepressants, that contain a soft 
nucleophile, usually nitrogen, sulfur, selenium or phosphorus (Phillips et al. 2007; 
Hao et al. 2009). Like cytochromes P450 (CYPs), FMOs utilize the reducing 
power of NADPH to reduce one atom of molecular oxygen to water, while the 
other is used to oxidize the substrate (Ziegler and Petit 1964; Krueger and 
Williams 2005). 
FMOs and CYPs also exhibit similar cellular and tissue location, substrate 
specificity and molecular mass, and exist as multiple enzymes under 
developmental control.  The human FMO gene family is much smaller (one 
family with five functional members) than that of CYP. The mammalian FMO 
gene family contains five genes (FMO1 through FMO5) (Lawton et al. 1994; 
Phillips et al. 1995). An interesting feature of the enzyme is that substrate binding 
has no effect on the velocity of the enzyme-catalyzed reaction, since the rate 
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limiting steps of this reaction occur independent of substrate (Ziegler 1988; 
Krueger and Williams 2005). 
It is thought that, over the course of evolutionary history, an arms race has 
developed between plants and the animals that consume them. To deter animals 
from consuming them, plants often produce toxic substances, usually through 
plant secondary metabolism. In turn, animals have evolved both avoidance 
mechanisms such as bitter taste receptors (many plant toxins are bitter), and 
metabolic solutions such as detoxifying enzymes like FMO, to circumvent 
toxicity. As a result, FMO, as with CYP monooxygenases, developed broad 
substrate specificity at the expense of turnover rate (Krueger and Williams 2005).  
In general, the metabolites produced by FMO oxygenation usually have 
reduced pharmacological and toxicological properties. Sometimes, however, FMO 
converts chemicals into products that can cause toxicity like in the case of 
thiourea and if they can be bio-activated by CYP to a toxic metabolite, e.g, an 
epoxide (Cashman and Zhang 2006; Zhang et al. 2006a).                                                                                                         
Genetic variability and splicing variants may contribute to the interindividual 
and interethnic variability observed for metabolism mediated by FMO (Cashman 
and Zhang 2006).  
FMO expression can by regulated by various physiological factors including 
cofactor supply, diet, insulin (Borbas 2006) and sex hormones (Hukkanen and 
Dempsey 2005), and this may have implications for the clinical significance of 
FMO (Cashman et al. 1997). It is possible that ancestral FMO was important in 
processing environmental products (e.g, pesticides), because many such materials 
are detoxified by FMO (Phillips et al. 2007). For example, certain FMOs may 
have evolved to detoxify specific toxins. The prevalence of abnormal FMO3 in 
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individuals from the tropics and the role of this enzyme in trimethylamine (TMA) 
metabolism may be an example of evolutionary pressure to decrease metabolism 
of TMA so that TMA could be used as some primitive volatile insecticide 
(Cashman et al. 1997; Cashman and Zhang 2006). 
1.2 Human FMO gene family 
To date, eleven FMO genes have been discovered, five of which are functional, 
designated FMO1-FMO5, whereas the others, FMO6P-FMO11P, are 
pseudogenes (Hernandez et al. 2004). FMO1 to FMO4 lie within a 220-kb cluster 
on chromosome 1, in the region q24.3. FMO5 is located ~26 Mb closer to the 
centromere at 1q21.1. A sixth gene, which is present in the cluster, is FMO6P. 
Five other FMO genes which are all pseudogenes, FMO7P to FMO11P, are 
located within a cluster ~4 Mb closer to the centromere than the functional FMO 
gene cluster (Hernandez et al. 2004) (Figure 1). Interestingly, 3 of these 
pseodogenes are functional in mice (Hernandez et al. 2004). 
It is predicted that all mammals possess the functional FMO genes FMO1 to 
FMO5, since phylogenetic analysis suggests that these genes arose from a 
common ancestor gene through a series of gene duplications which predated the 
divergence of mammals, some 85 million years ago (Hernandez et al. 2004). 
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Figure 1. Localizations of the human FMO gene clusters on chromosome 1. 
Taken from (Hernandez et al. 2004). 
 
Functional FMO genes contain eight coding exons and either one or two 5’ 
non-coding exons (Hernandez et al. 2004). FMOs 1, 2, 3, 4 and 5 have 51 to 57% 
amino-acid sequence identity, whereas FMO6 is 72% identical to FMO3. FMOs 
of other mammalian species have >80% sequence identity to their human 
orthologues (Phillips et al. 2007).  
1.3  Mechanism of action of FMOs 
FMO belongs to a class of monooxygenases capable of generating a stable C4a 
peroxyflavin intermediate (Massey 1994). In the first step of the catalytic cycle, 
FAD undergoes a two-electron reduction by NADPH (Figure 2). The reduced 
flavin reacts rapidly with molecular oxygen to form the peroxyflavin intermediate, 
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and it is in this state that FMO may exist predominantly in the cell, waiting for a 
suitable nucleophilic substrate with which to react (Krueger and Williams 2005). 
This nucleophilic attack by the substrate on FADOOH results in one atom of 
molecular oxygen being transferred to the substrate and another to form water 
(this step is important because it makes the substrate soluble, which in turn 
facilitates excretion). The rate-limiting steps in the catalytic cycle are believed to 
be the breakdown of the FADOH pseudobase or the release of NADP+ (Krueger 
and Williams 2005; Cashman and Zhang 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. FMO catalytic cycle, adapted from (Kathamart and Stresser 2000). 
1.4  Structure of FMO 
Because human FMO proteins have not been crystallized yet, active site 
models have been postulated based on substrate profiles (Nagata et al. 1990). 
Information about the structure can be predicted from related proteins with crystal 
structures (Krueger and Williams 2005). In particular residues 12-23 of FMOs 
IGGGPGGLAAAR, are 83% identical to a glutathione reductase sequence, 
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IGGGSGGLASAR, which is a ß-sheet and turn region that forms the `floor` of the 
FAD-binding site (Mittl and Schultz 1994). A model for the active site of several 
FMOs (rabbit and pig FMO1 and rabbit FMO2) has been proposed (Polyzos 
2003). In this model (Figure 3), the substrate-binding channel leads to two 
compartments: one larger less accessible pocket (A) that binds large, planar 
aromatic residues, and another smaller pocket (C ) that can accommodate short n-
alkyl chains or a p-tolyl moity, (Cashman 1995; Fisher and Rettie 1997; Polyzos 
2003).     
                    
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Model of the active site of rabbit and pig FMO1 and rabbit FMO2 
proposed by Cashman (Cashman 1995) and Fisher (Fisher and Rettie 1997), showing the 
orientation substrates would adopt in the active site. There are two principal substrate-binding 
pockets, A and C, adjacent to the flavin cofactor, B and the binding channel D is open to the 
surface of the enzyme. (Picture taken from (Polyzos 2003). 
 
 
The substrate-binding channel is clearly distinct among forms of FMO studied 
so far and provides enzymes with stereo- and substrate-selectivity. Larger 
substrates readily oxidized by pig, guinea pig and rabbit FMO1 are excluded from 
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the active site of human FMO1, indicating a large variation among orthologues 
(Nagata et al. 1990; Lomri et al. 1993; Polyzos 2003). FMOs are generally 533-
535 amino-acid residues long (Figure 4).  
All FMOs contain two GXGXXG motifs, the FAD-binding domain at residues 
9-14 and the NADPH-binding domain at residues 191-196 (Stehr et al. 1998). The 
FAD-binding site is contained within a fingerprint sequence which predicts a βαβ 
secondary structure, the "Rossman fold" (Wieranga et al. 1985; Ziegler 1993). A 
hydrophobic motif, characteristic of FMOs, is present at residue 330 (Krueger and 
Williams 2005). All mammalian FMOs studied to date have a strong membrane 
association, which is revealed by their poor solubility in aqueous solvent and the 
highly intractable nature of the purified proteins (Guan et al. 1991).   
 
 
 
 
 
 
Figure 4. Linear representation of the ~535 amino acid polypeptide of rabbit 
FMOs 1, 2 and 3. In the N-terminal region there is the FAD-binding domain followed by an 
NAD(P)H-binding domain, and a lipophilic portion in the C-terminal region (Taken from (Polyzos 
2003). 
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1.4.1 The three-dimensional structure of yeast and bacterial FMOs   
The three dimensional structure has been determined of a yeast and bacterial 
FMO (Eswaramoorthy et al. 2006; Alfieri et al. 2008). FMO from the yeast 
Saccharomyces cerevisiae has 18-23% amino-acid sequence identity to 
mammalian FMOs (Eswaramoorthy et al. 2006). Unlike mammalian FMO, the 
yeast enzyme does not accept xenobiotics as substrates, but may be involved in 
maintaining cellular reducing power, probably through its action on cysteamine 
(Suh et al. 1996). Bacterial FMO from Methylophaga sp. Strain SK1 has a two-
domain structure, with well defined FAD and NADP+ binding domains. Both 
domains are connected through a flexible hinge (Choi et al. 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Ribbon representation of FMO of Yeast. FAD binds to the large domain. 
The strand-turn-helix motifs and the interlinking loop are labelled. Diagram from (Eswaramoorthy 
et al. 2006). 
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1.5 Function of FMOs 
Little information exists about the functions of FMOs, other than in xenobiotic 
metabolism. However, it was observed that some individuals with defective 
FMO3 displayed abnormal metabolism of biogenic amines, which are involved in 
the control of blood pressure, suggesting that FMO3 may play a role in the 
regulation of blood pressure (Duescher et al. 1994). 
Ziegler and Poulsen in the 1970s, hypothesized that FMO may play a role in 
the synthesis of disulfide bonds of protein, through cysteamine oxidation (Poulsen  
and Ziegler 1977; Poulsen and Ziegler 1979). 
1.6 FMO gene expression 
Each FMO gene exhibits a distinct developmental and tissue-specific pattern of 
expression in all species including humans (Dolphin et al. 1992; Hernandez et al. 
2004).  
1.6.1  FMO1 gene 
Human FMO1 has 10 exons. Exons 0 and 1 are non-coding. The protein-
coding sequence is located within exons 2 to 9, and the translation initiation codon 
is located in exon 2.  
In humans FMO1 is not expressed in the adult liver. This is in contrast to other 
mammals, such as rabbit, pig, rat and mouse, in which FMO1 constitutes the 
major form of the enzyme in the liver of adult animals. This species-dependent 
difference in expression may be because of the presence, upstream of exon 0, of a 
sequence which acts as a powerful transcriptional repressor (Shephard et al. 
2007). 
The kidney is the main site of expression of FMO1 in adult human (Dolphin 
1991; Phillips et al. 1995; Dolphin et al. 1996; Yeung et al. 2000). The gene is 
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also expressed in the stomach, small intestine and in various endocrine tissues, 
including adrenal cortex and medulla, pancreas, thymus, thyroid and testis 
(Hernandez et al. 2004).  
1.6.2 FMO3 gene 
The FMO3 gene comprises 9 exons, of which the first is non-coding (Dolphin 
et al. 1997). In humans, the expression of FMO3 is switched on after birth 
(Koukouritaki 2002), and it becomes the major isoform in adult liver (Lomri et al. 
1992; Phillips et al. 1995; Dolphin et al. 1996; Zhang and Cashman 2006).  
FMO3 mRNA has also been detected in adrenal medulla and cortex, pancreas, 
thyroid, gut and brain, lung and kidney (Hernandez et al. 2004; Phillips et al. 
2007).  
1.6.3 FMO4 gene 
The FMO4 gene contains ten exons, of which eight are coding (Hernandez et 
al. 2004). FMO4 mRNA in contrast to other FMO mRNAs contains sequences 
from all ten exons. FMO4 encodes a protein that is 558 amino-acids long. This is 
longer than other FMOs, which contain between 532 and 535 residues (Phillips et 
al. 1995). It was suggested by Phillips et al (2007), that this additional block of 
residues are a result of a single point mutation in the termination codon of 
ancestral FMO4 (Phillips et al. 2007). FMO4 is mainly expressed in the liver and 
kidney (Dolphin et al. 1996; Hernandez et al. 2004; Zhang and Cashman 2006). 
1.6.4 FMO5 gene 
FMO5 is the most ubiquitously expressed member of the FMO gene family and 
the protein that it encodes does not catalyze the oxygenation of common FMO 
substrates except for short-chain amines (Overby et al. 1997), which suggests that 
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it may be more involved in endogenous metabolism than in the detoxification of 
xenobiotics. FMO5 is expressed in many foetal and adult tissues (Benedetti and 
Keith 2007; Phillips et al. 2007). 
The abundance of mRNAs encoding FMO3 and FMO5 are similar in the adult 
liver (Zhang and Cashman 2006). The contribution of FMO5 to hepatic 
metabolism has not been clearly established, although FMO5 represents 
approximately 46% or more of the total FMO transcripts in adult human liver 
(Zhang and Cashman 2006). The different amounts of FMO mRNAs in different 
tissues suggests that the promoter regions of these FMOs contain regulatory 
elements responsive to transcription factors specifically present and active in these 
tissues.  
1.6.5 FMO2 gene 
The FMO2 gene comprises of 9 exons, the first of which is non-coding 
(Hernandez et al. 2004). FMO2 is the predominant isoform in human foetal and 
adult lung (Cashman and Zhang 2006; Hines 2006), but, in most humans, 
functional FMO2 is not expressed because of a nonsense mutation: g.23238C>T 
at position 472, that changed a glutamine-codon to a premature stop-codon 
(Dolphin et al. 1998). Thus, in the majority of individuals, although FMO2 
mRNA is present in the lungs, no catalytically functional enzyme is expressed. In 
contrast, functional FMO2 is expressed in the lungs of nonhuman primates 
(Cashman and Zhang 2006). FMO2 is also expressed in skeletal muscle, kidney, 
prostate gland and blood vessels (Hernandez et al. 2004).  
1.7 FMO substrate specificity 
FMOs catalyze the oxygenation of a diverse group of compounds, which 
contain a soft nucleophile such as nitrogen, selenium, sulfur or phosphorus. The 
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size and shape of the substrates are important factors that limit access to the 
catalytic site of FMOs, and these two factors are primarily responsible for 
differences in the substrate specificities of the FMO isoforms.  
Substrates include primary, secondary (Cashman et al. 1999) and tertiary 
amines (Wu and Ichikawa 1995; Narimatsu et al. 1996) as well as thiourea, 
thioacetamide, methimazole, cysteamine and thiobenzamide (Ziegler 1991). 
FMOs differ in substrate specificity and range. 
1.7.1 Endogenous and xenobiotic substrates 
As previously mentioned, an absolute structural requirement for an FMO 
substrate is a soft-nucleophilic heteroatom, typically a nitrogen or sulfur, with 
fewer examples of selenium- or phosphorus-containing substrates (Krueger and 
Williams 2005). Uncharged or singly positively charged compounds are the best 
substrates. Although compounds with a single negative charge can be substrates, 
the charge must be located a certain distance from the oxygenation site (Krueger 
and Williams 2005). Compounds with more than a single charge are almost 
universally excluded from the FADOOH site (Krueger and Williams 2005). These 
charge restrictions for access to the substrate channel leading to FADOOH 
exclude many potential nucleophilic endogenous substrates from FMO-dependent 
oxygenation (Krueger and Williams 2005).. Many substrates for FMOs can be 
chemically synthesized in the body (endogenous), or are a result of conjugation of 
a xenobiotic with an endogenous nucleophile such as cysteine, (Krueger and 
Williams 2005). Examples of nitrogen-containing endogenous substrates of FMOs 
are the biogenic amines tyramine and phenethylamine, which are N-oxygenated 
by FMO to the N-hydroxy metabolite, followed by a rapid second oxygenation to 
the trans-oximes (Lin and Cashman 1997a; Lin and Cashman 1997b). Since the 
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oximes appear to have little pharmacological activity, this N-oxygenation pathway 
is a mechanism for inactivation (Krueger and Williams 2005). 
Another example of an endogenous compound is trimethylamine, precursors of 
which are present in the diet. Trimethylamine is primarily formed in vivo from the 
breakdown of choline and is N-oxygenated by FMO3 (Lambert et al. 2001; 
Cashman et al. 2004; Krueger and Williams 2005). Trimethylamine is extremely 
odorous (Mitchell 2005), whereas the N-oxide has little or no odour. Failure to 
efficiently N-oxygenate trimethylamine leads to a genetic disorder known as 
trimethylaminuria or fish-odour syndrome (Dolphin et al. 1997; Mitchell et al. 
1997; Mitchell and Smith 2001) 
Sulfur-containing endogenous substrates for FMO have also been documented 
(Poulsen 1981). Examples of sulfur-containing endogenous substrates of FMO are 
sulfhydryls, such as cysteamine, which is S-oxygenated to the disulfide 
(cystamine) (Poulsen and Ziegler 1977; Poulsen and Ziegler 1979). Cysteamine 
has been used therapeutically to slow down the progression of Huntington`s 
disease (Berman and Greenamyre 2006) and as a radioprotector (Biaglow et al. 
1984). Cysteamine is the only approved treatment for paediatric cystinosis 
(Belldina et al. 2003). Cysteamine hydrochloride can regulate various hormones: 
Cysteamine hydrochloride supressess circulating growth hormone levels in male 
pigs (McElwain et al. 1999) and is a potent inhibitor of growth hormone-
inhibiting hormone (Somatostatin) (Brown et al. 1983) FMO oxygenation of 
cysteamine may help control the overall thiol/disulfide redox state of the cell. By 
this indirect way, FMO may control the level of H2O2 in the cell and the 
expression of genes regulated by H2O2, sulfhydryl/disulfide ratios and the general 
redox state of the cell (Khomenko et al. 2004). 
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1.7.1.1   FMO1 protein 
FMO1 has the broadest substrate range, including a wide range of pesticides 
and endogenous compounds and therapeutic drugs. A detailed explanation of how 
each of these drugs is metabolized by FMO1 is beyond the scope of this thesis. 
For more information see (Krueger and Williams 2005). However, one drug was 
selected, tamoxifen, because of potential conflict between detoxification and 
bioactivation, as well as its widespread use in the treatment breast cancer. FMO1 
mediates the N-oxygenation of tamoxifen, which is considered as a detoxification 
process. So in tissues expressing FMO1, there would be expected to be fewer 
tamoxifen-related DNA adducts (a DNA adduct is a stretch of DNA which binds 
cancer-causing chemicals) (Hemminki et al. 1996). In contrast, the drug can be 
bioactivated by CYP-mediated hydroxylation. So the combined effects of FMO1 
and CYP genetic variants may influence the balance between the efficacy and 
harmful side effects of tamoxifen (Parte and Kupfer 2005). 
1.7.1.2  FMO3 protein 
     FMO3 catalyzes the oxygenation of nicotine, tertiary amines, such as 
trimethylamine and many therapeutic drugs (Cashman 2000). 
Reduced activity of FMO3 can enhance the anticancer effect of nonsteroidal 
anti-inflammatory drugs (especially cyclooxygenase 2 inhibitors such as 
sulindac). Sulindac is a prodrug that contains a racemic S-oxide, which is reduced 
to the sulfide by gut bacteria (Duggan et al. 1977; Etienne et al. 2003). The active 
sulfide (i.e., sulindac sulfide) is S-oxygenated to the sulfoxide and then to the 
sulfone by FMO3 (Hamman et al. 2000). Polymorphisms of FMO3 that decrease 
the functional activity of the enzyme may decrease retrooxygenation of sulindac 
sulfide to inactive sulfoxide and thus, increase the efficacy of sulindac, by 
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increasing the amount of sulindac sulfide to the patient`s circulation (Etienne et 
al. 2003; Hamman et al. 2000). FMO3, Like FMO1, catalyzes the metabolism of 
thiacetazone, through S-oxygenation. 
1.7.1.3 FMO4 protein 
The expression of a stable form of FMO4 in heterologous systems has been 
proved difficult, consequently, little is known about its substrate specificity 
(Itagaki et al.  1996). 
1.7.1.4 FMO5 protein 
In contrast to other FMOs, FMO5 has weak catalytic activity towards 
compounds such as methimazole (Rettie et al. 1994; Cherrington 1998; (Overby 
et al. 1995). FMO5 catalyzes the N-oxygenation of short-chain aliphatic primary 
amines like N-octylamine. FMO5 has been reported to catalyze the oxygenation of 
thioethers, such as the anti-rheumatic drug easonarimod (Ohmi et al. 2003), which 
are not substrates for other FMOs. Consequently, FMO5 is regarded as an atypical 
FMO. 
1.7.1.5 FMO2 protein 
FMO2 differs from other FMOs, for it can catalyze the N-oxygenation of some 
primary alkylamines to their oximes (Lin and Cashman 1997a; Lin and Cashman 
1997b), but is unable to catalyze the oxygenation of certain tertiary amines, such 
as imipramine and chlorpromazine (Ohmiya  and Mehendale 1982; Williams et al. 
1984). FMO2 has a more restricted substrate range, with a preference for 
substrates with longer side chains, suggesting that the active site of FMO2 is 
located further from the surface of the enzyme than that of other FMOs and is 
accessed by a relatively narrow channel (Williams et al. 1984). FMO2 is also less 
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sensitive to inactivation by anionic detergents and elevated temperature (Guan et 
al. 1991). 
Substrates include thioether-containing organophosphate pesticides, such as 
phorate and disulfoton (Henderson et al. 2004). The products of the FMO2-
catalyzed reaction are less toxic than the parent compounds (Neal and Halpert 
1982) and therefore, the enzyme has a protective role.  
The role of FMO2 in drug metabolism is still unclear. However, the 
antipsychotic drugs prochloperazine and trifluoperazine are substrates of rabbit 
FMO2 (Lomri et al. 1993). 
Substrates of particular interest are thiacetazone and ethionamide (Henderson 
et al. 2008; Francois et al. 2009), the second-line antitubercular drugs (Brown 
1992; Peloquin 1993; Alahari et al. 2007) which are activated by the 
mycobacterial enzyme EtaA (Vanelli et al. 2002). Pulmonary tuberculosis is a 
widespread disease, especially in Africa: according to the World Health 
Organization 31% of all the new cases in 2006 were in Africa: 
(http://www.who.int/mediacentre /factsheets /fs104/en/). 
In contrast to most other substrates of FMOs, which are metabolized into less 
toxic substances, the thiourea in these drugs is bioactivated by FMO2-mediated S-
oxygenation to toxic sulfenic and/or sulfinic acid metabolites (Figure 6). Sulfenic 
acid is capable of undergoing redox cycling following conjugation with 
glutathione, resulting in oxidative stress due to depletion of reduced glutathione 
and NADPH (Smith and Crespi 2002; Henderson et al. 2004) (Figure 6).  This 
process is believed to be an important mechanism of thiourea toxicity in the lung 
(Henderson et al. 2004).  
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Figure 6. Pathway of FMO2-mediated S-oxygenation of thiourea. Diagram from 
the international Chemical Assessment document 49 (http://www.inchem.org/documents/cicad). 
 
1.8 Association of FMO with human disease 
A global gene expression investigation of patients diagnosed with atrial 
fibrillation documented a significant increase in the expression of FMO1 mRNA 
(Kim et al. 2003). Studies of the spinal cord of patients with amyotrophic lateral 
sclerosis indicated that FMO1 mRNA was under-represented (Malaspina et al. 
2001), also, the expression of certain FMO enzymes in some neoplastic tissues 
has been observed (Rebhan et al. 1997). There is suggestive evidence that FMO 
deficiency may be associated with sideroblastic anaemia (Barber et al. 2000). 
FMO3 deficiency causes trimethylaminuria (TMAU), also known as fish-odour 
syndrome (Dolphin et al. 1997; Mitchell and Smith 2001; Mitchell 2005), which 
is manifested clinically by a body odour similar to that of rotten fish and is 
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accompanied by various psychological abnormalities (Ayesh et al. 1993; Mitchell 
and Smith 2001). It is classified as a rare but ancient disorder. As the name 
implies, the disorder is associated with an excess of extremely odorous 
trimethylamine in the urine, sweat and breath of the patient (Mitchell and Smith 
2003). Trimethylamine is normally metabolized to the N-oxide, which has no 
offensive odour, by FMO3 in the liver (Sardas et al. 1996; Mitchell et al. 1997). 
The type of mutation in the FMO3 gene defines the severity of the disease (Park 
et al. 2002; Hernandez  et al. 2003; Zhang et al. 2003).     
Diagnosis is by determination of urinary ratios of trimethylamine N-oxide to 
trimethlylamine following a challenge dose of choline. The severity of the disease 
can be predicted to be greater with a lower ratio (Mitchell and Smith 2001). 
1.9 FMO2 variants 
Two major FMO2 alleles are present in humans: FMO2*1, which encodes a 
full-length active protein and FMO2*2A, which encodes a truncated inactive 
protein (Dolphin et al. 1998; Whetstine et al. 2000).  
A comparative analysis of the cDNA for FMO2 of human with that of FMO2 
of  rabbit (Lawton et al. 1990), guinea pig (Nikbakht et al. 1992) and Rhesus 
macaque (Yueh et al. 1997), revealed that the former encoded a truncated protein 
which lacks 64 amino-acid residues from its carboxy terminus (Dolphin et al. 
1998). This was caused by a nonsense mutation (See section 1.6.5 page 11).       
Heterologous expression of the cDNA revealed that the truncated polypeptide 
was catalytically inactive (Dolphin et al. 1998). The nonsense mutation that gave 
rise to the truncated polypeptide, is not present in the FMO2 gene of closely 
related primates, including gorilla and chimpanzee (Dolphin et al. 1998), and 
must therefore have arisen in the human lineage after the divergence of the Homo 
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and Pan clades which took place some 5-6 million years ago (Brunet et al. 2002) 
and has subsequently spread to attain a frequency of close to 100% in present day 
human populations (Asians and Europeans) (Whetstine et al. 2000; Furnes et al. 
2003; Phillips et al. 2007). 
The protein product of FMO2*1 allele is 97% identical to FMO2 of Rhesus 
macaque and 85% identical to FMO2 of rabbit and mouse (Dolphin et al. 1998).  
FMO2 is usually inactive in humans, it is found in an active form only in 
Africans and individuals of recent African origin (Whetstine et al. 2000).  
Interestingly 27% of Africans (Dolphin et al. 1998; Whetstine et al. 2000), as 
well as 5% of Hispanics (Krueger et al. 2004; Hickey 2007) possess at least one 
allele coding for the full-length protein.  
FMO2 gene expression has been demonstrated to be regulated by sex hormones 
in experimental animals (Lee et al. 1993; Dolphin et al. 1998), and putative 
glucocorticoid-responsive elements have been identified in the 5'-flanking region 
of the rabbit FMO2 gene (Wyatt et.al 1996).  
The similarities in the pattern and size of expression of FMO2 mRNA in 
humans and other mammalian species indicate that the human FMO2 gene has 
suffered no mutations that affect either the expression of the gene or the 
processing or stability of the corresponding mRNA (Dolphin et al. 1998). So the 
absence of FMO2 in human lung might be explained by the lack of 64 residues 
from its carboxyl terminus. The truncated protein might be unable to fold 
correctly, and thus would be detected by cellular surveillance systems, such as the 
ubiquitin pathway, and rapidly degraded (Dolphin et al. 1998). The lung plays an 
important role in the metabolism of inhaled foreign chemicals, including drugs, 
environmental toxicants and carcinogens (Zhang et al. 2006b). Human FMO2 
  20
thus represents an unusual case of a gene that has become non-functional in 
humans, but not in other primates. 
Furnes et al. (2003) have identified additional variants in FMO2 in African-
Americans. Krueger et al. (2005) investigated the effect of the occurrence of four 
common polymorphic variants of FMO2 [g.7700-7702 insGAC (71Ddup) in exon 
3, g.10951delG (V113fsX) in exon 4, g.13732C→T (S195L) in exon 5 and 
g.22060T→G (N413K) in exon 8)] identified in African-Americans (50 
individuals) by Furnes et al. (2003) and in Hispanics by Krueger et al. (2005). Of 
these, only the g.22060T>G (N431K) variant had full catalytic activity. The allelic 
frequency of these variants was lower in Hispanics than in African-Americans. 
Krueger et al. (2005) demonstrated through inferred haplotype determination that 
these variants are located on the major, g.23238T allele which encodes a 
truncated, non-functional protein and, thus, would not significantly impact the 
activity of the full-length functional enzyme produced by the g.23238C allele 
(Krueger et al. 2005). Veeramah et al. (2008) conducted a study on the frequency 
of the functional allele FMO2*1 in 24 groups from different regions of Africa, as 
well as from Yemen and Turkey, and found that the distribution of the allele is 
relatively homogeneous across sub-Saharan Africa with approximately one-third 
of individuals possessing at least one FMO2*1 allele, though in some populations 
the incidence of these individuals approached 50%. Coding-region variants of 
FMOs are shown in Table 1. 
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Table 1. Coding-region variants for FMOs 1, 2, 3, 4 and 5 
 
Gene Variant exon Amino acid change Functional consequence Reference  
FMO1 g.9614C>G 3 H97Q no effect (Furnes et al. 2003; Furnes and Schlenk 2004) 
FMO1 g.22739G>A 6 R223Q n.d. dbSNP126 
FMO1 g.22818C>T 6 T249T - 
 
(Furnes  et al. 2003),  dbSNP126 
FMO1 g.23970A>G 7 I303V no effect (Furnes  et al. 2003; Furnes and Schlenk  2004); dbSNP126 
FMO1 g.23971T>C 7 I303T no effect (Furnes  et al. 2003; Furnes and Schlenk  2004); dbSNP126 
FMO1 g.25061A>G 8 V396V - 
 
(Furnes et al. 2003), dbSNP126 
FMO1 g.27258A>G 9 P467P - 
 
dbSNP126 
FMO1 g.27362C>T 9 R502X substrate-dependent decrease 
 
(Furnes  et al. 2003; Furnes and Schlenk 2004) 
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 M 
  
FMO2 g.107A>G 2 D36G n.d. (Furnes et al. 2003) 
FMO2 g.7661G>A 3 V59I no effect (Dolphin et al. 1998) 
FMO2 g.7695T>A 3 F69Y n.d. dbSNP126 
FMO2 g.7700_7702dupGAC 3 D71dup loss of function (Furnes et al. 2003; Krueger et al. 2005) 
FMO2 g.7731T>C 3 F81S 
 
n.d. dbSNP126 
FMO2 g.10951delG 4 V113fsX loss of function (Furnes et al. 2003; Krueger et al. 2005) 
 
FMO2 g.13693T>C 5 F182S 
 
n.d. (Furnes et al. 2003) 
FMO2 g.13732C>T 5 S195L loss of function (Furnes et al. 2003; Krueger et al. 2005) 
 
FMO2 g.13733A>G 5 S195S 
 
- (Furnes et al. 2003) 
FMO2 g.18237G>A 6 R238Q 
 
n.d. (Furnes et al. 2003) 
FMO2 g.18269C>T 6 R249X n.d. (but likely loss of function) dbSNP126 
FMO2 g.19679A>G 7 E314G 
 
n.d. dbSNP126 
FMO2 g.19839G>A 7 A367A 
 
- (Furnes et al. 2003) 
FMO2 g.19898_19899ins TCAAGCTC 7 R387RfsX5 
n.d. (but likely loss of 
function) (Furnes et al. 2003) 
FMO2 g.19910G>C 7 R391T 
 
n.d. (Furnes et al. 2003) 
FMO2 g.22027G>A 
 
8 E402E - (Furnes et al. 2003) 
FMO2 g.22060T>G 8 N413K no effect  (Furnes et al. 2003; Krueger et al. 2005) 
FMO2 g.23238C>T 9 Q472X loss of function (Dolphin et al. 1998; Whetstine et al. 2000) 
FMO2 g.23300A>G 
 
9 K492K - (Furnes et al. 2003) 
FMO2 g.23405_23406insT 
 
9 F528FfsX32 n.d. dbSNP126 
FMO2 g.23412_23413insT 
 
9 C530LfsX30 n.d. (Whetstine et al. 2000) 
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FMO3  g.72G>T 2 E24D limited (Koukouritaki et al. 2007) 
FMO3 g.11177C>A 3 N61K* reduced or abolished (Koukouritaki et al. 2007) 
FMO3 g.15089G>C 4 D132H substrate-dependent decrease (Furnes et al. 2003; Lattard et al. 2003) 
FMO3 g.15167G>A 4 E158K moderate, substrate-dependent decrease 
(Dolphin et al. 1997; Brunelle et al. 1997; Treacy et al. 
1998; Akerman et al. 1999a; Zschocke  et al. 1999; 
Furnes et al. 2003) 
FMO3 g.15475G>T 5 G180V no effect (Dolphin et al.  2000) 
FMO3 g.15550C>T 5 R205C moderate decrease 
 
)Fujieda et al.  2003(  
FMO3 g.18281G>A 6 V257M no effect or limited substrate -dependent decrease 
(Treacy et al. 1998; Dolphin et al.  2000;  Furnes 
et al. 2003) 
FMO3 g.18290A>G 6 M260V n.d (Shimizu  et al. 2006) 
FMO3 g.21350T>C 
 
7 V277A n.d (Cashman and Zhang 2002) 
FMO3 g.21443A>G 7 E308G moderate substrate-dependent decrease 
(Treacy et al. 1998; Akerman  et al. 1999b; Zschocke et 
al.  1999) 
FMO3 g.21599T>C 7 L360P increased activity (Furnes et al. 2003; Lattard et al.  2003) 
FMO3 g.21604G>C 7 E362Q n.d. (Cashman and Zhang 2002; Furnes et al. 2003) 
 
FMO3 g.23613G>T 8 K416N limited (Koukouritaki  et al. 2007) 
FMO3 g.24642G>A 9 I486M n.d. (Cashman and Zhang 2002) 
FMO3 g.24691G>C 9 G503R n.d. (Furnes et al. 2003) 
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Mutation nomenclature follows that recommended by the Human Genome Organization (http://www.hgvs.org/mutnomen/). *Likely to be causative for 
TMAuria. Data in table is from Phillips et al. (2007) (Phillips et al. 2007).  There are 28 additional rare mutations for FMO3, see (Phillips et al. 2007). 
SNP, single-nucleotide polymorphism. 
FMO4 g.110T>C 2 I37T n.d. (Furnes et al. 2003) 
FMO4 g.14601C>T 7 F281F n.d. dbSNP126 
FMO4 g.14680A>T 7 T308S n.d. dbSNP126 
FMO4 g.14724T>C 7 D322D n.d. (Furnes et al. 2003) 
FMO4 g.14726T>C 7 V323A n.d. (Furnes et al. 2003) 
FMO4 g.14770G>C 7 E339Q n.d. (Furnes et al. 2003) 
FMO5 g.23716G>A 7 P337P n.d. dbSNP126 
 
FMO5 g. 23806A>G 7 A367A n.d. (Furnes et al. 2003) 
FMO5 g.37917C>T 9 P457L n.d. (Furnes et al. 2003) 
FMO5 g.38059G>T 9 R506S n.d. dbSNP126 
 
FMO5 g.23716G>A 7 P337P n.d. dbSNP126 
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1.10  Natural selection 
Natural selection works to either decrease or increase the frequency of alleles 
that have a detrimental or favourable effect on an individual`s fitness (Campbell 
and Tishkoff 2008). There are several types of selection including positive 
selection. In positive selection, an advantageous allele can increase in frequency, 
together with linked variants (i.e., genetic hitchhiking), and decrease the genetic 
variation in a given population (i.e., a selective sweep) (Harris and Meyer 2006; 
Nielsen et al. 2007; Sabeti et al. 2007). This will result in strong linkage 
disequilibrium (LD) (the non-random association between two loci not necessarily 
on the same gene) (Sabeti et al. 2002; Voight et al. 2006; Tishkoff 2007b). The 
size of the sequence being subjected to selection depends on the local 
recombination rate and on the power of selection. In time, recombination will 
result in the accumulation of new mutations, which will in turn breakdown the 
extent of LD (Campbell and Tishkoff 2008). Other forms of selection include 
purifying and balancing selection. Purifying selection acts to keep deleterious 
mutations at low frequency in a population due to their negative effect on fitness. 
Therefore, weak purifying selection also displays a pattern of an excess of low-
frequency mutations (Campbell and Tishkoff 2008). Balancing selection leads to 
an increase in intermediate-frequency alleles, it usually occurs when 
heterozygotes have an advantage over homozygotes (Campbell and Tishkoff 
2008).  In this form of selection, multiple alleles (different versions of a gene) are 
selected at frequencies higher than expected under neutral evolution.  
The evolutionary patterns of sequences subjected to selection are not easily 
detectable, since demographic processes can mimic some of these patterns. An 
example of a demographic process is population size changes. Population 
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expansion, for example, results in an increase in low-frequency variants, which is 
similar to the pattern observed due to positive or purifying selection (Campbell 
and Tishkoff 2008), whereas a population bottleneck (drastic decrease in 
population size either due to death or failure to reproduce) results in an increase in 
genetic drift (the change in frequency of an allele due to random sampling across 
generations). Genetic drift may cause the disappearance of an allele and therefore 
reduces genetic variation by decreasing the frequency of rare variants. This results 
in a pattern similar to the one caused by balancing selection and population 
structure (Nielsen et al. 2007).  
It is believed that the migration of some modern humans out of Africa into 
diverse environments has resulted in non-African populations having more 
recently selected loci than African populations (See section 1.11) (Akey et al. 
2004; Storz et al. 2004; Hawks et al. 2007; Williamson et al. 2007). It should be 
noted that, although the exposure to a novel environment may result in adaptive 
pressures in the exposed populations, the lower rate of selection detected in Africa 
could be due to the studies being restricted to a limited number of African 
populations and that African-Americans have often been used to represent African 
populations. The admixture of African-Americans with Europeans (Carlson et al. 
2005; Williamson et al. 2007), will result in lower power to detect selection, since 
population structure can mimic balancing selection (Oleksyk et al. 2010). There 
are many candidate genes for natural selection, for example, the HbS mutation in 
the ß-globin gene, which causes sickle cell anaemia in homozygous individuals. 
Individuals who are heterozygous for the sickle cell trait are protected against 
malarial infection and have higher reproductive fitness (Kwiatkowski 2005). 
Other examples include the G6PD gene (Tishkoff et al. 2001), the Duffy gene on 
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chromosome 1 (Hamblin and Di Rienzo 2000), genes involved in dietary 
adaptations (e.g., genes involved in lactase persistence (Hollox et al. 2001; Itan et 
al. 2009) and bitter-taste receptors (Kim et al. 2005). Other candidate genes 
include ones involved in antibody-antigen reactions or encoding drug-
metabolizing enzymes like FMO2 (Stahl and Bishop 2000; Nielsen et al. 2005). It 
is of interest that evidence has been reported for balancing selection of FMO3 
(Allerston et al. 2007). 
1.11  Human origins and evolution 
Anthropogeny is the study of the evolution and the origins of the human race. 
The word “human” originates from the Latin humanus, which is the adjective of 
homo. A detailed description of human origins is beyond the scope of this thesis. 
The interested reader can refer to (Stringer and Andrews 2005). 
Gaining insights into the evolutionary history of modern humans is important 
for a better understanding of how human genetic variation relates to susceptibility 
to disease and to differences in response to various pharmacological agents 
(mainly therapeutic drugs). 
Africa has more human genetic diversity in both nuclear and mitochondrial 
genomes (Tishkoff and Verrelli 2003; Garrigan et al. 2007; Jakobsson et al. 2008) 
than observed anywhere else on Earth (Tishkoff et al. 2009). This variation is due 
to Africa`s complex population history, in that humans existed for a long time and 
in bigger population sizes, making Africa the ideal geographic location for 
studying human genetic variation (Atkinson et al. 2008; Campbell and Tishkoff 
2008).  
There has been a paucity of large-scale autosomal studies of populations that 
are ethnically diverse, especially in Africa (Conrad and Hurles 2007). The 
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importance of these studies lies in the identification of population-specific 
variants, as well as variants playing roles in susceptibility to complex diseases in 
people of recent African ancestry (Tishkoff and Williams 2002; Reed and 
Tishkoff 2006;  Sirugo et al. 2008).  
In an attempt to estimate the frequency of common SNPs shared among major 
population groups in the United States of America, Guthery et al. (2007) 
resequenced 154 chromosomes from African-American, European, Asian and 
Latino/Hispanic populations for 3873 genes. This study revealed higher genetic 
diversity of individuals with recent African origin (African Americans). African 
Americans had the lowest frequency of common SNPs (36%) and the highest 
frequency of rare SNPs (64%), of which 44% were population-specific (Guthery  
et al. 2007). 
Haplotype and nucleotide variation studies indicated that the geographical and 
historical separation of African populations predates the out-of-Africa migration 
(Garrigan et al. 2004; Plagnol and Wall 2006; Yotova et al .2007).  
This observed pattern of genetic variation in Africa reflects the region`s 
demographic history, such as admixture and population size, as well as natural 
selection, recombination and mutation (see Section  1.10 and Campbell and 
Tishkoff 2008). The decrease in genetic diversity moving out and away from 
Africa (Ramachandran et al. 2005; Liu et al. 2006) is believed to be the result of a 
bottleneck (Forster and Matsumina 2005; Macaulay et al. 2005) associated with 
the migration of modern humans out of Africa. 
There are two models for the migration of humans from Africa, the out-of-
Africa model (OOA), developed by Chris Stringer and Peter Andrews (Stringer 
and Andrews 1988) and the multiregional model (Wolpoff et al. 2000), which 
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remains a possibility due to the presence of archaic admixture in modern humans 
with Neanderthales (Green et al. 2010; Reich et al. 2010). 
The OOA model suggests that modern Homo sapiens originated in Africa 
~200,000 years ago and then spread across the rest of the world within the past 
~100,000 years (Tishkoff et al. 2003). This has been supported by fossil remains 
from Ethiopia, dated to ~150-190 kya (White et al. 2003; McDougall et al. 2005).  
The OOA model has favoured two routes, one being migration into the Levant, 
via the Nile Valley and North Africa, followed by subsequent migration into both 
Europe and Asia (Campbell and Tishkoff 2008). The second, earlier route, was 
across the Bab-el-Mandeb strait at the mouth of the Red Sea, travelling along the 
Indian ocean into Southeast Asia and Australia, ~50,000, and then into Europe, 
~30,000 years ago (Forster and Matsumina 2005; Reed and Tishkoff 2006) 
(Figure 7). Archaeological data,  as well as results from both mitochondrial and 
Y-chromosome DNA studies suggest that anatomically modern humans originated 
in eastern Africa and migrated to southern Africa (Wood et al. 2005), although a 
southern African origin cannot be ruled out (Campbell and Tishkoff 2008; Henn 
et al. 2011). The multiregional model (Wolpoff et al. 2000) is thought to have 
involved an initial dispersal of Homo erectus from Africa ~1,000,000 years ago, 
and expanded into Eurasia. 
The multiregional model has been contradicted by the observed shared patterns 
of genetic diversity among non-African populations, e.g, at the CD4 locus, and the 
presence of old mtDNA haplotypes in Eurasia, South Asia and Australia, which 
indicates that all non-African populations derive from a single ancestral gene pool 
(Tishkoff et al. 1996) and this, in turn, supports the out-of-Africa model 
(Quintana-Murci et al. 1999; Macaulay et al. 2005; Thangaraj et al. 2005). But 
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despite this, the multiregional (multiple dispersal) model remains a possibility 
because of the presence of archaic admixture in modern humans (see above) 
(Green et al. 2010; Reich et al. 2010). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Map of African Language Families and hypothesized migration out 
and within Africa adapted from (Reed and Tishkoff 2006). African languages are 
divided into four families: Afro-Asiatic, Nilo-Saharan, Khoisan and Niger-Kordofanian (Campbell 
and Tishkoff 2008). Red dots indicate the locations from where the African samples included in 
the Centre d`Etude du Polymorphisme Humain (CEPH) Human Genome Diversity Panel (CEPH-
HGDP) originated (Reed and Tishkoff  2006).  
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Recently, interest has arisen in examining human genetic variability in Africa. 
One of the studies involved examined 400 INDELs and 800 short tandem-repeat 
polymorphisms (STRPs) by genotyping more than 2000 ethnically diverse 
African individuals. The study revealed high levels of admixture between most 
African populations (at least 13) (Tishkoff  et al. 2009), with the only exception 
being Bantu speakers (Niger-Kordofanian), who are more genetically 
homogeneous compared with other African populations. This is believed to be 
caused by the resent expansion of Bantu from a common origin in 
Cameroon/Nigeria (see Section 1.13.5). 
1.12 Geographical features of sub-Saharan Africa 
Sub-Saharan Africa consists of the area that lies south of the present day 
Sahara Desert (Quintana-Murci et al. 1999; Von Cramon-Taubadel and Lycett 
2008).  
The Sahel stretches across northern Africa from the Red Sea to the Atlantic 
Ocean. It is the transitional zone between the Sahara desert in the north and the 
wetter rainforests and savannas of Equatorial Africa in the south (Figure 7).  
The horn of Africa (sometimes called Somali Peninsula) is located in the north-
east of Africa along the southern side of the Gulf of Aden. The Horn of Africa and 
areas of Sudan, although being part of the Arab world (see above), are also 
geographically part of sub-Saharan Africa (Figure 8). 
 The population of sub-Saharan Africa was ~800 million in 2008 (Group 
2010). 
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Figure 8. Geographic map of Africa: Map illustrates the Saharan Desert, the Sahel, the 
Sahara Desert, the Horn of Africa in the north and northeast, respectively, and the Kalahari basin 
in the southwest, light and dark green are tropical savannas and rainforests of Equatorial Africa, 
Map taken from (GraphicMaps.com). 
 
1.13 Sub-Saharan African populations 
1.13.1  West-African populations 
1.13.1.1 Ethnic groups from Cameroon 
1.13.1.1.1 The Fulbe 
The ethnic name ‘Fulbe’ is the plural of ‘Pullo’, and the autonym for the 
Fulbe people as an ethnic group (also known as the Fulani) (Barreteau et al. 
1984). The Fulbe are Muslim pastoralists who started migrating into Cameroon 
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from present-day Nigeria in the beginning of the 13th century (Neba 1999). The 
Fulbe included in this study are from Mayo Darle, Adamawa, in northern 
Cameroon.  
There are estimated to be 165,000 individuals (http://www.mandaras 
.info/Fulbe.html). Fulfide (Fulbe), is their language. It is a west-Atlantic language 
(Niger-Kordofanian). 
1.13.1.1.2 Shuwa Arabs 
     Shuwa Arabs are semi-nomadic, agricultural people who are descendants of 
Arab tribes originating from present-day Saudi Arabia (http://encyclopedia2.the 
freedictionary. com / Shuwa+Arab). They are Muslims. The Shuwa Arabs used in 
this study reside in Sadigo, a populated region in Cameroon. They speak Arabic, 
which is an Afro-Asiatic Language (www.Ethnologue.com). 
1.13.1.1.3   Mambila 
The Mambila live on both sides of the Nigeria/Cameroon border, the majority 
living on the Mambila plateau in Nigeria. A smaller number (c.12,000) are found 
in Cameroon, especially on the Tikar Plain (Zeitlyn 1994). The Mambila included 
in this study are from the Somie village. The villagers are self-sufficient in food, 
since they grow several crops including rice, maize, bananas, sweet potato and 
tobacco. They have also grown coffee as a cash crop since the 1960s (Rehfish 
1960). Most people in the village are members of either the Catholic or Protestant 
church. They speak Mambile, which is a member of the Niger-Kordofanian 
language family (www.Ethnologue.com). 
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1.13.1.2  Ethnic groups from Ghana 
1.13.1.2.1   The Asante 
The Asante, also called the Ashanti, are a major ethnic group of the Ashanti 
region in Ghana. They are Twi-speaking Akan people. Twi is a member of the 
Niger-Kordofanian language family. The Ashanti settled in central present-day 
Ghana. The Ashanti make up 19% of the Ghanaian population (~7 million). They 
continue to be influential, although their power has fluctuated since Ghana's 
independence. The majority are Christians (Protestant), with a Muslim minority 
(Crentsil 2007). 
1.13.1.2.2   The Bulsa 
The Bulsa are an ethnic group of about 174,000 people practicing subsistence 
agriculture and cattle holding (Schott 1987). They are from Sandema, the capital 
of the Bulsa district. They speak Buli, a Niger-Kordofanian language. Their main 
religion is Christianity, but there are also Muslims. The Bulsa are a group quite 
distinct from all their neighbours (Schott 1977). 
1.13.1.3  Ethnic groups from Senegal 
1.13.1.3.1   Manjak 
The Manjak people are an ethnic group in Guinea-Bissau. The Manjak also 
have a strong community in Senegal from which the samples used in this project 
were collected. They number 201,000 in Senegal (http://www.joshuaproject.net/ 
people-profile.php). The Manjak language belongs to the Niger-Kordofanian 
language family (www.Ethnologue.com). 
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1.13.2  Central-east African populations 
1.13.2.1  Ethnic groups from Tanzania 
1.13.2.1.1   The Chagga 
The Chagga are the third largest ethnic group in Tanzania (2,000,000 
individuals) (Yakan 1999). They are Bantu-speaking people who migrated into 
the hills of Kilimanjaro from northern Cameroon (Greenberg 1949).  
The Chagga reside on the slopes of both Mount Kilimanjaro and Mount 
Meru, as well as in the Moshi area. The Chaggas included in this study live 
around Mount Kilimanjaro. The climate, as well as successful agricultural 
methods, are reasons for the relative wealth of these people. Another factor that 
gave them an economic advantage over other African population groups is that 
they were one of the first tribes to convert to Christianity (Yakan 1999). The 
Chagga mainly work in agriculture, banana being their main food. But their best 
known export is Arabica coffee, resulting in coffee being a primary cash crop 
(Ehret 2002). 
1.13.3  South-east African populations 
1.13.3.1  Ethnic groups from Malawi 
1.13.3.1.1   Malawi 
Malawi is a south-east African country with various environments. The 
people of Malawi belong to various Central Bantu groups. The Chewa and Nyanja 
group, collectively known as Malawi (or Maravi), make up 58% of Malawi`s 
population. The main language of the Chewa is Nyanja, but the two most spoken 
languages are Chichewa (also called Chewa) and Chitumbuka. These languages 
are members of the Niger-Kordofanian language family (www.ethnologue.com). 
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The Maravi were the first Bantu people to move into present-day Malawi. 
The Chewa live on the Lilongwe plains (Reader 1999), while the Nyanja are 
located in Chikwawa in southern Malawi after migrating there from central Zaire. 
The main religion is Christianity, although the traditions of ancestral worship still 
play an important role for most Nyanja (Ntara 1973). Samples from Malawi in 
this study are from the Chewa. 
1.13.3.2  Ethnic groups from Mozambique 
1.13.3.2.1   Sena 
The Sena are a Mozambican ethnic group, which is prominent in the Zambezi 
valley. There are 1,500,000 individuals. They speak Sena, which is member of the 
Niger-Kordofanian family (www.ethnologue.com). The people of Mozambique 
have managed to retain their small-scale agricultural culture, despite the influence 
of European colonizers and Islamic coastal traders (http://www.theseedcompany. 
org /project/sena-nt). 
1.13.4  East-African populations 
1.13.4.1  Ethnic groups from Ethiopia 
1.13.4.1.1   The Afar 
The Afar are an ethnic group who live in the Afar region of Ethiopia, Eritrea 
and Djibouti (Weeks 1984). They make up 2% of the total Ethiopian population 
(1,300,000), ~10% of whom are urban inhabitants, according to the most recent 
census (2007) http://www.csa.gov.et/pdf/Cen2007_firstdraft.pdf. The Afar 
language is part of the Cushitic branch of the Afro-Asiatic language family. They 
are mainly nomadic-pastoralists and are Muslims. 
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1.13.4.1.2   The Amhara 
The Amhara are mostly farmers inhabiting the north central highlands of 
Ethiopia. They speak the Amhara language which has semetic origin represented 
by sharing alphabet and words with both Hebrew and Arabic. Their language is 
related to other Semitic languages like Gurage (Jenkins 1997). 
     The Amhara are thought to originate from modern-day Yemen. This explains 
their skin colour (olive skin), and their southern Arab features. Their ancestors 
migrated from the Arabian peninsula into Eritrea and Ethiopia (Jenkins 1997). 
The majority of the Amhara are Christian, but around 18% are Muslims. 
1.13.4.1.3   The Anuak 
The Anuak are a river people. They live in villages scattered along the river 
banks of western Ethiopia, in the Gambela region and the rivers of southeastern 
Sudan. They number between 100,000-150,000 http://en.wikipedia.org/wiki 
/Anuak_people. The Anuak are ethnically, historically, religiously and 
linguistically different from most other Ethiopians, and so is their indigenous 
land. The Anuak, unlike other Nilotic people in the region (Nilotic people or 
Nilotes, refers to some ethnic groups in southern Sudan, Uganda, northern 
Tanzania and Kenya, who speak Nilotic languages, a large sub-group of the Nilo-
Saharan languages), who raise cattle, are herdsmen and farmers. 
The Gambela region is tropical and hot with well-watered soil from the 
highland rivers. This difference in geography has separated Ethiopians into 
“lowlanders”, such as the Anuak, and “highlanders,” such as the Amharas (see 
above) and the Oromos (see below). The Anuak and other lowlanders have been 
the victims of discrimination due to their dark skin colour, for they are considered 
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to be black Africans, as opposed to most other highland Ethiopians, who are of 
lighter colour (Collins 1971). 
A recent study based on cluster analysis that looked at a combined sample of 
Amhara and Oromo found that they share 62% of their genome with Caucasians 
(Askenazi Jews, Norwegians and Armenians), 24% with other sub-Saharan 
Africans (Bantus), 8% with Austro-Melanesians (Papua New Guineans) and 6% 
with East Asians (Chinese) (Wilson et al. 2001). The Caucasoid contribution to 
the Ethiopian gene pool was estimated to be >60% (Cavalli-Sforza et al.  1994) 
and occurred predominantly through males (Wilson et al. 2001). Conversely, the 
Niger-Kordofanian contribution to the Ethiopian population occurred mainly 
through females (Quintana-Murci et al. 2010). 
1.13.4.1.4   The Gurage 
The Gurage are an ethnic group in southwest Ethiopia in a semi-mountainous 
region. They make up 2.5% of the total Ethiopian population (1,900,000, of which 
50% are urban dwellers), according to the 2007 national census 
http://en.wikipedia.org/wiki/Gurage_people. 
The Gurage included in this study are from Indibir and Buta Jira. The Gurage live 
a life based on agriculture, involving a complex system of crop rotation and 
transplanting, their main crops include staple crops such as rice and maize (Nida 
2005). 
The Gurage languages, more than other Ethiopian semetic languages, have 
been influenced by Cushitic languages, mainly the Oromo, which is the most 
populous language with 35 million speakers (Shack 1966). More than 50% of the 
Gurage are Christian (Orthodox), while 40% are Muslims (Nida 2005). 
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1.13.4.1.5   The Nuer 
The Nuer are tribes which live in southern Sudan and western Ethiopia. They 
are mainly pastoral people. The Nuer have gradually migrated east into Ethiopia. 
The Nuer included in this study were from the lowlands of Gambela and Akobo. 
It is named after the Akobo River, which flows westwards then north into the Bro 
river, defining Ethiopia`s border with Sudan (Evans-Pritchard 1940). They speak 
Nuer, which is a Nilo-Saharan language (www.ethnologue.com). 
1.13.4.1.6   The Oromo 
     The Oromo are an ethnic group found in Ethiopia, northern Kenya and in parts 
of Somalia (http://en.wikipedia.org/wiki/ Oromo_people). The have migrated into 
Ethiopia from the land of Cush, present-day Nubia. They make up ~35% of 
population groups (30 million), according to the 2007 census 
(http://en.wikipedia.org/wiki/ Oromo_people). Therefore they make up the single 
largest ethnic group in Ethiopia. They are mostly agriculturalists. The language of 
the Oromo is Oromiffa (Afaan Oromo), a Cushitic language belonging to the 
Afro-Asiatic language family (Shinn et al. 2004). Their religions include 
traditional, Christianity and Islam.  
(Bates 1979) contends that the Oromo "were a very ancient race, the 
indigenous stock, perhaps, on which most other peoples in this part of eastern 
Africa have been grafted". (See Figure 9) for the locations from where all sub-
Saharan African samples were collected). 
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Figure 9. Map displaying the geographical locations from where African 
samples were collected 
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1.13.5 The Bantu Expansion 
The Bantu are a diverse group made up of 300-600 ethnic groups. Bantu also 
refers to a large language category. The Bantu language belongs to the Niger-
Kordofanian language family. An example of a Bantu language is Swahili. 
Although it is not a populous language (only 5-10 million speakers), its 
importance lies in that it has been taken up as a second language by millions of 
Africans. 
At present, the majority of Bantus live in southern, central and east Africa. 
This is a result of the Bantu expansion. The Bantu expansion, or migration, was 
the long series of migrations of the ancestors of Bantu speakers (proto-Bantu, or 
pre-Bantu) from what is present-day Nigeria and Cameroon (Clark 1984; Adler 
2007). The exact date of the first migration is unclear, but it is believed to have 
begun after agriculture had already been introduced, which would indicate a date 
around 3000-2500 BC (http://en.wikipedia.org/wiki/ Bantu_expansion).  
This is thought to have resulted in an increase in population size and, 
therefore, increased pressure to expand and cultivate new land. Bantu speakers 
had developed skills in iron-working, which were useful in the manufacture of 
weapons and tools for cutting trees for shifting “slash-and-burn” cereal 
agriculture. These factors lead to an early expansion within west Africa (phases Ι 
and ΙΙ), followed by eastwards and southwards migrations beyond west Africa 
into present day Angola around 1500 BC (phase ΙΙΙ) (Figure 10) (Vansina 1995). 
The Bantu expansion has been considered to be one of the most important human 
migrations within the past thousand years due to the impact of Bantu admixture 
with indigenous populations on genetic variation of modern Africans ( Wood et 
al. 2005; Tishkoff et al. 2007a). 
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Figure 10. The three phases of the Bantu expansion from West Africa. 
 
1.14 Aims 
Because of the implications of expressing functional FMO2, especially in 
regard to drug efficacy and public safety, it was important to assess the 
distribution of the FMO2*1 and FMO2*2A alleles in sub-Saharan Africa, as well 
as the evolutionary relationship among mutations. The role of functional FMO2 in 
the metabolism of xenobiotics, and thus its role in mediating interactions between 
humans and their chemical environment, makes FMO2 a likely target for natural 
selection. 
One aim was to determine whether potentially deleterious SNPs occur on a 
full-length functional FMO2*1 or on a truncated non-functional FMO2*2A 
background.  
Another aim was to estimate the frequency of functional FMO2, and to 
investigate this, samples were initially genotyped for six SNPs reported by the 
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National Centre for Biotechnology information (NCBI) to be present at high 
frequency in Africa, and then resequenced to examine whether other 
nonsynonymous SNPs occur on a full-length background. This will help provide 
insights into the evolutionary history and future of the FMO2 gene.  
A further aim was to determine the evolutionary relationships of the 
mutations, i.e., the order in which they occurred, this was performed using 
network, whereas GeneTree was used to estimate the date to the most recent 
common ancestor (TMRCA) and to date some of the mutatons. 
     FMO2 being an enzyme involved in the metabolism of foreign chemicals, 
makes it a likely candidate for natural selection, therefore FMO2 sequences were 
be tested for evidence of selection. 
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2.  Methods and Materials 
2.1 Selection of samples 
2.1.1  Criteria for selecting samples for genotyping 
Population samples were chosen from throughout Africa (especially sub-
Saharan Africa) on the basis of a high frequency in the population group of the 
full-length allele (FMO2*1), the availability of fifty or more individuals from the 
group and its geographical location. 
2.1.2 Criteria for selecting samples for resequencing 
The samples were chosen according to their genotype for the truncation SNP 
from two ascertainment plates available in the Centre of Genetic Anthropology 
(TCGA) at University College London (UCL). The samples were chosen to 
represent the overall frequency in Africa of both g.23238C and g.23238T FMO2 
alleles. 
2.2 Sample collection 
All sample collection procedures mentioned have been performed by 
individuals other than the author of this Thesis. 
2.2.1 Genotyping samples 
2.2.2 Resequencing samples 
Genomic DNA samples were prepared from mouth swabs taken from 747 
individuals from various populations grouped into east (EA), and west-Africa 
(WA). Signed consent was obtained from all individuals (Available on request). 
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2.2.2.1  West-African ascertainment plate 
The 370 DNA samples included in the plate were chosen to include the 
regions associated with the expansion of the Bantu speaking people throughout 
west-Africa (see Section 1.13.5). 
2.2.2.2 East-African ascertainment plate 
The 377 DNA samples included in the plate were chosen by sampling a north 
east to south west transect across Ethiopia to capture the majority of genetic 
variation based on pairwise FSTs from Y chromosome and mtDNA hypervariable 
region 1 sequence.  
2.3 Genotyping 
2.3.1 Adjusting the concentration of genomic DNA samples 
Genomic DNA samples were electrophoresed through 0.9% agarose gels in 
order to estimate their concentration. The concentration was estimated by 
comparison of the band intensity to a standard curve of DNA concentration. 
Concentrations were adjusted to 1ng/µl by addition of an appropriate volume of 
TE buffer. 
2.3.2 Design of primers for genotyping 
For designing the primers, the software file builder version 3.1, provided by 
Applied Biosystems (ABI), was used. Initially, a target sequence has to be chosen. 
This sequence is preferably 600 bases long, to increase assay design possibilities, 
and contains the target site (SNP) in the center. This target sequence was obtained 
from NCBI, according to the SNP being genotyped. The target sequence was then 
tested for uniqueness. This was performed using the BLAST (Basic Local 
Alignment Search Tool) search provided on the NCBI website to detect regions 
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with sequence similarities and repetitive elements (www.ncbi.nlm.nih.gov 
/BLAST).  
To further test for repetitive elements, the target sequence was run through a 
program called Repeat Masker (www.repeatmasker.genome.washington.edu). All 
ambiguities in the target sequence were then masked by an N. It was important to 
make sure that there were no Ns in close proximity to the target site (SNP site), 
since this would reduce the number of available primers and probes for optimal 
assay selection: http://www.icmb.utexas.edu/core/DNA/Information_Sheets 
/Realtime%20PCR/7900ABDsnp.pdf. The resulting file was then loaded onto file 
builder and was submitted to Applied Biosystems (ABI).  
Samples were genotyped for six common, nonsynonymous FMO2 SNPs, 
which have a high frequency in Africa. Genotyping was performed using TaqMan 
assays designed by ABI (40X assay mix). 
2.3.3 Principle of TaqMan genotyping assay 
     TaqMan assays use the 5` to 3` exonuclease activity of the Taq DNA 
polymerase. Each reaction contains a gene-specific primer and a fluorescently 
labelled TaqMan probe. The probe contains a 5`reporter dye and a 3`quencher 
dye. The 3` end is blocked to prevent extension during PCR. The probe is 
designed to anneal the target sequence between the forward and reverse PCR 
primers. While the probe is intact, the quencher suppresses the fluorescence of the 
reporter dye. During amplification, Taq DNA polymerase cleaves the probe and 
removes it from the target, allowing extension to continue. Scission of the probe 
separates the reporter dye from the quencher dye, resulting in an increase in 
fluorescence (Figure 11). The increased fluorescence only occurs if the target 
sequence is amplified and is complementary to the probe, thus preventing 
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detection of non-specific amplification. For any given cycle, the amount of 
fluorescence signal (amount of product), is directly proportional to the initial copy 
number (http://www.diagnostickits.in/Analytical%20principle.html). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. TaqMan assay diagram 
Polymerization: A fluorescent reporter (R) dye and a quencher (Q) are attached to the 5' and 3' 
ends of a TaqMan probe respectively. 
Strand displacement: When the probe is intact the reporter dye emission is quenched. 
Cleavage: During each extension cycle the DNA polymerase cleaves the reporter dye from the 
probe. 
Polymerization completed: Once separated from the quencher, the reporter dye emits its 
characteristic fluorescence (Hiller 2007). 
Text adapted from Applied Biosystems. 
Graphics courtesy of Molecular Probes. 
 
2.3.4 TaqMan Protocol 
DNA was amplified in 4 µl reaction volumes in 384-well microplates 
containing 2 µl of 1ҳ TaqMan Genotyping Master mix (Applied Biosystems 
(ABI), Warrington UK), 0.74 µl of sterile water, 0.16 µl of MgCl (25 mM), 1 µl 
of 1ng/ µl DNA and 0.05 µl of 80ҳ assay mix (containing probes and primers 
from (ABI). Thermal cycling conditions on the GeneAmp PCR System 9700 
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thermal cycler were as follows: an initial incubation at 95°C for 10 min, to 
activate the Ampli TaqGold enzyme, then 40 cycles of 92°C for 15 sec, to 
denature the double-stranded DNA, and 60°C for 1 min, to anneal primers and 
extend the DNA. An endpoint plate read of the resultant PCR product was 
performed using TaqMan 7900HT software (Applied Biosystems (ABI), 
Warrington UK).          
2.3.4.1 TaqMan genotyping of g.23238 C>T 
TaqMan technology (ABI), was used for the genotyping of g.23238 C>T, as 
well as for the other five SNPs. The primers FMO2-g.23238F, ACTCTATTTCG 
GACCCTGCAA, and FMO2-g.23238R, GCATTTCTGGCTCCTTCCCATT, 
were used to amplify a region of 511 bp containing the c.23238C>T SNP. The 
fluorogenic probes VIC, AGGCGATACTGATAGGAG, and FAM, AGGCGATA 
CTAATAGGAG, were included in the PCR to detect, respectively, the presence 
of a G (C on forward strand) or A (T on forward strand) at position +1414.  
The probes were designed to ensure that if they annealed specifically between 
the forward and reverse primers, this would result in probe degradation by the 
5`nuclease activity of the Taq-polymerase during PCR. Primers for the 
genotyping of the other five SNPs are listed in Table 2. 
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Table 2. Genotyping primers 
 
SNP dbSNP 
Cluster# Forward Primer Reverse Primer VIC FAM 
1)rs2020870 5`AGCCCACTTGCTTTGAGAGAA3` 5`TCACTCTAAAAGAACCCAGAACTTGT3 CTCCTCCAATATCTTCAG TCCTCCAATAACTTCAG 
2)rs2020860 5`GTTACCAACACCAGCAAAGAAATGT3` 5`AGATTTGAAGACCTTATAAAGTCCTAAAAACG3` ATTATGCAGGGAGTTTG TGCAGGAAGTTTG 
3)rs28369860 5`GATGCCTTCTCTGTGTTTCTTCAAG3` 5`TCTAAAGAGTAGGAGACCGGTTAC3` ACAACTGTCCTTAGTTGAGAA AACTGTCCTTAGTGTGAGAA 
4)rs2307492 5`CCATAGCCGCCAATACAAGCA3` 5`TAGGACCACTAACCTTACCCTTTG3` TTTTCCCTCAGATCCAT TTTCCCTCAAATCCAT 
5)rs2020862 5`GCATCCTGGTGATTGGAATGG3` 5`GACAACTCGACTCATTCTTACGAC3` TGAGCCTGAGTTTC CTGAGCCTAAGTTTC 
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2.4 DNA resequencing 
Samples (50 ng of genomic DNA) were sequenced by Macrogen (Rockville, 
Maryland, USA) for all eight coding exons as well as flanking intronic regions of 
the FMO2 gene. The complete sequence of human FMO2, described in the 
National Institute of Environmental Health Sciences (NIEHS) SNP Database in 
fasta format was used as a reference and primers to amplify each exon were 
designed. Sense and antisense primers are described in (Table 3). Primers were 
selected based on the following criteria: GC contents 50% + /-3%, a length of 10-
21 nucleotides. PCR was performed with Platinum polymerase (Invitrogen), with 
an annealing temperature of 55oC as a default. PCR products were sequenced on 
both strands using an Applied Biosystems BigDye Termination Cycle Sequencing 
Kit, version 3.1. Ethanol precipitation was used to remove excess dye. An ABI 
PRISM 3730xl DNA analyzer (Applied Biosystems) was used to analyse the 
eluates (Macrogen).  
     Traces were viewed using Sequencher 49, demo version (http://www.gene 
codes.com/). Since these traces cannot be saved or exported using the demo 
version, sequence scanner v.1 from Applied Biosystems was used as well.  
Sequence traces for each exon and flanking intronic regions were visualized using 
both sequencher v.4.9 and sequence scanner, and checked for the presence of 
SNPs (novel or previously identified), against a reference sequence obtained from 
GenBank (accession number AL021026).  The traces were edited, and low quality 
regions of sequence from each individual were removed. For each exon and its 
flanking intronic regions, the longest stretch of high-quality sequence that was 
available for all individuals was taken for analysis. 
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Table 3. Sense and Antisense Primers for resequencing 
 
Exon Number 
 
Sense Primer Antisense Primer 
Exon 2 
 
5`AAGGCAAGAAGAGAGCAGGA3`  
 
5`GTCTTCACTATAGAACTCTTC3` 
Exon 3 
 
5`GGTAGAGACCTAGGATGCTA3` 
 
5`GTCTCACTCTGAGACAGAGT3 
Exon 4 
 
5`CATGAGGAACCCGCTCTTTCT3` 
 
5`GTCTTCTTGGTCAAACTACAC3` 
Exon 5 
 
5`TTCACTATGCTGCTCAGGCT3` 
 
5`ACGTCACTCGGTACAACTAC3` 
Exon 6 
 
5`CTTAAGGAGCAGCAAACCAC3` 
 
5`CTTTCCGTCCAGCATTAGAG3` 
Exon 7 
 
5`TGACCATAGGCACAGGCATT3` 
 
5`TAAACGTCTATACGACTCC3` 
Exon 8 
 
5`AACCACTAGTCATGGCTGC3` 
 
5`GAGATTGGTGTCTACATCC3` 
Exon 9 
 
5`GACACCAAGCTATGCTTT3` 
 
5`CCGACGAAAAGTACGACACA3` 
 
 
2.5 Data analysis 
2.5.1 Genotyping Data 
2.5.1.1   Haplotype inference 
Haplotypes were inferred using Phase v.2.0 Phase is a statistical algorithm 
that uses a Bayesian method to reconstruct haplotypes from genotype data 
(Stephens et al. 2001). The algorithm initially identifies all unambigous 
haplotypes from homozygote and single-site heterozygote genotypes observed in 
the population sample, and then moves on to inferring all ambiguous haplotypes 
using a Markov chain-Monte Carlo (MCMC) algorithm (see Gilks et al. 1996, for 
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an example). It does so, by repeatedly choosing an individual at random and 
attempts to estimate haplotypes assuming that all other haplotypes are correctly 
reconstructed. The software is freely available at: http://www.stat.washington.edu 
/stephens/phase/download.html, from where I downloaded v.2.0. 
2.5.1.2 Genotypes 
2.5.1.2.1  Hardy-Weinberg equilibrium (HWE) 
The Hardy-Weinberg equilibrium states that both genotype and allele 
frequencies are in equilibrium in a random-mating population. Disturbances to 
this equilibrium are caused by selection, small population size, meiotic drive, 
random genetic drift, gene flow, non-random mating. It is calculated by the 
formula: p2+2pq+q2 = 1, where p is the frequency of the major allele and q = 1-p. 
An online Hardy-Weinberg calculator was used, which is accessible at 
http://www.oege.org/soft ware/hwe-mr-calc.shtml (Rodriguez et al. 2009). This 
calculator also performs the chi-square test (see below) for genotypes. 
2.5.1.2.2  Pearson`s chi-square test 
This test examines a null hypothesis stating that the frequency distribution of 
certain events observed in a sample is consistent with a particular theoretical 
distribution. The events considered must be mutually exclusive and have a total 
probability of 1 (Plackett 1983). All Chi-square goodness of fit tests were 
performed using an interactive chi-square test calculator (Preacher 2001), 
accessible at http://www.people.ku.edu/~preacher/chisq/chisq.htm. 
2.5.1.2.3  Network diagrams 
The mutational relationship among the haplotypes was visualized using both 
the median-joining (MJ), and the reduced-median algorithms of Network. 
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Network is useful for the visualization of reticulation which may indicate 
recurrent mutation, recombination and genotyping errors. The median-joining 
(MJ) algorithm is used for constructing networks from recombination-free 
population data (Bandelt et al. 1999), whereas the reduced-median (RM) 
algorithm is preferential for simple sequences in binary format. Network 
generates diagrams and networks from genetic, linguistic and other data. The 
diagrams are represented as ball and chain diagrams, where the size of the ball is 
proportional to haplotype frequency (Bandelt et al. 1995).  
 
All tests marked with an (*) were performed using DnaSP, version 5. 
All test marked with (#) were performed with Arlequin, version 3.1. 
2.5.2 Resequencing Data 
2.5.2.1   Allele frequencies and haplotype inference*# 
Allele frequencies for each SNP were determined by gene counting, on both 
the full-length (23238C) and truncated (23238T) backgrounds. Haplotypes were 
inferred using three approaches: the Phase algorithm of DnaSP, version 5 
(http://www.ub.es/dnasp/), and the maximum-likelihood approach, using the EM 
(Excoffier et al. 1995) and ELB algorithms of Arlequin (Excoffier et al. 2003). 
DnaSP is a software package for Windows. It can be used to estimate several 
measures of DNA sequence variation between and within populations, as well as 
various statistical tests.  
2.5.2.2 Prediction of the effect of nonsynonymous mutations on function 
The PolyPhen algorithm was used to predict the possible impact of an amino-
acid substitution on the structure and function of a human protein (Xi et al. 2004). 
The predictions are based on the nature of the amino-acid change and the degree 
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of conservation across species. The algorithm performs this by using amino-acid 
sequence alignments and protein structure database information (such as the Uni 
Prot database). The predicted effect is one of the following: benign (no damage); 
possibly damaging; probably damaging; presume definite damage. 
2.5.2.3 Network visualization of haplotypes 
To gain insights into the mutational relationship between haplotypes, the 
median-joining (MJ) and the reduced-median algorithms of Network were used 
(Bandelt et al. 1995; Bandelt et al. 1999) (see Section 2.5.1.2.3). 
2.5.2.4  Statistical tests 
2.5.2.4.1 Fisher`s exact test* 
Fisher`s exact test is used in the analysis of small sample size contingency 
tables. It is called an exact test because the deviation from a null hypothesis can 
be calculated exactly, rather than approximately (Fisher 1922). The test is useful 
for examining the significance of association (contingency) between two kinds of 
categorical classifications. Fisher`s exact test was performed using an online 
server (www.quantitativeskills.com/sisa/statistics/fisher.htm). 
2.5.2.4.2 Four-gamete test* 
The four-gamete test estimates the minimum number of recombination events 
(Rm) by locating pairs of segregating sites that cannot have arisen without either 
recurrent mutation or recombination (Hudson and Kaplan 1985). 
2.5.2.4.3 Pairwise linkage disequilibrium (LD)* 
Linkage disequilibrium is the non-random association of alleles at two or 
more loci, not necessarily on the same chromosome. Linkage describes whether 
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alleles occur more or less frequently in a population than would be expected from 
random haplotype formation. 
Factors which influence the level of linkage disequilibrium are genetic drift, 
non-random mating, population structure, rate of recombination and selection. 
Since the oldest measure of LD, D is of little use for measuring the strength of and 
comparing LD level (Lewontin 1964), another common measure of linkage 
disequilibrium, R2, was used. The measure of R2 is equal to D2 divided by the 
product of the allele frequencies at the two loci. Hill and Robertson deduced that 
E [R2]=1/1=4Nc, where c is the recombination rate in morgans between the two 
markers and N is the effective population size (Hill and Robertson 1968). 
Significant associations between variant sites were identified by using both 
Fisher`s exact test and chi square test (χ2) with a Bonferroni correction for 
multiple comparisons.  
ZnS (Kelly 1997), which is the average of R2 over all pairwise comparisons 
(Hill and Robertson 1968), Za (Rozas et al. 2001), the average of  R2 (Hill and 
Robertson 1968) over all pairwise comparisons between adjacent polymorphic 
sites; ZZ (Rozas et al. 2001) = Za - ZnS; and Wall`s B and Q tests (Wall 1999) 
were calculated using DnaSP. Lower than expected values of ZnS are caused by 
intragenic linked sites that have been subjected to a form of selection. ZZ can be 
used for detecting intragenic recombination (larger positive values of ZZ are 
expected with increasing recombination). Wall`s B and Q tests are used to detect 
balancing selection or population substructure, they do so by detecting events that 
produce trees with relatively longer external branches (Soriano 2008). Confidence 
intervals (95%) for these test statistics were estimated by coalescent-based 
simulations using DnaSP (Librado and Rozas 2009). 
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2.5.2.4.4 Nucleotide diversity (π and θ)* 
Theta and it`s estimates 
Nucleotide diversity is used to measure the degree of polymorphism within a 
population. One measure of nucleotide diversity is Theta. 
Theta (θ) is known as the population mutation parameter. It is estimated from 
the observed number of polymorphic sites using the formula: θ = 4Neµ, where Ne 
is the effective population size and µ  is the neutral mutation rate per locus per 
generation. 
There are several methods of measuring θ from sequencing data (Theta 
estimators). These methods are calculated using different parameters derived from 
the observed diversity and making different assumptions (Jobling et al. 2004), 
including: 
The number of alleles, the number of segregating sites (S), the number of 
singletons (ƞ) (see Sections 2.5.2.4.9 and 2.5.2.4.10, page 56 and 57, 
respectively), the observed homozygosity and the mean number of pairwise 
differences (π) (Jobling et al. 2004), These measures can be represented as θS. 
They should have the same value under neutral evolution.  
 Two of the previous measures of nucleotide diversity were used: The 
observed homozygosity (θ) and the mean number of pairwise differences (π). 
These two measures are calculated from the number of effectively silent sites in a 
sequence. π is calculated by the formula of Nei (1987): π = n(Σxixjπij)/(n-1), 
where n is the number of sequences, xi and xj the frequencies of the ith and jth 
sequences respectively and πij the proportion of different nucleotides between 
them. Standard deviation of π is the square root of the variance of π (Nei 1987) 
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(see above for how to calculate θ). The test statistics used in this Thesis compare 
various Theta estimates based on the number of segregating sites, the pairwise 
number of differences and the number of derived alleles (see below). 
2.5.2.4.5 Tajima`s D statistic* 
Tajima`s D statistic (Tajima 1989) is used to test the neutral theory of 
evolution (Kimura 1983). D measures departure from neutrality reflected in the 
difference between low-and intermediate-frequency alleles. It is based on the fact 
that estimates of the number of segregating sites and the average number of 
nucleotide differences should be correlated under the neutral model. 
2.5.2.4.6 Haplotype diversity and Fu`s Fs statistic* 
Haplotype diversity (H) is a measure of the uniqueness haplotypes in a given 
population. It is calculated as: H = (N/N-1) Σxi2, where N is the size of the 
sample and xi is the frequency of each haplotype in the sample (Nei and Tajima 
1981). Fu`s Fs statistic (Fu 1997) compares the observed number of haplotypes 
with the number expected under the assumption of an infinite-sites model of 
neutral mutation with no recombination.  
2.5.2.4.7 Pairwise number of differences *# and raggedness (r) * 
The pairwise number of differences shows the observed pairwise nucleotide 
differences (also called Roger and Harpending`s mismatch distribution), and the 
expected values in a population with constant size and no recombination and also 
with population growth-decline with free recombination (Rogers  1992). 
     The raggedness statistic is used to detect population expansion by quantifying 
the smoothness of the observed pairwise differences distribution (Harpending 
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1994). Under neutrality, the pairwise differences distribution has ragged peaks, 
which will be smoothed if the population has increased in size. 
2.5.2.4.8 Allele-frequency spectrum* 
The test compares the observed distribution of allelic frequency in a site 
(frequency spectrum) with the expected values in a constant size population 
(Tajima 1989). 
2.5.2.4.9 Fu and Li`s D* and F* tests* 
Fu and Li`s D* and F* test statistics (Fu and Li 1993) compare the observed 
number of singleton polymorphisms (η) with the number expected under a neutral 
model (Kimura 1983). 
2.5.2.4.10 Fu and Li`s D and F test statistics with an outgroup* 
Fu and Li`s D and F test statistics (Fu and Li 1993) are used to test the 
hypothesis that all mutations are selectively neutral (Kimura 1983). The D test 
statistic is based on the differences between ηe, the total number of mutations in 
external branches of the genealogy, and η, the total number of mutations (Fu and 
Li 1993), whereas the F test statistic is based on the differences between ηe, the 
total number of mutations in external branches of the genealogy, and k, the 
average number of nucleotide differences between pairs of sequences. Assuming 
the infinite sites model, DnaSP calculates the total number of mutations in the 
external branches of the genealogy as follows: at a given polymorphic site, the 
number of mutations in external branches is counted as the number of distinct 
singleton nucleotide variants (in the intraspecific data file) that are not shared with 
the outgroup. The total number of mutations in external branches of the genealogy 
is then calculated as the sum of the number of mutations in external branches of 
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every polymorphic site. These tests require polymorphic data as well as data from 
an outgroup. Chimpanzee data was used as an outgroup. 
2.5.2.4.11   Fay and Wu`s H test* 
The H statistic (Fay and Wu 2000) measures departure from neutrality 
reflected in the difference between low-frequency and intermediate-frequency 
alleles. It is based on the differences between two estimators of θ: θpi (or k), the 
average number of nucleotide differences between pairs of sequences, and θH (Fay 
and Wu 2000), an estimator based on the frequency of the derived variants. The 
normalized H statistic is the scaled version of the H statistic (Zeng et al. 2006).  
2.5.2.4.12   McDonald-Kreitman test (MKT)* 
Under the neutral theory of evolution, the ratio of nonsynonymous to 
synonymous mutations within species (PN/PS) is expected to be equal to the ratio 
of nonsynonymous to synonymous mutations between species (Dn/Ds) also called 
(Ka/Ks) (see below). The McDonald-Kreitman test is used for the detection of 
signatures of selection (McDonald and Kreitman 1991). It compares the variation 
at synonymous and nonsynonymous sites within a species with the divergence 
between species.  
2.5.2.4.13 Ka/Ks ratio* 
The Ka/Ks ratio (or ω, dN/dS), is the ratio of the rate of nonsynonymous 
substitutions (Ka) to the rate of synonymous substitutions (Ks). This ratio can be 
used as an indicator of selection acting on a protein-coding gene. The ratio was 
calculated using different methods implemented in three software programs, 
DnaSP, Datamonkey and the Ka/Ks calculator. DnaSP uses the distance-based 
methods of Nei and Gojobori (Nei and Gojobori 1986). This method is a simpler 
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version of the method developed by Miyata and Yasunaga (1980) (Miyata and 
Yasunaga 1980).  
The advantage of this method over others is that it gives accurate results even 
when the per site number of nucleotide substitution is small. Datamonkey 
implements counting methods that count the number of nonsynonymous and 
synonymous substitutions: the fixed effect-likelihood (FEL) method estimates the 
Ka/Ks ratio on a site-by-site basis and the random-effect-likelihood method (REL) 
assumes Ka/Ks rates distributes across sites and then infers the rate at which sites 
evolve (Kosakovsky et al. 2005), whereas the Ka/Ks calculator (Zhang et al. 
2006b) uses various methods, of these, the NG algorithm (Jukes-Cantor Models) 
and maximum-likelihood methods were used.  
The NG algorithm by Jukes and Cantor (1969) (Jukes and Cantor 1969) uses 
the following formula for calculating Ka/Ks: d = 3/4 loge (1-4/3p), where p is 
either pS or pN. The maximum-likelihood method calculates nonsynonymous (Ka) 
and synonymous (Ks) substitution rates by model selection and model averaging. 
This method adopts the Akaike information criterion to measure fitness of data 
and models. This method aims to accurately capture evolutionary patterns in 
DNA-coding sequences (Zhang et al. 2006b). 
2.5.2.5  Testing for purifying selection 
2.5.2.5.1 Gene diversity 
Gene diversity (H) at its most elementary level is represented by differences 
in nucleotide sequences. In diploid organisms it is equivalent to heterozygosity. It 
was estimated according to the formulae of Nei (1987): H = n(1 - Σxi2)/(n – 1), 
where n is the number of gene copies and xi is the frequency of the ith allele (Nei 
1987). 
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A web-based server called SMOGD, v1.2.5 was used to estimate genetic 
diversity (http://www.ngcrawford.com/django/jost/). SMOGD (Software for the 
measurement of genetic diversity) calculates the measures of genetic 
differentiation described by Hedrick (2005) and Jost (2008) (Hedrick 2005; Jost 
2008). Bootstrap calculations of 95% confidence intervals were used to test the 
significance. 
2.5.2.5.2 Genetic distance (FST)# 
Wright`s fixation index (FST) is a measure of population differentiation, 
genetic distance based on differences in SNP allele frequencies in samples. FST is 
the correlation of randomly chosen alleles within a sub-population relative to the 
entire population. A common definition given is by Hudson et al. (1992) (Hudson 
et al. 1992): FST = ΠBetween - ΠWithin/ ΠBetween, where ΠBetween and 
ΠWithin represent the average number of pairwise differences between two 
individuals sampled from the same or different populations. 
2.5.2.6 Time to the most recent common ancestor (TMRCA) 
2.5.2.6.1 GeneTree 
The GeneTree analysis was performed by Dr Charles Allerston of the 
University of Oxford, UK. 
GeneTree, v.9.0 (http://www.stats.ox.ac.uk/griff/software.html) was used to 
estimate the time to the most recent common ancestral sequence (TMRCA) and the 
ages of some of the mutations. GeneTree uses maximum-likelihood coalescent 
analysis (Griffiths and Tavare 1997). The analysis is based on a coalescent model, 
and assumes an infinite-sites model of mutation with no recombination. Under 
this model, it is assumed that mutations occur along ancestral lineages, following 
a Poisson rate of θ/2. θ is the population mutation rate. θ is calculated using the 
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following formula: θ = 4 Neµ , where Ne is the effective population size and µ  is 
the neutral mutation rate per region per generation. The neutral mutation rate µ  
can be calculated using: µ = υgL, where υ is the neutral mutation rate per 
nucleotide per year, g is the generation time in years and L is the number of silent 
sites in the sequence. 
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3. Results and Discussion 
Because of the implications of expressing full-length functional FMO2 (e.g, 
altered therapeutic drug metabolism), it is important to investigate whether any of 
the full-length alleles (23238C) are functional (i.e, do not have any 
nonsynonymous SNPs associated with them), and if so, at what frequency?  
This was investigated by typing African individuals for six SNPs that were at 
high frequency in Africa, including the SNP g.23238C>T (Q472X), which causes 
the truncation of human FMO2. These SNPs were chosen on the basis of their 
high frequency in Africa and it is important to determine whether any of these 
SNPs occur on a full-length background, because of the possible effect on 
function. 
3.1 Typing African individuals for six high-frequency SNPs 
A total of 689 African samples from nine population groups (Table 4) (Bulsa 
n=90, Mambila n=48, Fulbe n=52, Manjak n=94, Sena n=83, Anuak n=109, Nuer 
n=80, Gurage n=83 and Chagga n=50) were genotyped for six SNPs that are at 
high frequency in African populations (Table 5), by TaqMan assay (see Section 
2.3.4). 
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Table 4. The nine African population groups 
Population Group Name of Country Number of Individuals 
 
Fulbe Cameroon 53 
Mambila  50 
Anuak Ethiopia 109 
Nuer  80 
Gurage  83 
Sena Mozambique 83 
Manjak Senegal 94 
Chagga Tanzania 50 
Bulsa** Ghana 90 
 
Table shows the nine population groups from Africa that were genotyped for six high-frequency 
SNPs. It also gives the number of individuals in each group as well as the country of origin. 
Population groups from the same country are color marked. 
 
 
Table 5. The six SNPs and their frequency in Africa 
dbSNP rs # cluster id Position and amino acid 
change  
Frequency in the 
HapMap-Yoruba panel 
rs2020870 g.107A>G (D36G) 0.10 
rs2020860 g.7731T>C (F81S) 0.28 
rs28369860 g.10951delG (V113fsX) 0.21 
rs2307492 g.13693T>C ( F182S) 0.17 
rs2020862 g.13732C>T ( S195L) 0.56 
rs6661174 g.23238C>T (Q472X) 0.83 
 
Table displays the dbSNP rs # cluster id, the position in the gene, the amino acid change and the SNP 
frequency in the HapMap-Yoruba panel.   
 
The genotyping results are shown in Table 6. 
  65
3.1.1 Genotypes 
3.1.1.1   Hardy-Weinberg equilibrium (HWE) 
 Genotypes were tested for deviation from the HWE (Table 6). 
Genotyping revealed that three of the SNPs g.7731T>C (F81S), g.13693T>C 
(F182S) and g.13732C>T (S195L) are in HWE in all nine of the population 
groups, whereas the other three SNPs are in HWE only in some of the population 
groups. The significance of the deviation of genotype frequency from HWE was 
examined using Pearson`s chi-square test. There is one degree of freedom for the 
“within-a-group” test and eight degrees of freedom for the between-groups” test. 
The 5% significance level is 3.84 for one degree of freedom and 15.51 for eight 
degrees of freedom. Significant deviation from HWE is observed for the SNP 
g.107A>G (D36G) in the Mambila (P<0.001), Fulbe (P<0.001) and the Gurage 
(P<0.005).  
      The deviation from HWE in Mambila is caused by a higher number of 
observed heterozygote genotypes, whereas in the Fulbe and Gurage it is caused by 
fewer than expected heterozygote genotypes. The SNP g.10951delG (V113fsX) 
deviated significantly from HWE in Manjak (P<0.005), Gurage (P<0.001) and in 
all population groups combined (P<0.005) due to fewer than expected observed 
heterozygotes.  
The SNP g.23238C>T (Q472X) deviated significantly from HWE due to 
more than expected heterozygotes in Manjak (P<0.05), Nuer (P<0.005) and in the 
Gurage, although not significantly (P>0.05).  
     Most of the deviation from HWE was because of fewer than expected observed 
heterozygote genotypes. The presence of fewer heterozygote genotypes in these 
population groups may be due to inbreeding, which leads to a reduction in 
heterozygotes and an increase in homozygotes (Charlesworth and Charlesworth 
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1987). In an attempt to test whether these results are confined to any geographic 
location, west and east-African genotyping results were pooled and Pearson`s chi 
square test was used to test for any significant differences in the number of 
derived SNP alleles between west and east Africa. Chi square, (χ2 = 1.8) was not 
significantly different between west and east-African populations (P<0.2) (results 
not shown). 
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Table 6. Genotyping results for the nine population groups 
 
  
Ethnic 
Group 
Genotyping 
 
 
g.107A>G    D36G 
A/A A/G G/G   
g.7731T>C    F81S 
T/T  T/C  C/C    
g.10951delG  V113fsX 
G/G  G/-   -/-   
g.13693T>C   F182S 
T/T   T/C  C/C    
g.13732C>T  S195L 
C/C  C/T   T/T  
g.23238C>T  Q472X 
C/C  C/T  T/T 
Bulsa 
(n=90) 
Observed  
Chi-square 
66     9     0  (n=75) 
0.13 
46    39    4  (n=89) 
1.45 
44    29    11    (n=84)     
2.83 
57     29     3    (n=89) 
0.09 
23    41     23  (n=87) 
0.29 
3       21     66  (n=90) 
0.65 
Mambila 
(n=48) 
Observed 
Chi-square 
9   29***  1 (n=39) 
11.91*** 
28   14    5   (n=47) 
2.24 
29     14    5     (n=48) 
2.37 
36      11    1    (n=48) 
0.02 
12    22      12  (n=46) 
0.09 
7      20      23  (n=50) 
0.59 
Fulbe 
(n=52) 
Observed 
Chi-square 
27   6***7   (n=40) 
14.4*** 
30    19   3   (n=52) 
0 
30      18     4   (n=52) 
0.31 
36      16      0  (n=52) 
1.72 
14     19      15 (n=48) 
2.08 
0      18      34  (n=52) 
2.28 
Manjak 
(n=94) 
Observed 
Chi-square 
71    5      1  (n=77) 
3.05 
40    40  10  (n=90) 
0 
36    30**   23 (n=89) 
8.62** 
55       35    3   (n=93) 
0.84 
18    35     19   (n=72) 
0.05 
6      22*    66  (n=94) 
4.15* 
Nuer 
(n=80) 
Observed 
Chi-square 
49 17    0     (n=66) 
1.44 
37    36   7   (n=80) 
0.18 
62      18      0  (n=80) 
1.29 
50      26     3   (n=79) 
0.03 
25    38       17 (n=80) 
0.13 
11  20**    48  (n=79) 
9.75** 
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n in the ethnic group column represents the total number of samples from that ethnic group, whereas the n (italics) in the other columns represents the number of individuals 
of each group who were successfully genotyped for a particular SNP.  
Cases in which a SNP genotype departs significantly from HWE are indicated in red. *P<0.05, **P<0.005 and ***P<0.001. 
Gurage 
(n=83) 
Observed 
Chi-square 
53    13**  6    (n=72) 
9.9** 
38     34    11      (n=85) 
0.58 
66    12***   5    (n=83) 
11.44*** 
75       6      1   (n=82) 
3.67 
22    40    20    (n=82) 
0.05 
14     30      38 (n=82) 
3.27 
Anuak 
(n=109) 
Observed 
Chi-square 
66    27    4      (n=97) 
0.33 
55     43     9     (n=107) 
0.02 
84    24       1    (n=109)  
0.25 
66      34    8  (n=108) 
1.43 
32    57    19  (n=108) 
 0.55 
5  8   55         (n=108) 
1.86 
Chagga 
(n=50) 
Observed 
Chi-square 
38     4     0      (n=42) 
0.11 
19      23      6     (n=48) 
0.06 
34    15      1       (n=50) 
0.2 
31      17    2    (n=50) 
0.03 
14    25     10   (n=49) 
0.04 
2     18      30   (n=50) 
0.12 
Sena 
(n=83) 
Observed 
Chi-square 
57    8      0      (n=65) 
0.28 
43     33       5     (n=81) 
0.16 
47    29      6       (n=82) 
0.27 
43      37    3    (n=83) 
2.16 
20    43     13   (n=76) 
1.52 
3    23      56    (n=82) 
0.11 
Combined 
(n=691) 
Observed 
Chi-square 
435   118   14 (n=567) 
2.97 
336  281     60  (n=677) 
0.01 
432   189*   56  (n=677) 
25.11* 
449 211  24   (n=684) 
0.02 
180 320 148  (n=648) 
0.06 
51   220  416  (n=687) 
7.96 
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3.1.2   SNP frequencies 
Frequencies of the SNPs are shown in Table 7. All the frequency values are 
for the derived allele.  The g.23238C>T (Q472) SNP occurred at high frequency 
in the combined samples (0.77), followed by g.13732C>T (S195L), with a 
relatively high frequency (0.48), whereas the other four SNPs occurred at a 
relatively low frequency, 0.14 and 0.19 respectively for g.107A>G (D36G) and 
g.13693T>C (F182S), the g.10951delG (V113fsX) and the g.7731T>C (F81S) 
SNPs had an intermediate frequency of 0.23 and 0.30, respectively.  
The frequencies of three of the SNPs, g.107A>G (D36G), g.10951delG 
(V113fsX) and g.13693T>C (F182S)), are significantly different (P<0.001), 
(P<0.001) and (P<0.05), respectively, among populations. The g.107A>G 
(D36G) SNP occurs at a higher frequency in the three Ethiopian groups: Nuer, 
Gurage and Anuak, at 0.23, 0.17 and 0.17, respectively, and at an even higher 
frequency (0.40) in a group from Cameroon, the Mambila, whereas the 
g.10951delG (V113fsX) SNP has a higher frequency in five of the population 
groups, Bulsa (0.30), Mambila (0.25), Fulbe (0.32), Manjak (0.43) and Sena 
(0.25). For the g.13693T>C (F182S) SNP, the frequency is significantly lower in 
the Gurage (0.05).  
The frequency of the other three SNPs [g.7731T>C (F81S), (F182S), 
g.13732C>T (S195L) and g.23238C>T (Q472X)] was not significantly different. 
The frequencies of all six SNPs in the combined African populations are 
similar to the frequency reported for the NCBI database in the African-HapMap 
Panel. The frequency of the g.107A>G (D36G) SNP in the combined African 
populations is 0.14, compared with 0.10 in the panel; the frequency of the 
g.7731T>C (F81S) SNP in the combined African population is 0.30, compared 
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with 0.28 in the panel, the frequency of the g.10951delG (V113fsX) SNP in the 
combined African populations is 0.23, compared with 0.21 in the panel; the 
frequency of the g.13693T>C (F182S) SNP in the combined African population is 
0.19, compared with 0.17 in the panel, the g.13732C>T (S195L) SNP frequency 
in the combined African populations is 0.48, compared with 0.56 in the panel; and 
the frequency of the g.23238C>T (Q472X) SNP is 0.77 in the combined African 
populations compared with 0.83 in the panel.  
The results show that these SNPs are not distributed evenly across Africa, 
which might have important implications for the frequency of potentially 
functional FMO2 across sub-Saharan Africa, depending on whether SNPs occur 
on a full-length, 23238C allele or on a truncated, non-functional, 23238T allele.  
3.1.3 Haplotype inference 
Haplotypes were inferred for each of the nine African population groups, but 
only for individuals who had been successfully typed for all of the six SNPs. 
Phase, version 2.1 (see Section 2.5.1.1), both with and without recombination was 
used for inferring haplotypes. Only inferred haplotypes with a confidence value of 
>95% were chosen. The number of high-confidence inferred haplotypes obtained 
was greater when using Phase without recombination than with recombination. 
Therefore results from the former were used. 
Table 8 shows the haplotypes inferred from the Phase analysis of the 
genotypes, and identifies the nucleotide sequence as well as the amino acid 
residues the nucleotides code for.  
The ancestral haplotype at each of the six SNP positions was inferred by 
comparison of FMO2 SNP sequences with the corresponding positions in FMO2 
of chimp and mouse. At all six positions, one of the SNP variants was identical to 
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the nucleotide present in the FMO2 of both chimpanzee and mouse and, thus, was 
considered to be the ancestral form. The inferred ancestral sequence at the six 
SNP positions referred to in Table 8, the pie charts and Network diagrams is 
5’ATGTCC3’.  
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Table 7. SNP frequencies in the African populations 
 
n=number of individuals genotyped. 2n (number of alleles genotyped) was used in calculating the frequency of the derived allele for each SNP. 
SNP, single-nucleotide polymorphism. Significant differences in the derived allele are marked with * (P<0.05) and **(P<0.001). 
 
SNP Frequencies 
Ethnic 
Group 
rs2020870 rs2020860 rs28369860 rs2307492 rs2020862 rs6661174 
g.107A>G        ( D36G) g.7731T>C        ( F81S)   g.10951delG  (V113fsX) g.13693T>C      (F182S) g.13732C>T       (S195L) g.23238C>T      (Q472X) 
No of 
individuals  
Genotyped 
(n) 
No & 
frequency  
of derived 
allele 
No of 
individuals  
genotyped 
(n) 
No & 
frequency  
of derived 
allele 
No of 
individuals  
genotyped 
(n) 
No & 
frequency  
of derived 
allele 
No of 
individuals  
genotyped 
(n) 
No & 
frequency  
of derived 
allele 
No of 
individuals  
genotyped 
(n) 
No & 
frequency  
of derived 
allele 
No of 
individuals  
genotyped 
(n) 
No & 
frequency  
of derived 
allele 
Bulsa  74 9             (0.06) 89 47               (0.26) 84 51           (0.30) 89 35           (0.20) 87 87           (0.50) 90 153             (0.85) 
Mambila  39 31**       (0.40) 47 24               (0.26) 48 24           (0.25) 48 13           (0.14) 46 46           (0.50) 50 66               (0.66) 
Fulbe  40 10           (0.14) 52 25              (0.24) 52 36           (0.32) 52 16           (0.15) 48 49           (0.51) 52 86               (0.83) 
Manjak  77 7             (0.05) 90 60              (0.33) 89 76* *      (0.43) 93 41           (0.22) 72 73           (0.51) 94 154             (0.82) 
Nuer  66 35           (0.23) 80 50               (0.31) 80 18           (0.11) 79 32          (0.22) 80 72          (0.45) 79 116             (0.73) 
Gurage  72 25           (0.17) 85 56              (0.34) 83 22           (0.13) 82 8*           (0.05) 82 80           (0.49) 82 106             (0.64) 
Anuak  97 35           (0.18) 107 61              (0.29) 109 26          (0.12) 108 50           (0.23) 108 95          (0.44) 108 158            (0.73) 
Chagga  42 4             (0.05) 48 35               (0.36) 50 17           (0.17) 50 21          (0.21) 49 45          (0.46) 50 78               (0.78) 
Sena  65 8             (0.06) 81 43               (0.27) 82 41           (0.25) 83 43          (0.26) 76 69          (0.45) 82 135             (0.82) 
Combined 572 164         (0.14) 679 401             (0.30)               677 311         (0.23) 684 259         (0.19) 648 616         (0.48) 687 1052          (0.77) 
Chi2 (df=8) 37.3** 1.8 31.3** 16.5* 3.64 1.43 
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Table 8. Haplotypes inferred from Phase analysis of genotypes 
 Haplotype Number DNA Protein 
                    1 (Ancestral) ATGTCC DFVFSQ 
2 ATGCCT DFVSSstop 
3 AC-TTT DS-FLstop 
4 ATGTTT DFVFLstop 
5 ATGTCT DFVFSstop 
6 GTGTTT GFVFLstop 
7 AT-TTT DF-FLstop 
8 ACGTCT DSVFSstop 
9 ACGTTT DSVFLstop 
10 ACGTCC DSVFSQ 
11 GCGTTT GSVFLstop 
12 ATGCCC DFVSSQ 
13 ATGTTC DFVFLQ 
14 ACGCCT DSVSSstop 
15 AT-CCT DF-SSstop 
16 AT-TCC DF-FSQ 
17 GTGTTC GFVFLQ 
18 GCGTTC GSVFLQ 
19 AC-TCT DS-FSstop 
20 GCGTCC GSVFSQ 
21 GC-TTT GS-FLstop 
22 AT-TTC DF-FLQ 
23 GCGTTC GSVFLQ 
24 GTGTCC GFVFSQ 
25 GTGCCT GFVSSstop 
26 AC-TTC DS-FLQ 
27 ACGCCC DSVSSQ 
28 GT-TCC GF-FSQ 
29 GTGTCT GFVFSstop 
30 AT-TCT DFVFSstop 
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Haplotype frequencies were estimated by counting.  
Table 9 shows the frequency of the Phase-inferred haplotypes in the nine 
African populations. The haplotype frequencies were tested for significant 
differences among population groups. The significantly different values are 
marked with an asterix. It was not possible to calculate the chi-square values for 
some of the haplotypes, since there were many zero values and the expected 
values were below 5. For others, such as haplotype 2, groups with zero were 
excluded and the degrees of freedom adjusted accordingly. In Table 9, the 
haplotypes are listed from top to bottom, according to their frequency in the total 
population sample.  
The results showed that six haplotypes, 1 (ancestral), 2, 3, 4, 5 and 6, are 
present at relatively high frequency in some of the population groups. Haplotypes 
1 (ancestral), 4 and 5 are present in all groups, but at different frequencies. 
Haplotype 2 is not observed in Gurage, whereas haplotype 3 is not observed in 
Nuer and haplotype 6 is not observed in Fulbe.  
Another five haplotypes are present at moderate frequency in some population 
groups: haplotypes 7, 8, 9, 10 and 11.  These eleven haplotypes make up 0.93 of 
all haplotypes observed. A few haplotypes were observed in only one of the 
groups: haplotype 17 in Gurage, haplotype 18 in Nuer and haplotype 20 in Anuak, 
whereas other haplotypes were individual-specific: haplotypes 22 and 23 in 
Mambila, haplotype 24 in Sena, haplotypes 25 and 29 in Fulbe, haplotype 26 in 
Sena, haplotype 27 in Nuer, haplotype 28 in Manjak and haplotype 30 in Bulsa. 
All of the group–specific haplotypes occur at a low frequency. 
Pie charts displaying the haplotype frequencies in each of the population 
groups are shown in Figure 12. The charts indicate that there are differences in 
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haplotype frequencies among the groups. The haplotypes have been sorted 
according to frequency.  
The frequencies of haplotypes 1 (ancestral), 2, 3, 5 and 6 were significantly 
different between groups. The significant difference in haplotype 1 (ancestral) is 
due to the higher than expected frequency in Mambila (0.35, P<0.05), for 
haplotype 2 it is caused by the absence of the haplotype in Gurage and by lower 
than expected frequency in Mambila (0.06, P<0.01), whereas for haplotype 3 it is 
due to the frequency ranging from as low as 0.00 in Nuer and 1 and 0.02 in Anuak 
and Chagga respectively, to a higher than expected frequency of 0.29 in Manjak 
(P<0.001). The significant difference in the frequency of haplotype 5, however, is 
due to the higher than expected frequency in Gurage and Nuer, 0.24 and 0.21, 
respectively (P<0.001). Haplotype 6 has a significantly higher than expected 
frequency in Anuak (0.15, P<0.001). The results indicate that haplotype 1 
(ancestral) has a relatively high frequency in all population groups, which 
suggests that the frequency of potentially functional FMO2 may be high across 
sub-Saharan Africa. Interestingly, the other haplotypes that had a significantly 
different frequency, haplotypes 2, 3, 5 and 6 are all non-functional. These 
differences in non-functional haplotype frequencies may be explained by the  
23238T allele accumulating other mutations in different regions and therefore 
resulting in these differences. 
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Table 9. Haplotype number and frequency in the African Populations 
  
Haplotype ID  
 
Anuak   (n=108) Gurage  (n=72) Bulsa  (n=106) Fulbe     (n=50) Chagga (n=48) Manjak   (n=106) Sena    (n=110) Mambila    (n=72) Nuer      (n=66) Total    (n=738) Chi Square 
1 24                0.22 8                 0.11 14              0.13 8                0.16 6                0.13 22                  0.21 18              0.16 25*                 0.25 5                 0.08 n=130      0.176 16.4* 
2 23                0.22 0*               0.00 25              0.24 5                 0.10 8                0.17 20                  0.19 26              0.24 4*                   0.06 8                0.12 n=119      0.161 24** 
3 1*                 0.01 3                 0.04 20              0.19 13              0.26 1*               0.02 31*                 0.29 26              0.24 22                   0.31 0*               0.00 n=117      0.158 54.9*** 
4 13                0.12 6                 0.08 25              0.24 12              0.24 9                0.19 14                   0.13 22               0.20  8                     0.11 7                0.11 n=116      0.157   7 
5 6                   0.06 17*             0.24 12              0.11 9                0.18 5                0.10  6                    0.06 9                 0.08 6                     0.08 14*            0.21 n=84        0.114 42*** 
6 16 *              0.15 7                 0.10 2                0.02 0                 0.00 2                 0.04 2                     0.02 3                 0.03 5                   0.074 7                 0.11 n=44          0.06 39.6*** 
7 7                   0.06 4                 0.06 2                0.02 0                 0.00 7                0.15 2                     0.02 0                 0.00 0                     0.00 7              0.00 n=29          0.04 N/A 
8 2                   0.02 7                 0.10 0                0.00 0                 0.00 1                 0.02 0                     0.00 0                 0.00 0                     0.00 7                0.11 n=17          0.23 N/A 
9 4                   0.04 0                 0.00 0                0.00 1                 0.02 3                 0.06 1                     0.01 1                 0.01 0                     0.00 2                 0.03 n=12          0.16 N/A 
10 2                   0.02 5                 0.07 0                0.00 0                 0.00 3                 0.06 0                     0.00 0                 0.00 0                     0.00 0                 0.00 n=10          0.13 N/A 
11 4                   0.04 5                 0.07 0                0.00 0                 0.00 1                 0.02 0                     0.00 0                 0.00 0                     0.00 0                 0.00 n=10          0.13 N/A 
12 0                   0.00 3                 0.04 1                0.01 0                 0.00 0                 0.00 0                     0.00 1                 0.01 0                     0.00 2                 0.03 n=7            0.01 N/A 
13 0                   0.00 4                 0.06 0                0.00 0                 0.00 0                 0.00 0                     0.00 0                 0.00 0                     0.00 2                 0.03 n=6          0.008 N/A 
14 2                   0.02 0                 0.00 0                0.00 0                 0.00 2                 0.04 0                     0.00 0                 0.00 0                     0.00 1                 0.02 n=5          0.007 N/A 
15 2                   0.02 0                 0.00 0                0.00 0                 0.00 0                0.00 3                     0.03 0                0.00 0                     0.00 0                 0.00 n=5          0.007 N/A 
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Haplotype 1 is the ancestral haplotype, n=number of alleles. Haplotypes are listed from top to bottom according to frequency. Significant differences are marked with * 
P<0.05, **P<0.01, ***P<0.001. 
 
 
16 0                   0.00 0                 0.00 1                0.01 0                 0.00 0                 0.00 3                     0.03 1                 0.01 0                     0.00 0                 0.00 n=5          0.007 N/A 
17 0                   0.00 3                 0.04 0                0.00 0                 0.00 0                 0.00 0                     0.00 0                 0.00 0                     0.00 0                 0.00 n=3          0.004 N/A 
18 0                   0.00 0                 0.00 0                0.00 0                 0.00 0                 0.00 0                     0.00 0                 0.00 0                     0.00 3                  5% n=3          0.004 N/A 
19 0                   0.00 0                 0.00 2                0.02 0                 0.00 0                 0.00 0                     0.00 1                 0.01 0                     0.00 0                 0.00 n=3          0.004 N/A 
20 2                   0.02 0                 0.00 0                0.00 0                 0.00 0                 0.00 0                     0.00 0                 0.00 0                     0.00 0                 0.00 n=2          0.003 N/A 
21 0                   0.00 0                 0.00 1                0.01 0                 0.00 0                 0.00 1                     0.01 0                 0.00 0                     0.00 0                 0.00 n=2          0.003 N/A 
22 0                   0.00 0                 0.00 0                0.00 0                 0.00 0                0.00 0                    0.00 0                 0.00 1                     0.01 0                 0.00 n=1          0.001 N/A 
23 0                   0.00 0                 0.00 0                0.00 0                0.00 0                0.00 0                    0.00 0                 0.00 1                     0.01 0                 0.00 n=1          0.001 N/A 
24 0                   0.00 0                 0.00 0                0.00 0                0.00 0                0.00 0                    0.00 1                 0.01 0                     0.00 0                 0.00 n=1          0.001 N/A 
25 0                   0.00 0                 0.00 0                0.00 1                 0.02 0                0.00 0                    0.00 0                 0.00 0                     0.00 0                 0.00 n=1          0.001 N/A 
26 0                   0.00 0                0.00 0                0.00 0                0.00 0                0.00 0                   0.00 1                 0.01 0                     0.00 0                 0.00 n=1          0.001               N/A              
27 0                   0.00 0                0.00 0                0.00 0                0.00 0                0.00 0                   0.00 0                 0.00 0                     0.00 1                 0.02 n=1          0.001 N/A 
28 0                   0.00 0                0.00 0                0.00 0                0.00 0                0.00 1                     0.01 0                 0.00 0                     0.00 0                 0.00 n=1          0.001 N/A 
29 0                   0.00 0                0.00 0                0.00 1                 0.02 0                0.00 0                   0.00 0                 0.00 0                     0.00 0                 0.00 n=1          0.001 N/A 
30 0                   0.00 0                0.00 1                0.01 0                 0.00 0                0.00 0                   0.00 0                 0.00 0                     0.00 0                 0.00 n=1          0.001 N/A 
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Figure 12. Phase-inferred Haplotype Frequency Pie Charts 
                                                                                     
                     Anuak n=108                                 Gurage n=72                                  Bulsa n=106 
                                                          
                        Fulbe n=50                                  Chagga  n=48                                Manjak n=106 
                                                                             
  Sena n=110        Mambila n=72               Nuer  n=66 
1 (ancestral)
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17-30
 
Each pie chart represents the 
frequency of haplotypes in a 
population. n=number of alleles. 
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3.1.4 Impact of SNPs on a23238C allele background 
Because of the implications of expressing functional FMO2 (i.e., altered drug 
metabolism), it is important to estimate the proportion of 23238C alleles that are 
associated with a nonsynonymous SNP. Studies have shown that two of the five 
SNPs, g.10951delG (V113fsX) and g.13732C>T (S195L), cause loss of function 
(Furnes et al. 2003; Krueger et al. 2005), whereas the effect of the other three is 
unknown.         
Table 10 shows the number of full-length, 23238C, and truncated, 23238T, 
alleles. For each of the five SNPs, the proportion of truncated alleles on which the 
SNP occurs is greater than the proportion of full-length alleles. 
It is expected that the truncated 23238T alleles will accumulate more 
nonsynonymous mutations because it is a null-allele and therefore there is a 
relaxation in the selective constraint (no purifying selection). 
The results indicate that the frequency of potentially functional FMO2 may 
be high across sub-Saharan Africa. The frequencies displayed in Table 11 are the 
percentage of full-length, 23238C, and truncated, 23238T, alleles on which a 
derived SNP allele is present. For this calculation, haplotypes of individuals who 
had been genotyped for all six SNPs were inferred by Phase (see Tables 8 and 9). 
To examine the percentage of full-length 23238C, and truncated, 23238T alleles 
on which one of the derived alleles of the five other SNPs [(g.107A>G (D36G), 
g.7731T>C (F81S), g.10951delG (V113fsX), g.13693T>C (F182S) and 
g.13732C>T (S195L)] occur, first the total number and proportion of the derived 
alleles for each SNP were calculated by adding all haplotypes that contain the 
derived SNP allele and dividing the resulting number by the total number of 
successfully typed alleles. Second the number of full-length 23238C alleles that 
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have a SNP present was counted using the haplotype data in Table 9, and the 
proportion is calculated by dividing the number of full-length 23238C alleles on 
which the derived allele for a SNP is present by the number of total full-length 
23238C alleles. This was repeated for each of the five SNPs. For the g.107A>G 
(D36G) SNP for example, the total number of derived alleles is 69, this number is 
the sum of all 11 haplotypes (6, 11, 17, 18, 20, 21, 23, 24, 25, 28 and 29) that 
contain the derived allele of the SNP.  The proportion is calculated by dividing 69 
by 738, which is the total number of successfully typed alleles. Out of the 69 
derived alleles, 11 are present on full-length 23238C alleles. The proportion is 
calculated by dividing 11 by the total number of full-length alleles, 171. The same 
is repeated for the truncated, 23238T alleles. 
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Table 10. Number of full-length and truncated haplotypes in each population 
group 
 
 
Numbers display the number of haplotypes in each population group that have a C or T at the 
g.23238C>T (Q472X) locus. 
 
Table 11. Proportion of 23238C and 23238T alleles on which a nonsynonymous 
SNP is present 
SNP  
Amino acid 
change 
Effect on 
function 
Total number 
and 
proportion of 
derived allele 
Number and 
proportion of 
full-length 
alleles on which 
SNP is present 
Number and 
proportion of 
truncated 
alleles on which 
SNP is present 
g.107A>G            
(D36G) 
(Effect 
unknown) 
69             0.09 11                 0.06  58               0.10 
g.7731T>C          
(F81S) 
(Effect 
unknown) 
184          0.25 18                0.11 166              0.29 
g.10951delG   
(V113fsX) 
(Loss of 
function) 
164          0.22 8                   0.05 156              0.28 
g.13693T>C       
(F182S) 
(Effect 
unknown) 
138          0.19 8                   0.05 130              0.23 
g.13732C>T       
(S195L) 
(Loss of 
function) 
345          0.47 8                   0.05 337              0.59 
 
Total number of 23238C alleles=171 
Total number of 23238T alleles=567 
Total number of alleles=738. 
Population group 
Haplotype Anuak Gurage Bulsa Fulbe Chagga Manjak Sena Mambila Nuer All  
23238C 
Full-length 
28 23 16 8 9 26 22 26 13 171 
23238T 
Truncated 
80 49 90 42 39 80 88 46 53 567 
Total 108 72 106 50 48 106 110 72 66 738 
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The results show that each of the five SNPs can occur on a 23238T or a 
23238C allele background. However, for each SNP, the proportion of 23238C 
haplotype backgrounds on which it occurs is relatively low (0.05-0.11). 
In an attempt to estimate the frequency of potentially functional FMO2 in each 
of the nine population groups (i.e., haplotypes that contain none of the other five 
SNPs i.e., the ancestral haplotype) the frequency of total 23238C alleles (ancestral 
+ all others with nonsynonymous SNPs associated) was estimated for each 
population group (Table 12). In Anuak, for example, the total number of alleles 
(both full-length 23238C and truncated 23238T alleles) was 108, the total number 
of full-length 23238C alleles (both functional ancestral and full-length with 
nonsynonymous SNPs associated) was 28 and out of these, 24 were on ancestral 
haplotypes, i.e, contained none of the five nonsynonymous SNPs. 
 To estimate the frequency of full-length 23238C alleles, the total number of 
23238C alleles (28) was divided by the number of total alleles (108), which 
resulted in a frequency of 0.26. This was repeated for each of the nine population 
groups. As for the numbers and frequencies in the third column of Table 12, they 
represent the number of ancestral (functional) 23238C alleles and the frequency 
was calculated by dividing the number of functional 23238C alleles (24), by the 
number of total 23238C alleles (28), which resulted in a frequency of 0.86. 
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Table 12. Frequency of expected potentially functional FMO2 in the African   
                                                 Populations 
 
 
*Chi-square=25.4, P<0.001. DF=8 
#Chi-square=35.7, P<.0.001. DF=8 
DF, Degrees of freedom. 
Numbers in brackets are the 95% confidence intervals calculated using an online calculator 
available at: http://www.dimensionresearch.com/resources/calculators/conf_prop.html. 
Population Group 
Number of total alleles 
Number of full-
length C alleles and 
their frequency 
Number of C alleles that encode a   
potentially functional FMO2  
 Frequency of full-length          Frequency of total  
Anuak                             108 28  [0.18-0.34]   (0.26) 24               (0.86) (0.22) 
Gurage                              72 23  [0.21-0.43]   (0.32) 8                 (0.35) (0.11) 
Bulsa                               106 16  [0.08-0.22]   (0.15) 14               (0.88) (0.13) 
Fulbe                                 50 8*  [0-0.06]        (0.02) 8                 (1.00) (0.16) 
Chagga                              48 9    [0.08-0.30]   (0.19) 6                 (0.67) (0.13) 
Manjak                           106 26  [0.17-0.33]   (0.25) 22               (0.85) (0.21) 
Sena                                 110 22  [0.12-0.27]   (0.20) 18               (0.82) (0.16) 
Mambila                           72 27  [0.27-0.49]   (0.38) 25               (0.93) (0.35) 
Nuer                                  66 13  [0.10-0.30]   (0.20) 5#               (0.38) (0.08) 
In all groups combined 738      172                     (0.23) 130             (0.76) (0.18) 
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The groups with the highest frequency of potentially functional 23238C 
alleles, compared with the total number of alleles in a population, were Mambila, 
Anuak and Manjak, with a frequency of 0.35, 0.22 and 0.21, respectively. The 
group with the lowest frequency was Nuer, with a frequency of 0.08.  The 
proportion of the full-length (23238C) alleles in each group that is expected to be 
potentially functional was observed to be high in most of the groups, reaching 
values of 1.00 in Fulbe and 0.93 in Mambila (Table 12). It was interesting to note 
that Gurage and Nuer had a relatively low frequency, 0.35 and 0.38, respectively.     
Recombination could result in the five SNPs occurring on a 23238C allele 
background in these groups, which might explain the relatively low frequency of 
potentially functional FMO2 observed in some of these groups. The number of 
23238C alleles that encode a potentially functional FMO2 is significantly 
different among groups (P<0.001). The frequency of potentially functional 
FMO2, in comparison with total alleles in each population group, was 
significantly different among groups (P<0.001) (Table 12). The results show that 
the frequency of potentially functional FMO2 is relatively similar in west and east 
Africa, 0.19 and 0.15, respectively (results not shown).  
     These results are similar to those of Veeramah et al. (Veeramah et al. 2008), in 
regards to the frequency of the FMO2*1 allele being high and relatively uniform 
across sub-Saharan Africa, but, interestingly, in contrast, the frequency of 
potentially functional 23238C haplotypes is significantly different across sub-
Saharan Africa. This is an important finding since the study of Veeramah et al. 
only looked at the frequency of full-length 23238C alleles across sub-Saharan 
Africa, but did not determine whether these alleles have any nonsynonymous 
SNPs associated with them, which if present, would render the full-length alleles 
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nonfunctional. My results indicate that a high proportion of full-length 23238C 
alleles are potentially functional since they do not have any of the five 
nonsynonymous SNPs associated. This was further examined by resequencing, to 
test for the presence of other nonsynonymous SNPs. 
3.1.5   Visualization of haplotypes using Network 
The inferred haplotypes were input into Network to gain insights into the 
mutational relationship of the SNPs. The reduced-median algorithm was used, 
since all the SNPs were in the binary form. An input file was created for each of 
the nine population groups separately and one with all the groups combined. 
Figure 13 displays the mutational relationship among haplotypes in the combined 
African groups. As the diagram shows, mutations occur on both an ancestral allele 
background (23238C) as well as on the 23238T allele background. Some 
population groups like the Anuak and Gurage, for example, have a more 
complicated Network diagram compared with the one for some of the other 
groups, like the Mambila, for example. This could be due to a number of reasons, 
including recurrent mutations, recombination and genotyping errors. Genotyping 
errors can be reasonably excluded, since the individuals in question fall into the 
middle of a called cluster. Furthermore, genotyping was repeated several times, 
with the same result.  
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Figure 13. Network diagram for the combined African Populations. This diagram 
indicates that one of the five nonsynonymous SNPs, g.7731 T>C (F81S) occurs on a 23238C 
background, whereas the other four occur on a 23238T background, i.e, after the g.23238C>T (Q472X) 
SNP. The identity and number of haplotypes are shown in the legend. 
 
    
Haplotype  id Haplotypes Frequency 
A ATGTCC 130 
2 ATGCCT 119 
3 AC-TTT 117 
4 ATGTTT 116 
5 ATGTCT 84 
6 GTGTTT 44 
7 AT-TTT 29 
8 ACGTCT 17 
9 ACGTTT 12 
10 ACGTCC 10 
11 GCGTTT 10 
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     The results indicate that the frequency of potentially functional FMO2 is high 
in sub-Saharan Africa and that linked SNPs mostly occur on a 23238T allele 
background. The low frequency of occurrence of SNPs on a 23238C allele 
background could be explained by recombination causing mutations to be 
associated with a 23238C allele. The Network diagram (see Figure 13) indicates 
that the five nonsynonymous SNPs mostly occur on a 23238T allele background, 
i.e, after the g.23238C>T (Q472X) SNP, and that when these SNPs are observed 
on a 23238C allele background, it is at low frequency as observed in Figure 13, 
where the SNP g.107A>G (D36G) occurs on a 23238C allele background only 
once (haplotype 18). This is further supported by the SNPs occurring at high 
frequency on a 23238T allele background and if they do occur on a 23238C allele 
background, they do so at low frequency as a result of recombination.  
It is important to determine whether any other nonsynonymous SNPs occur 
on a 23238C allele background, therefore resequencing was performed. In 
addition, this will provide insights into the evolutionary history of FMO2 and will 
make available data for testing for evidence of natural selection at the FMO2 
locus. 
3.2 FMO resequencing data 
The genotype of individuals with respect to the g.23238C>T (Q472X) 
mutation had to be determined before performing resequencing since a sample of 
individuals had to be chosen that represents the proportion of 23238C and 23238T 
alleles in Africa. Individuals were chosen from two African (west and east) 
ascertainment plates (see Sections 2.2.2.1 and 2.2.2.2).  
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3.2.1 23238C→T genotyping 
Of the 747 individuals in the two ascertainment panels, 336 had been 
previously genotyped for g.23238C>T (dbSNP #rs6661174) by Dr. Krishna 
Veeramah of UCL. The remaining 411 samples were genotyped by me using 
TaqMan assays (see Section 2.3.4.1 for methods and Table 13 for genotyping 
results). Genotyping results showed that for both ascertainment plates all three 
genotypes (23238C homozygotes, 23238T homozygotes and 23238C/T 
heterozygotes) are in HWE.   
None of the three genotypes had a significantly different frequency when the two 
ascertainment plates were compared (P<0.4). 
Of the 747 DNA samples from both west and east Africa, 12 homozygotes for 
the full-length FMO2*1 allele (CCs) and 12 homozygotes for the truncated 
FMO2*2A allele (TTs) were chosen randomly from both the west- and east-
African ascertainment plates. The resequencing samples do not reflect the 
frequency of the full-length (FMO2*1) allele in either west or east Africa. To 
reflect the overall frequency of the 23238C alleles in the west- and east- African 
panels (0.21 and 0.18, respectively, with an average of ~0.20), the number of 
23238C alleles in the resequencing sample should be reduced to 6 alleles, in 
comparison with the 24 23238T alleles.  
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Table 13. 23238C→T genotyping results for individuals from African 
ascertainment plates 
 
Ascertainment 
plate 
Total 
number of 
individuals 
23238C 
homozygotes 
23238T 
homozygotes 
23238 C/T 
heterozygotes 
Undetermined 
West Africa 370 14 215 126 15 
East Africa 377 10 243 114 10 
 
There is no significant difference in genotype frequencies between plates (P<0.4). 
3.2.2  FMO nucleotide sequence variation 
Forty-eight African DNA samples, 24 23238C and 24 23238T homozygotes, 
were resequenced for all eight coding exons and flanking intronic sequences of 
FMO2. In total, 4705 bp of the human FMO2 gene were sequenced comprising 
1605 bp of coding sequence, from exons 2 to 9 (535 codons, including the stop-
codons in exons 6 and 9) and 3100 bp of intronic and 5`- and 3`-untranslated 
region. 
The sequencing resulted in the identification of 32 variants. No novel SNPs 
were discovered. There were 8 transversions, 23 transitions and 1 
insertion/deletion variants. Eighteen were in the coding region, of which 12 were  
nonsynonymous: in exon 2, g.107A>G (Asp→Gly change at amino acid residue 
36; in exon 3, g.7695T>A (Phe→Tyr change at residue 69), g.7731T>C 
(Phe→Ser change at residue 81); in exon 5, g.13693T>C (Phe→Ser change at 
residue 182), g.13732C>T (Ser→Leu change at residue 195); in exon 6, 
g.18237G>A (Arg→Gln change at residue 238), g.18269C>T (Arg→Stop-codon 
at residue 249); in exon 7, g.19679A>G (Glu→Gly change at residue 314; 
g.19910G>C (Arg→Thr change at residue 391); in exon 8, g.22060T>G 
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(Asn→Lys change at residue 413); in exon 9, g.23115A>C (Asn→Thr change at 
residue 431), g.23238C>T (Gln→Stop-codon at residue 472).  
One causes a frame shift: in exon 4, g.10951delG (Val→Stop-codon at 
residue 113), and 5 were synonymous: in exon 5, g.13733G>A (Ser→Ser at 
residue 195), in exon 7, g.19910G>C (Ala→Ala at residue 367), in exon 8, 
g.22027G>A (Glu→Glu at residue 402), in exon 9, g.230087A>G (Gly→Gly at 
residue 421) and g.23300A>G (Lys→Lys at residue 492). 
For the combined samples, there were two singletons: g.18269C>T (R249X) 
in exon 6, and g.19679A>G (E314G) in exon 7, and three doubletons: g.7695T>C 
(F69Y) in exon 3, g.10951delG (V113fsX) in exon 4 and +18559T>C in intron 6. 
The numbers of singletons and doubletons increased slightly when individual 
population groups were considered separately.  
For the west-African samples the number of singletons was one, with four 
doubletons, whereas for east-Africans there were three singletons and two 
doubletons. As for the samples grouped according to expression of a full-length 
(23238C) allele, or truncated (23238T) allele, there were two singletons and five 
doubletons for the 23238C alleles and three singletons and three doubletons for 
the 23238T alleles. The number of singletons and doubletons in each population 
was tested for deviation from a neutral model of evolution, using Fu and Li`s D* 
and F* test statistics (see Section 3.2.9.6)  .  
The FMO2 chimp sequence was used as a reference to infer the ancestral state 
of each of the human diallelic SNPs (Table 14). In almost all cases, the more 
common human variant corresponded to the inferred chimp allele, except for 
g.23238C>T (Q472X), in exon 9.  
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There were five nonsynonymous SNPs [other than g.23238C>T (Q472X)] 
that occurred at relatively high frequency in the combined African sample, 
g.13693T>C (F182S) (0.09) and g.13732C>T (S195L) (11%) in exon 5, 
g.18237G>A (R238Q) (0.09) in exon 6, g.19910G>C (R391T) (13%) in exon 7 
and g.22060T>G (N413K) (0.17) in exon 8. Haplotypes had to be inferred for 
further analysis. 
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Table 14. SNP alleles and their frequencies 
 
 
DbSNP #             Positiona Amino acid 
changeb 
Number and 
frequency of 
derived  alleles 
(Combined 
samples) n=96 
Number and  
frequency of 
derived  alleles 
(West Africa) n=48 
Number and  
frequency of 
derived  alleles 
(East Africa) 
n=48 
Number and  
frequency of 
derived  alleles  on a 
23238C background 
 n=48 
Number and  
frequency of 
derived  alleles on a 
23238T background 
 n=48 
rs2020870       (g.107A>G) (D36G) 6              (0.06) 2                 (0.04) 4           (0.08) 4                 (0.08) 2                 (0.04) 
rs6657314         (+251T>C)  7              (0.07) 3                 (0.06) 4           (0.08) 2                 (0.04) 5                 (0.10) 
rs28369800       (+409C>T)  13            (0.14) 7                 (0.15) 6           (0.13) 8                 (0.17) 5                 (0.10) 
rs28369551     (+7586C>T)  11            (0.11) 4                 (0.08) 7           (0.15) 6                 (0.13) 5                 (0.10) 
rs28745274    (g.7695T>A) (F69Y) 2              (0.02) 2                 (0.04) 0           (0.00) 2                 (0.04) 0                 (0.00) 
rs2020860      (g.7731T>C)  (F81S) 12            (0.13) 5                 (0.10) 7           (0.15) 6                 (0.13) 6                 (0.13) 
rs16864165     (+7883T>A)  13            (0.14) 6                 (0.13) 7           (0.15) 7                 (0.15) 6                 (0.13) 
rs28369860  (g.10951delG)  (V113fsX) 2              (0.02) 0                 (0.00) 2           (0.04) 2                 (0.04) 0                 (0.00) 
rs2307492    (g.13693T>C)  (F182S) 9              (0.09) 2                 (0.04) 7           (0.15) 5                 (0.10) 4                 (0.08) 
rs2020862    (g.13732C>T)  (S195L) 11            (0.11) 3                 (0.06) 8           (0.17) 4                 (0.08) 7                 (0.15) 
rs2020861   (+13733G>A)  (S195S) 53            (0.55) 30               (0.63) 23         (0.48) 25               (0.52) 28               (0.58) 
rs7542361    (+13841C>T)  8              (0.08) 4                 (0.08) 4           (0.08) 5                 (0.10) 3                 (0.06) 
rs2075987    (+13952C>A)  53            (0.55) 30               (0.62) 23         (0.48) 26               (0.54) 27               (0.56) 
rs10912559  (+17928C>T)  47            (0.49) 28               (0.58) 19         (0.40) 26               (0.54) 21               (0.44) 
rs28369895 (g.18237G>A) (R238Q) 9              (0.09) 6                 (0.13) 3           (0.06) 6                 (0.13) 3                 (0.06) 
rs2020866    (g.18269C>T)  (R249X) 1              (0.01) 0                 (0.00) 1           (0.02) 0                 (0.00) 1                 (0.02) 
rs7517460    (+18390T>C)   45            (0.47) 28               (0.58) 17         (0.35) 22               (0.46) 23               (0.48) 
rs2075988    (+18559T>C)  2              (0.02) 2                 (0.04) 0           (0.00) 1                 (0.02) 1                 (0.02) 
rs2020863   (g.19679A>G)  (E314G) 4              (0.04) 3                 (0.06) 1           (0.02) 2                 (0.04) 2                 (0.04) 
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n Number of alleles,  
a Positions of SNPs are given relative to the A of the ATG translational initiation codon. In addition, for each of the 18 coding-region SNPs, the position and identity of the 
   resultant change in amino acid residue is given. 
b Amino acid change and the protein position at which it occurs. The ancestral state of each SNP was inferred from the chimp sequence.  
   SNPs, single-nucleotide polymorphisms. 
rs7536646   (g.19839A>G)  (A367A) 49            (0.51) 20               (0.42) 29         (0.60) 22               (0.46) 27               (0.56) 
rs28369899 (g.19910G>C)  (R391T) 12            (0.13) 6                 (0.13) 6           (0.13) 7                 (0.15) 5                 (0.10) 
rs7536745   (+19969G>A)  41            (0.43) 26               (0.54) 15         (0.31) 22               (0.46) 19               (0.40) 
rs6671692   (g.22027G>A) (E402E) 45            (0.47) 28               (0.58) 17         (0.35) 24               (0.50) 21               (0.44) 
rs2020865    (g.22060T>G) (N413K) 16            (0.17) 6                 (0.13) 10         (0.21) 8                 (0.17) 8                 (0.17) 
rs28369908 (+22216G>A)  14            (0.15) 7                 (0.15) 7           (0.15) 8                 (0.17) 6                 (0.13) 
rs2075989    (+22267T>C)  3              (0.03) 1                 (0.02) 2           (0.04) 1                 (0.02) 2                 (0.04) 
rs2075990    (+22353T>G)  9              (0.09) 4                 (0.08) 5           (0.10) 2                 (0.04) 7                 (0.15) 
rs28369911  (+23006G>T)  83            (0.86) 41               (0.85) 42         (0.88) 40               (0.83) 43               (0.90) 
rs28369912 (g.23087A>G) (G421G) 6              (0.06) 3                 (0.06) 3           (0.06) 2                 (0.04) 4                 (0.08) 
rs61730973  (g.23115A>C) (N431T) 1              (0.01) 0                 (0.00) 1           (0.02) 0                 (0.00) 1                 (0.02) 
rs6661174    (g.23238C>T) (Q472X) 48            (0.50) 24               (0.50) 24         (0.50) 0                 (0.00) 48               (1.00) 
rs2020869   (g.23300A>G)  (K492K) 11            (0.11) 4                 (0.08) 7           (0.15) 5                 (0.10) 6                 (0.13) 
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3.2.3 Haplotypes 
Haplotypes were inferred from genotypes using the Phase algorithm of 
DnaSP, version 5, and the EM and ELB algorithms of Arlequin. Both EM and 
Phase were more accurate than ELB when handling rare haplotypes (Sabbagh and 
Darlu 2005). The Phase approach was chosen because of the occurrence of rare 
haplotypes in the dataset and it being better in inferring the former, and also 
because Phase had the lowest error rate according to (Sabbagh and Darlu 2005). 
This is consistent with studies that evaluated the performance of various 
algorithms using both simulated and empirical datasets (Stephens et al. 2001; 
Stephens and Donnelly 2003). Because some analysis, such as nucleotide 
diversity, requires complete sequence information only individuals with complete 
genotypes were used.  It is important to analyse a sample that represents the 
frequency of both 23238C and 23238T alleles in sub-Saharan Africa. Individuals 
have been chosen according to that criterion. In contrast, when looked at 
separately, the maximum number of successfully phased 23238C and 23238T 
alleles can be used for analysis. 
3.2.3.1   Combined African sample 
In the sample of 30 chromosomes, (twenty-four 23238T and six 23238C 
alleles), the SNPs segregate as ten distinct haplotypes (Table 15). The ten 
haplotypes are shown, together with the inferred ancestral state (chimp) of each 
allele, in (Table 16). No haplotype in the study exactly matched the ancestral 
haplotype. The closest were haplotypes 2, 4 and 10. The most common haplotype 
is haplotype 5, with a frequency of 0.40. 
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3.2.3.2   West- and east African samples 
Eight distinct haplotypes were identified in the sample of 22 west-African 
chromosomes, and four in the east-African sample of eight chromosomes (Table 
15). 
3.2.3.3 23238C and 23238T allele groups 
In the sample of twenty-four 23238C alleles, there were fourteen haplotypes, 
whereas the twenty-four 23238T alleles segregated as six haplotypes (Table 15). 
 
Table 15. Number of haplotypes inferred for the combined African 
resequencing and for the separated groups 
 
 
Population Group Number of haplotypes inferred 
Combined resequencing group 10  
West-African group 8 
East-African group 4 
23238C allele group 14 
23238T allele group 6 
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Table 16. Inferred haplotypes for the combined African group 
  
 
Haplotypes and their estimated frequencies in the combined African groups (30 chromosomes). The nucleotide positions of SNPs are given relative to the A of the ATG 
translational initiation codon. Those that result in amino-acid substitutions, 7731T>C (F81S), 10951delG (V113fsx), 13732C>T (S195L), 18237G>A (R238Q), 19910G>C 
(R391T), 22060T>G  (N413K) and 23238C>T (Q472X) are shown in bold. All polymorphisms are shown as derived changes in comparison with the chimpanzee sequence. Bases 
identical to the chimpanzee sequence are indicated by a dot. Haplotypes are numbered arbitrarily. 
Nucleotide position 
 
 
 
 
 
 
 
Haplotype id  
and occurence 
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2 
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0 
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0 
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+ 
2 
2 
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3 
5 
3 
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G 
+ 
2 
3 
0 
0 
6 
G 
> 
T 
+ 
2 
3 
2 
3 
8 
C 
> 
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Frequency 
Ancestral                0 T C C T T G C G C C G T A G G G T G T G C 0 
1                              1 . . . . . . . A A T A C . . A A . . . T . 0.033 
2                             2 . . T C A del T . . . . . G . . . . . . T . 0.066 
3                              1 . T . . . . . A A T . C . C A A . A . . . 0.033 
4                              2 . . . . . . . A A T . C . . A A . . . T . 0.066 
5                            12 . . . . . . . A A T . C . . A A . . . T T 0.40 
6                              2 . . . . . . . A A T A C . . A A . . . T T 0.066 
7                              2 . T . . . . . A A T . C . C A A . A . . T 0.066 
8                              2 . T . . . . . A A T . C . C . A . A . . T 0.066 
9                              3 . . T C A del T . . . . . G . . . G . . T T 0.10 
10                            3 C . . . . . . A A . . . G . . . . . G T T 0.10 
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3.2.4 Frequency of functional 23238C alleles in sub-Saharan Africa 
To estimate the frequency of functional alleles in the study sample, the 
23238C alleles from west and east Africa were pooled together, 48 chromosomes, 
of which 28 were phased successfully for all nonsynonymous SNPs (Table 17). 
The resulting eight haplotypes were examined for the presence of nonsynonymous 
SNPs. Results show that more than half of full-length 23238C alleles (0.54) are 
not associated with nonsynonymous SNPs and, therefore, are apparently 
functional. A reduced-median network diagram visualizes the haplotypes (Figure 
14). 
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Table 17. Frequency of functional and non-functional 23238C alleles 
 
 
aPosition from the A of the ATG initiation codon in the FMO2 genomic reference sequence (AL021026). 
 Total 23238C alleles=28.  
 Nucleotide changes that are predicted to cause loss of function are underlined. 
 Haplotype id refers to the numbering of the haplotypes in the RM network diagram (Figure 14). 
 
bEffect on function was according to prediction by PolyPhen based on single amino-acid changes. 
 
 
Nucleotide changea g.107 
A>G 
g.7695 
T>A 
g.13693 
T>C 
g.13732 
C>T 
g.18237 
G>A 
g.19679 
A>G 
g.19910 
G>C 
g.22060 
T>G 
Number 
and 
frequency 
Predicted effect on 
 FMO2 functionb 
Location Exon 2 Exon 3 Exon 5 Exon 5 Exon 6 Exon 7 Exon 7 Exon 8  
Amino acid change D36G F69Y F182S S195L R238Q E314G R391T N413K 
Haplotype id Ancestral A T T C G A G T 15       (0.54) Functional 
1 G A C T G A G T 1       (0.035) Non-functional 
2 G T T C G A G T 1       (0.035) Non-functional 
3 G T T C G G G T 1       (0.035) Non-functional 
4 A T C C G A G T 2         (0.07) Non-functional 
5 A T T C A A G T 4         (0.14) Non-functional 
 6 A T T C G A C T 3         (0.11) Non-functional 
 7 A T T C G A G G 1       (0.035) Probably functional 
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Figure 14. Reduced-median network of FMO2 haplotypes for the 23238C 
allele group of 28 chromosomes. Each of the eight unique haplotypes is represented by a 
circle, the size of which is proportional to the relative frequency of the haplotype. Mutational 
relationships are indicated by lines linking the haplotypes. Mutational differences between 
haplotypes are indicated on the branches of the network. Mutations are identified by the position 
of the amino-acid residue in the protein. Where multiple mutations are present on the same line, 
the order in which they occurred is not known.  
A, Ancestral. 
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3.2.5   Summary of the variation observed in sub-Saharan African                 
populations and in the NIEHS African population 
A total of 32 variants were observed in sub-Saharan populations, whereas 24 
were documented in the corresponding FMO2 sequence in the African NIEHS 
population. The ratio of coding to non-coding variants was 18:14 in Africans and 
16:8 in the NIEHS African population (Fisher`s exact test, P>0.3). It was 15:14 in 
23238C alleles and 15:14 in the 23238T alleles.  West-Africa had a ratio of 15:14, 
whereas east-Africa had a ratio of 18:13 (Fisher`s exact test, P>0.4).   
The transition to transversion ratio was 23:8 in Africans, compared with 16:4 
in the NIEHS population (Fisher`s exact test, P>0.4), 21:7 in the 23238C alleles 
and 22:7 in the 23238T alleles (Fisher`s exact test, P>0.2), 22:7 for west-Africa 
and 23:8 in east-Africa (Fisher`s exact test, P>0.5) 
The ratio of synonymous to nonsynonymous variants was 5:12 in Africans 
and 2:11 in NIEHS (Fisher`s exact test, P>0.3). It was 5:11 in the 23238C alleles 
and 5:10 in the 23238T alleles (Fisher`s exact test, P>0.2). It was 5:9 in west-
Africa and 5:9 in east-Africa.   
3.2.6  Prediction of effect of nonsynonymous SNPs on function 
     PolyPhen software, www.genetics.bwh.harvard.edu/pph/, was used to predict 
the effect on protein function of each of the 18 c.SNPs in this study (Table 18). In 
addition to the SNPs at position g.10951delG (V113fsX), g.13732C>T (S195L) 
(Furnes et al. 2003; Krueger 2005) and g.23238C>T (Q472X) (Dolphin 1998; 
Whetstine et al. 2000), which are known individually to cause loss of function, 
other SNPs that are predicted to be damaging by PolyPhen are: g.107A>G 
(D36G), g.7731T>C (F81S), g.13693T>C (F182S), g.18237G>A (R238Q), 
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g.18269C>T) (R249X), g.19679A>G (E314G), g.19910G>C (R391T) and 
g.23115A>C (N431T). The remaining SNPs are predicted to be benign. 
3.2.7   Recombination 
The presence of pairs of sites with four-gametic combinations is indicative of 
recombination (crossing-over between the two sites or gene conversion), or 
repeated mutation. Repeated mutation at the same site has a very low probability. 
Consequently, out of the 231 SNP pairs compared by the four-gamete test 
(Hudson and Kaplan 1985), the presence of the 35 four-gamete site pairs is most 
likely accounted for by recombination. The four-gamete test predicts a minimum 
of five recombination events in the combined African group: between (+409, 
g.13733), (g.18237, g.23238), (+13952, +18390) and (g.19910, +19969).  
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Table 18. PolyPhen prediction of the effect of c.SNPs on FMO2 function 
  
SNP Position in Gene Amino acid Position PSIC score difference Prediction SNP category Reference 
 
rs2020870 Exon 2 
 
D36G 2.425 Probably damaging Missense (radical) n.d 
rs28745274 Exon 3 
 
F69Y 0.058 Benign Missense (conservative) n.d 
rs2020860 Exon 3 
 
F81S 2.771 Probably damaging Missense (radical) n.d 
rs28369860* 
 
Exon 4 V113fsX 1.568 Possibly damaging Frameshift (Furnes et al. 2003; 
Krueger et al. 2005) 
rs2307492 Exon 5 F182S 
 
2.775 Probably damaging Missense (radical)  
rs2020862* 
 
Exon 5 S195L 2.702 Probably damaging Missense (radical) (Furnes et al. 2003; 
Krueger et al. 2005) 
rs28369895 Exon 6 
 
R238Q 2.314 Probably damaging Missense (radical)  
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Table displays the effect of c.SNPs on protein function, predicted by PolyPhen, the accession number of the SNP, its location in the gene, the amino-acid change and the SNP 
category. *Indicates SNPs the function of which have been determined experimentally. The last column shows references reporting the functional effect of these SNPs. 
 
 
 
 
 
 
rs2020866 Exon 6 R249X 2.141 Probably damaging 
 
Nonsense (stop-codon)  
 
rs2020863 Exon 7 
 
E314G 2.190 Probably damaging Missense (radical)  
rs28369899 Exon 7 
 
R391T 2.355 Probably damaging Missense (radical)  
rs2020865* Exon 8 N413K 0.645 Benign Missense (conservative) (Furnes et al. 2003; 
Krueger et al. 2005) 
rs61730973 Exon 9 
 
N431T 0.649 Benign Missense (conservative)  
rs6661174* Exon 9 Q472X 1.988 Possibly damaging Nonsense (stop-codon) (Dolphin et al. 1998; 
Whetstine et al. 2000) 
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3.2.8   Linkage disequilibrium 
Linkage disequilibrium (LD) was examined for the combined African group 
initially (results not shown) and then for individual groups. Interesting results 
were found when grouped into 23238T alleles. A plot of pairwise LD (measured 
as R2) against physical distance for the samples divided into truncated (Ts), 
indicates that relatively strong LD extends for a distance of 23 kb (Figure 15a), 
between the SNP at +409 and that at +23006, which lies some 22.6 kb apart 
(Figure 16). 
For the 23238C alleles, none of the ten pairwise comparisons between the 
five SNPs show significant LD, whereas for the 23238T alleles, 32 of the 153 
comparisons show significant LD (P<0.001) (Figure 16). The absence of any 
significant pairwise comparisons for the 23238C alleles may be due to the small 
sample number (six alleles). To test this, and since the 23238C alleles will be 
looked at separately and not in the context of a combined sample, which has to 
reflect the 23238C:23238T allele ratio found in sub-Saharan Africa, all 48 
23238C alleles were pooled together and 24 were successfully phased for SNPs. 
Pairwise LD comparisons were performed and results show that of the 120 
pairwise comparisons between the 14 SNPs, 51 show significant LD with 
Bonferroni correction (P<0.001) (Figure 15b), and, as is the case for the 23238T 
alleles, LD extends for 22.6 kb  (Figure 17) 
To assess the level of LD of FMO2, five test statistics, ZnS (Kelly 1997), Za 
(Rozas et al. 2001), ZZ (Rozas et al. 2001) Wall’s B and Wall’s Q (Wall 1999), 
were performed (Tables 19 and 20). No significant  values were found for any of 
the five test statistics for either the 23238C or 23238T alleles (Table 20), whereas 
significant values of Za and ZnS were observed for the NIEHS Asian group 
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(P<0.05) (Table 19). Za had a higher than expected value, whereas ZnS had a 
lower than expected value under neutrality. Significant LD for 11 SNPs in the 
NIEHS Asian group extends for 22.2kb across the FMO2 gene, between the SNPs 
at +107 and +22267, for example (results not shown). Twenty-eight of the 66 
pairwise comparisons are significantly different with Bonferroni correction 
(P<0.001) (Figure 18). The value of ZnS may suggest that the FMO2 gene in 
Asians has been subjected to some form of selection.  
Significantly higher than expected positive values for ZZ were observed for 
the NIEHS 23238T allele group (consists of 23238T alleles from African, 
European, Hispanic and Asian individuals) (P<0.001), this suggests intragenic 
recombination.  Significant LD for 19 SNPs extends for 23.1kb across the FMO2 
gene, for example, between +251 and +23353. Forty-six of the 190 pairwise 
comparisons show significant LD with Bonferroni correction (P<0.001) (results 
not shown). All statistical tests performed by DnaSP were tested by 5000 
coalescent simulations in the 95% confidence interval. Significant LD was also 
observed in the NIEHS European group. Significant LD for 10 SNPs extends for 
22.1kb for example between +251 and +22353 (results not shown). Twenty-one of 
the 45 pairwise comparisons show significant LD with Bonferroni correction 
(P<0.001) (Figure 19).  
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                                                         a)23238T alleles                                                                        b)23238C alleles 
                     R2     R2                                      
                                       Distance (kb) between variants                                                       Distance (kb) between variants 
Figures 15a and b. Plot of R2 against distance. 
15a) Relationship between pairwise LD measured as R2 and physical distance (in kb) for the 32 associations that display significant LD at the 0.001% level in 23238T alleles. 
15b)  Relationship between pairwise LD measured as R2 and physical distance (in kb) for the 51 associations that display significant LD at the 0.001% level in 23238C 
alleles. 
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Figure 16. Plot of the association among 17 SNPs for 12 African 
23238T homozygotous individuals. 
Blackened boxes indicate the 32 out of 153 possible associations that display 
significant LD at the 0.001% level by a ҳ2 test with Bonferroni correction. Numbers 
denote the nucleotide positions of the SNPs relative to the A of the ATG 
translational initiation codon. 
 
Figure 17. Plot of the association among 14 variants for 12 
African 23238C homozygotous individuals. 
 Blackened boxes indicate the 51 out of 120 possible associations that display 
significant LD at the 0.001% level by a ҳ2 test with Bonferroni correction.     
Numbers denote the nucleotide positions of the SNPs relative to the A of the 
ATG translational initiation codon. All are SNPs except for one 
indel:g.10951delG 
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Figure 18. Plot of the association among 11 variants for 22 NIEHS 
Asian 23238T homozygotous individuals. Blackened boxes indicate the 28 
out of 66 possible associations that display significant LD at the 0.001% level by a ҳ2 
test with Bonferroni correction. Numbers denote the nucleotide positions of the SNPs 
relative to the A of the ATG translational initiation codon. All are SNPs except for 
two indels: g.13592delA and g.23353-23354insT. Positions of the SNPs relative to the 
A of the ATG translational initiation codon. 
 
Figure 19. Plot of the association among 10 variants for 14 NIEHS 
European 23238T homozygotous individuals. 
Blackened boxes indicate the 12 out of 45 possible associations that display 
significant LD at the 0.001% level by a ҳ2 test with Bonferroni correction. Numbers 
denote the nucleotide positions of the SNPs relative to the A of the ATG 
translational initiation codon. All are SNPs except for one indel: g.23353-
23354insT. 
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• It has to be noted that when 23238C and 23238T allele groups (both from 
the combined African resequencing samples and the NIEHS samples) 
were analyzed separately for various neutrality tests (Tables 19 and 20), 
the assumptions of these tests were opposed. The analysis of these 
separated groups was still performed in order to get insights into what is 
occurring in these groups. 
3.2.9  Further testing for selection 
3.2.9.1  Nucleotide diversity π and θ 
Several tests were used to investigate the compatibility of the observed 
variation in the sequenced region with neutral evolution. These were based on (i) 
the allele frequency spectrum within a locus, (ii) the number and diversity of 
haplotypes in a sample, (iii) LD and (iv) interspecific comparisons of sequence 
variation. The two estimates of nucleotide diversity (theta estimates), θS and π, 
should be equal under neutrality, random mating and a constant population size, 
and, therefore, Tajima`s D statistic, which compares these two estimates, should 
be zero. Calculations of measures of nucleotide diversity were based on the 
number of effectively silent sites in the sequenced region. This was estimated to 
be 3442 and is the sum of all intronic and silent exon sites. The average expected 
per-site nucleotide heterozygosity (θS), estimated from the observed number of 
polymorphic sites (Sachidanandam et al. 2001), and nucleotide diversity (π), a 
direct estimate of per-site heterozygosity, derived from the average pairwise 
sequence difference between two random sequences in a sample (Bamshad and 
Wooding 2003), were calculated. 
None of the observed values for π or θS were significantly different from what 
is expected under neutrality in any of the groups. The 23238C allele group had 
higher nucleotide diversity (π) compared with the 23238T allele group: 0.00143 
and 0.00110, respectively (Table 20). East Africa had higher π compared with 
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west Africa: 0.0126 and 0.00116, respectively (Table 19). In the NIEHS groups, 
the highest π was observed in both the NIEHS African and Asian groups: 0.0015 
and 0.0015, respectively, this was followed by the NIEHS European group, 
0.0012, and the NIEHS Hispanic group, 0.0011 (Table 19). For the combined 
sequenced African samples, θS= 0.00118 and π = 0.00120 (Table 19). In this study 
the estimates of nucleotide sequence diversity (π) for FMO2 are higher than the 
average value of π (0.00075) for human genetic loci (Sachidanandam et al. 2001; 
Bamshad and Wooding 2003). It was found that for the NIEHS samples, both 
estimates, θS = 0.0012 and π = 0.0013, are lower than those observed for the 
combined sequenced African samples, but still higher than the average for human 
loci. All the observed π values are in the range mentioned by Sachidanandam et 
al. (Sachidanandam et al. 2001), which was 2-15.8 x 10-4. 
3.2.9.2 Tajima`s D statistic 
A significantly positive Tajima`s D statistic was observed for the NIEHS 
Asian group (P<0.001) (Table 19). This implies an excess of moderate-frequency, 
compared with low-frequency, variants. This may be due to population structure, 
another possibility is balancing selection, which can also lead to an excess of 
moderate-frequency variants, since in balancing selection more than one allele is 
maintained at moderate frequency in a population. 
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Table 19. Diversity estimates and neutrality tests for FMO2 
 
a Number of chromosomes surveyed. 
b Number of segregating sites.    
c Number of singleton sites.  
d Number of observed haplotypes.                                                                                                                      
e Number of expected haplotypes from coalescent simulations. 
f Minimum number of recombination events, based on the four-gamete test.  
g Haplotype diversity.            
h Average pairwise sequence difference per nucleotide assuming no recombination.  
R2 Ramos-Onsins and Rozas. 
A total of 4705 sites (3442 silent  sites) were analysed,  P Values are given only when significant  *(P≤0.05), no recombination, **(P≤0.05), with recombination ,  
***(P≤0.05), without recombination, #(P≤0.001) no recombination,  based on estimates from coalescent simulations E.A, East Africa, W.A, West Africa., combined,  
combined African resequencing samples. 
Sample Summaries NIEHS African European Hispanic Asian NIEHS   23238Cs NIEHS  23238Ts Combined W.A E.A 
na 106 10 28 24 44 6 100 30 22 8 
Sb 31 17 18 17 15 13 25 22 19 15 
sc 8 4 4 4 4 1 2 2  0 2 
hd 29* 8 12 12 10 6 23*** 10 8 4 
he 19 6 10 15 10 5 16 11 9 6 
Rmf 6* 1* 5* 3* 1* 2* 4* 5* 1* 2* 
Hdg 0.824 95%6 0.812 0.844 0.866 1 0.801 0.825 0.840 0.750 
π
 h
 0.0012 0.0015 0.0012 0.0011 0.0015 0.0015 0.0010 0.00120 0.00116 0.00126 
θS
i
 0.0013 0.0013 0.001 0.0009 0.0007 0.0012 0.00103 0.00118 0.00111 0.00123 
Tajima`s D -0.12197 0.76663 0.6761 -0.9939    3.3334# 1.47467 0.20838   0.01519 0.1689 0.19202 
Fu and Li`s D* -0.66596 0.61631 0.26441 0.2467* -0.2091 0.93041 1.09310* 0.79056 1.5811* 0.37963 
Fu and Li`s F* -0.54153 0.73656 0.46136 0.40154 1.14675 1.13464 0.90215 0.65784 1.350* 0.35618 
Fu and Li`s D 1.02540 0.83587  -3.101# 0.11403 1.66247* -0.68740  1.91496# 0.84864  1.7839* 0.24594  
Fu and Li`s F 0.59620 1.04734 -2.81041* 0.28716 2.58096* -0.38230 1.65970* 0.70170 1.5235* 0.25994 
Fu`s Fs -6.833 -1.127 -0.8070 -1.582 3.372** -1.521 -3.545 0.206 1.356 2.645 
Fay and Wu's H -2.47547 1.24444 -10.1935 2.41304 -15.8118# -0.6060 -11.2460* 3.779- -4.31169 -2.14286 
Raggedness 0.0401 0.0583  0.0506 0.0572 0.1046** 0.0800 0.0630 0.0287 0.0501 0.2691 
ZnS 0.1277 0.3135 0.1972 0.1727 0.3446** 0.4185 0.1233 0.2046 0.2964 0.3760 
Za 0.2093 0.4001 0.2255 0.2485 0.5104** 0.5727 0.3154 0.2140 0.3999 0.3211 
ZZ 0.0816 0.0866 0.0282 0.0758 0.1658 0.1542 0.1922# 0.0093 0.1035 -0.0549 
Wall`s B 0.1500 0.2667 0.0000 0.1333 0.0000 0.4545 0.2500 0.0476 0.3333 0.0714 
Wall`s Q 0.2381 0.3750 0.0000 0.2500 0.0000 0.5833 0.4286 0.0909 0.4211 0.1333* 
R2 0.0907 0.1865 0.1475 0.1448 0.2328* 0.2278 0.1027 0.1265 0.1434 0.1790 
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Table 20. Diversity estimates and neutrality tests for FMO2 for the 23238C and 
T alleles 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
a Number of chromosomes surveyed.                                                                                                                               
b Number of segregating sites.                                                                                                                                          
c Number of singleton sites.                                                                                                                                             
d Number of observed haplotypes    
e Number of expected haplotypes from coalescent simulations. 
f Minimum number of recombination events, based on the four-gamete test.  
g Haplotype diversity.            
h Average pairwise sequence difference per nucleotide assuming no recombination.  
I Expected heterozygosity per nucleotide assuming no recombination.  
R2 Ramos-Onsins and Rozas.  Number of expected P Values are given only when significant.   
A total of 4705 sites (3442 silent sites) were analysed,*(P≤0.05), no recombination, **(P≤0.05), with 
recombination, ***(P≤0.001) no recombination,  based on estimates from coalescent simulations. 
Sample 
Summaries 
23238Cs 23238Ts 
na 24 24 
Sb 23 18 
sc 1 0 
hd 14 6 
he 10 9 
Rmf 3* 2* 
Hdg 0.917 0.728 
π
 h
 0.00143 0.00110 
θS
i
 0.00131 0.00102 
Tajima`s D 0.34780    0.35824 
Fu and Li`s D* 0.36284 1.57669* 
Fu and Li`s F* 0.41904 1.37593* 
Fu and Li`s D 0.34900 1.76324*  
Fu and Li`s F 0.42290 1.53674* 
Fu`s Fs -2.230 3.47* 
Fay and Wu's H 1.62319 -2.47101 
Raggedness 0.0179 0.1127 
ZnS 0.1726 0.3225 
Za 0.2152 0.4011 
ZZ 0.0427 0.0787 
Wall`s B 0.0909 0.2941 
Wall`s Q 0.1739 0.3889 
R2 0.1403 0.1437 
  113
3.2.9.3 Haplotype diversity and Fu`s Fs statistic 
Haplotype diversity is a measure of the uniqueness of haplotypes in a given 
population, whereas Fu`s Fs statistic tests whether the number of haplotypes 
observed in a population is similar to that expected under neutrality. Haplotype 
diversity for all groups was not different from what is expected under a neutral 
model of evolution (Tables 19 and 20).  
There was an excess of haplotypes in two groups. The excess was noticed in 
the combined NIEHS group and in the separated NIEHS 23238T allele group 
(Table 19). For example, the NIEHS group had 29 haplotypes instead of the 
expected 19. The observed numbers were significantly different from the expected 
numbers under a neutral model for the two groups mentioned above (P<0.05).  
3.2.9.4 Pairwise number of differences and raggedness (r) 
The pairwise number of differences, also called Roger and Harpingding`s 
mismatch distribution, was estimated for all population groups. This test shows 
the observed pairwise nucleotide differences and the expected values in a 
population with constant size, without recombination, as well as with change in 
population size (growth-decline) with free recombination (Rogers and Harpending 
1992) (results not shown). The average number of pairwise differences for the 
combined NIEHS group was 5.7, for the NIEHS Asian, European and Hispanic 
group it was 7.1, 5.5 and 9.7, respectively, whereas for the west-African group it 
was 5.4. The 23238C and 23238T allele groups had an average number of 6.9 and 
5.5, respectively, whereas the NIEHS 23238C and 23238T alleles group had an 
average of 7.1 and 5.2, respectively. 
The raggedness statistic is shown in Tables 19 and 20 and is used to quantify 
the smoothness of the observed pairwise differences distribution. The raggedness 
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value (r) is significantly different from that expected in the NIEHS Asian group 
(0.1046) (P<0.05). The (r) value of raggedness for the NIEHS Asian group is 
either indicative of a population size that has been constant for a long time or 
balancing selection (Rogers and Harpending 1992). Caution has to be exercised 
since the raggedness statistic has low statistical power for detecting population 
expansion; a more powerful test is Fu`s Fs (see Section 3.2.9.3 3.2.9.3) and the 
Ramos-Onsins and Rozas`s R2 (Ramos-Onsins and Rozas 2002). The R2 statistic 
is used to detect recent population growth, which is indicated by low values of the 
test statistic.  
It is based on the difference between the number of singleton mutations and 
the average number of nucleotide differences. The R2 value for the NIEHS Asian 
group was higher than expected under neutrality and not low, so no recent 
population expansion was detected, therefore the observed increase in low-
frequency alleles for the NIEHS Asian group (see Section 3.2.9.7), can not be 
explained by population expansion. A plausible explanation for all these 
observations in addition to the excess in intermediate-frequency variants (see 
below for allele-frequency spectrum) could be a bottleneck after the migration of 
modern Homo sapiens out of Africa, which led to a decrease in population size 
and consequently, to an increase in genetic drift (Rosenberg et al. 2002). 
3.2.9.5 Allele-frequency spectrum 
     The allele-frequency spectrum of FMO2 for the 23238C and 23238T allele 
groups, as well as for the NIEHS Asian and European group indicates an excess 
of intermediate-frequency variants, when compared with a neutral model (Figures 
20a, b, c and d). 
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      a)                                                                                                             b) 
       
         c)                                                                                                    d) 
              
Figures 20a, b, c and d. Allele frequency spectrum of derived SNP alleles. Bars indicate the observed frequencies, whereas the dotted line indicates the 
frequencies expected under a neutral model of neutrality. SNP, single- nucleotide polymorphism. 
23238C allele group
0
5
10
15
20
25
30
1 2 3 4 5 6 7 8 9 10 11 12
Frequency of SNP in group
N
u
m
b
e
r
 
o
f
 
d
i
s
t
i
n
c
t
 
S
N
P
s Freq Obs
Freq Exp
23238T allele group
0
10
20
30
40
50
1 2 3 4 5 6 7 8 9 10 11 12
Frequency of SNP in group
N
u
m
b
e
r
 
o
f
 
d
i
s
t
i
n
c
t
 
S
N
P
s Freq Obs
Freq Exp
NIEHS Asian group
0
5
10
15
20
25
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Frequency of SNP in group
N
u
m
b
e
r
 
o
f
 
d
i
s
t
i
n
c
t
 
S
N
P
s
Freq Obs
Freq Exp
NIEHS European group
0
5
10
15
20
25
30
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Frequency of SNP in group
N
u
m
b
e
r
 
o
f
 
d
i
s
t
i
n
c
t
 
S
N
P
s Freq Obs
Freq Exp
  116
3.2.9.6  Fu and Li`s D* and F* test statistics 
Fu and Li`s D* and F* test statistics (Fu and Li 1993) compare the observed 
number of singleton polymorphisms with the number expected under a neutral 
model. The values of Fu and Li`s D* were significantly positive in the west- 
African group (P<0.05), the 23238T allele group (P<0.05) (Tables 19 and 20), the 
NIEHS Hispanic group (P<0.05) and the NIEHS 23238T allele group (P<0.001). 
Fu and Li`s F* was significantly positive in the west-African (P<0.05) and 
23238T allele groups (P<0.05) (Tables 19 and 20). Positive values are an 
indication of old versus young mutations which might be caused by balancing 
selection or population subdivision. 
An approach to test for population subdivision, Wright’s fixation index 
(Wright 1931), which measures population subdivision (or genetic differentiation) 
by comparing genetic diversity within subpopulations with that in the whole 
population, was used to analyse the heterozygosity of 32 FMO2 variants. The 
average FST value among the 23238C alleles and 23238T alleles is 0.11, which is 
high. This might be due to population subdivision, which is a possibility since 
populations from both west and east Africa were included in each of the 23238C 
and 23238T allele groups. It could also be explained by the effect of a selective 
sweep acting at the g.23238C>T (Q472X) locus in some groups and not others 
and, therefore, resulting in high differentiation between populations. A complete 
selective sweep decreases the level of polymorphism in the selected allele due to 
the hitchhiking effect in which neutral and nearly neutral genetic variation linked 
to the selected mutation rises in frequency together with the selected mutation 
(Figure 21), resulting in very low genetic diversity, since the selected allele and 
the hitchhikers are predominant for a long time. This will be accompanied by 
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strong LD between loci, which will need a long time to be broken down by 
recombination or the accumulation of new mutations. It takes approximately 2 
myr to regain 0.75 of genetic diversity (Diller et al. 2002). Partial selective 
sweeps could be detected by examining intra-specific variation of putatively 
neutral regions (e.g., intronic sequences surrounding the g.23238C>T (Q472X) 
locus. This will be examined later in the thesis (see Section 3.2.9.12.1).                         
The average FST among the NIEHS populations (African-American, African, 
European, Hispanic and Asian) = 0.20, which is very high. This high value can 
either be indicative of high population subdivision, which can be explained by the 
geographical locations of the individuals included, but there also is the possibility 
that the high value is due to selection acting on one population, therefore resulting 
in high diversity. Pairwise FST for 24 variants was estimated and results show that 
African populations were the most diverse and furthest away from other 
populations (Table 21). 
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Figure 21. A selective sweep. The diagram shows the pattern of polymorphisms along a 
chromosome, with a selected allele, before (left) and after (right) selection. Ancestral alleles are 
shown in grey, derived alleles in blue, while the selected allele is in red. As the selected allele 
increases in frequency, closely linked mutations `hitchhike` along to high frequency, resulting in a 
selective sweep. Diagram taken from (Schaffner and Sabeti 2008). 
 
Table 21. Pairwise FST comparisons among NIEHS populations 
 
 
 
Pairwise FST was between pairs of NIEHS populations for 24 variants. African population is made 
up of African-Americans and of Africans from Yoruba, Nigeria. 
Population  
 African European Hispanic 
European 0.16   
Hispanic 0.14 0.00  
Asian  0.19 0.06 0.00 
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3.2.9.7 Fu and Li`s D and F test statistics with an outgroup 
The significance of all obtained values for the individuals analysed was tested 
by comparison with those obtained from coalescent simulations with the same 
sample size as the observed data. Significantly positive values of Fu and Li`s D 
statistic (Table 19) were observed for the west-African group (P<0.05), the 
NIEHS Asian group (P<0.05) and the NIEHS 23238T allele group (P<0.001). A 
significantly negative value of Fu and Li`s D was observed for the NIEHS 
European group (P<0.001). Significantly positive values of Fu and Li`s F statistic 
were observed for the west-African (P<0.05), the NIEHS Asian group (P<0.05) 
and the NIEHS 23238T allele group (P<0.05). A significantly negative value of 
Fu and Li`s F statistic was observed for the NIEHS European group (P<0.05).   
This value was obtained from coalescent simulations with the same sample 
size as the test sample with no recombination. Significantly positive values for Fu 
and Li`s D statistic indicate that the number of singletons observed in the sample 
exceeds the number expected under a neutral model of evolution, whereas 
negative values indicate fewer than expected singletons under neutrality. The 
excess in singletons in the west-African sample may be due to population 
expansion, this is supported by the low value of R2, although not significant, 
whereas for the NIEHS Asian group, the positive Fu and Li`s D value may be due 
to population structure, since the value of R2 was not low, so recent population 
expansion can be ruled out and does not account for the excess in singletons.  
3.2.9.8 Fay and Wu`s H 
Results of Fay and Wu`s H are shown in Tables 19 and 20. The Fay and Wu`s 
H statistic tests for the presence of derived alleles at a high frequency (Fay and 
Wu 2000). In contrast to Tajima`s D test, which is sensitive to population 
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expansion (because the number of segregating sites responds faster to changes in 
population size than nucleotide heterozygosity), Fay and Wu`s H is not. So using 
both tests together may allow us to distinguish population expansion from natural 
selection.    
The NIEHS Asian and the NIEHS 23238T allele groups had significantly 
negative H, -15.8118 (P<0.001) and -11.2460 (P<0.05), respectively. This value is 
caused by the presence of derived alleles at high frequency, which can be 
indicative of positive selection of a derived allele, which then rises in frequency.            
The results of the neutrality tests for the NIEHS Asian group: significantly 
positive Tajima`s D (P<0.001) and Fu and Li`s D and F (P<0.05) and 
significantly negative Fay and Wu`s H test statistic (P<0.001) which indicates a 
higher than expected frequency of derived alleles, may be the result of the 
bottleneck that occurred after the migration out of Africa. 
3.2.9.9 McDonald-Kreitman test 
The results of the McDonald-Kreitman test for the combined African samples 
are shown in Table 22. Comparing human FMO2 sequences with homologous 
sequences of chimpanzee (Pan troglodytes), revealed 31 fixed differences, 9 of 
these were in the coding regions, of which 5 were nonsynonymous changes 
[g.7731T>C (F81S), in exon 3; g.13693T>C (F182S), in exon 5; g.19679A>G 
(E314G), in exon 7, g.23115A>C (N431T) and g.23238C>T (Q472X) in exon 9]. 
Under neutral evolution, the ratio of replacement to silent mutations between 
species should be equal to the within species ratio. An advantage of this test of 
neutrality is that it is not dependent on assumptions about population history (i.e., 
is not affected by demographic processes). 
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The test was performed for both the combined African group (Table 22) and 
separated 23238C allele and the 23238T allele groups (results not shown). Results 
for the combined (P<0.03) and the 23238T allele groups (P<0.03) indicate an 
excess of intraspecies replacement polymorphisms (nonsynonymous SNPs) that is 
significantly different from neutrality. The 23238C alleles showed a similar result, 
although not significant (P>0.05). One explanation for the observed excess may 
be positive selection acting on the 23238C alleles, which results in an excess of 
nonsynonymous SNPs, which have reached intermediate frequency. 
 
Table 22. McDonald-Kreitman test of Neutrality 
 
 
 
 
 
 
 
 
 
 
 
Numbers of fixed differences found at both silent and replacement (i.e., those that change the 
amino-acid residue) sites in 30 African chromosomes are contrasted with a 2x2 Fisher`s exact test 
of independence. 
 Silent 
 
Replacement Fisher`s exact 
test 
Fixed 31 4 P=0.02* 
Polymorphic 13 9 
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3.2.9.10 Ka/Ks ratio 
A Ka/Ks ratio of 1 may indicate neutral evolution, or a combination of 
purifying and positive selection at different loci in the gene, in a way that they 
cancel each other; a ratio of >1 implies positive Darwinian selection, whereas a 
ratio of <1 implies purifying selection. The Ka/Ks ratio was used to test for both 
purifying and positive selection in the data set divided into 23238C and 23238T 
allele groups. Comparisons of the human FMO2 gene with FMO2 from chimp 
and mouse were used as well. Results are shown in Table 23. 
Systematic bias in the frequency at which nucleotides are changed has to be 
taken into consideration, since certain mutations are more probable than others 
(Bielawski and Yang 2000). Some lineages, for example, may more frequently 
change C to T than C to A. Three different programs (Datamonkey, DnaSP and 
the Ka/Ks calculator) were used for the estimation of the Ka/Ks ratio between 
human-mouse and human-chimp sequences. Table 23 shows the average of the 
ratios obtained from these programs for the 23238C and 23238T allele groups 
with mouse and chimp lineages, respectively.  
Datamonkey (http://www.datamonkey.org) is a web-based, user-friendly 
online interface. Datamonkey aligns homologous DNA sequences in an attempt to 
infer signatures of natural selection according to a codon-based model of 
evolution. This is performed by estimation of the Ka/Ks ratio. Clustal X was used 
for the alignments. Datamonkey rejects any alignments containing stop-codons, 
therefore, all stop-codons were removed using an available function which cleans 
stop-codons. The mean Ka/Ks ratio for human 23238C and 23238T alleles in 
comparison with mouse were 0.30 and 0.35, respectively; with chimp the ratios 
were 1.20 and 0.40 respectively. The low values of the human-mouse for both the 
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23238C and 23238T allele groups could be explained by FMO2 being conserved 
in many mammals (rabbit, mouse and rat for example) (Dolphin et al. 1992), 
whereas the high values of human-chimp for the 23238C allele group compared 
with human-mouse 23238 allele group may indicate that the human 23238C allele 
has been positively selected. This has been further investigated in this thesis (see 
Section 3.2.9.12). 
 
Table 23. Average of the mean Ka/Ks ratios 
 
Population group Human-mousea 
Ka/Ks 
Human-chimpa 
Ka/Ks 
23238C alleles 0.30 1.20 
23238T alleles 0.35 0.40 
 
Results of the mean Ka/Ks ratios for human-mouse and human-chimp sequences. 
a Average for three methods 
 
The significantly positive values of Fu and Li`s D*, F*, D and F test statistics 
for the 23238T allele and the west-African group (P<0.05) (Tables 19 and 20) 
may indicate selection acting at the human FMO2 locus. Therefore, further 
analysis had to be performed to determine the type of selection. A plausible 
explanation could be purifying selection (in the west-African group, but not the 
23238T alleles, which are null alleles), since variation in non-coding sequences is 
more tolerated than coding-sequence variation. Testing for purifying selection was 
performed by various methods (see below). Comparing nucleotide diversity (π) 
between the 23238C and 23238T allele groups in intronic sequences will be 
informative in attempting to determine whether positive selection has been acting 
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on FMO2. Another possibility is that the observed values are a result of 
population subdivision, since both the west-African and the 23238T allele 
samples are from various population groups.  
3.2.9.11 Testing for purifying selection 
Purifying selection is a form of natural selection, also called negative 
selection. It selectively acts against mutations that alter important amino-acids 
and, thus, have deleterious effects on protein structure or that affect expression 
(Nei 1987). Purifying selection can be indicative of the deleterious consequences 
of a given allele (Zhao et al. 2003). Reduced genetic diversity at SNP loci and 
increased genetic distances between populations may be an indication of purifying 
selection (see below). 
3.2.9.11.1 Genetic diversity 
Estimation of gene diversity (heterozygosity), at SNP loci in the combined 
African resequencing samples (Figure 22), revealed differences with respect to 
gene diversity (although not significant) between nonsynonymous and 
synonymous SNP sites in the combined sample (Figure 22) as well as in the 
NIEHS sample (results not shown). Synonymous SNP sites in exons had the 
highest observed gene diversity, 0.40, followed by intronic SNP, which had a 
gene diversity of 0.31, whereas the mean gene diversities of nonsynonymous SNP 
sites were noticeably lower. Nonsynonymous SNP sites causing a conservative 
amino-acid change had a mean gene diversity of 0.19, whereas nonsynonymous 
SNP sites causing a radical-amino acid change had a mean gene diversity of 0.11. 
The lowest mean gene diversity (0.07) was for nonsense SNP sites, which result 
in a stop-codon. The difference in mean gene diversity between all SNPs 
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compared with SNPs causing a radical-amino acid changes, was not significant 
(P>0.1). 
A comparison of  genetic diversity in 23238C allele SNP categories with that 
in 23238T alleles (Figure 23), revealed similar results to those observed for the 
combined African sample, in that differences with respect to gene diversity 
(although not significant) were observed between nonsynonymous and 
synonymous SNP sites in both the 23238C and the 23238T alleles. Intronic SNPs 
had a high observed gene diversity in both groups (0.36 in 23238C alleles and 
0.33 in 23238T alleles), and nonsense SNPs had the lowest gene diversity (0.03 in 
23238C alleles and 0.01 in 23238T alleles). 23238C alleles had a slightly lower 
frequency of nonsynonymous SNP sites causing radical-amino acid changes 0.19 
compared to 0.22 in the 23238T alleles (Figure 23).   
 
                                                                                                                                                                                                
  126
 
                      Amino acid Change                        No Amino acid change 
Figure 22. Mean gene diversity (heterozygosity) at SNP sites categorized by 
location in the gene and effect on protein function for the combined African 
resequencing samples. Error bars indicate standard errors. All means were not significantly 
different from that for nonsynonymous radical SNPs. 
 
 
 
Figure 23. Mean gene diversity (heterozygosity) comparison between 23238C 
and 23238T alleles at SNP sites categorized by location in the gene and effect 
on protein function. All means were not significantly different from that for nonsynonymous 
radical SNPs. 23238C alleles are represented by blue bars, whereas the 23238T alleles are 
represented by purple bars. 
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3.2.9.11.2 Testing for natural selection at conservative nonsynonymous SNP 
sites 
      Sequences of FMO2 of human and chimp (Pan troglodytes) and human and 
mouse (Mus musculus), taken from Ensembl, were aligned using the ClustalX, 
v.2.0.11. It was assumed that the chimp and mouse sequences represented the 
more common allele in these species. Following the maximum parsimony 
principle (Fitch 1971), the assumption that the amino-acid residue that represents 
the more common allele in all three species: human, chimp and mouse, has been 
conserved since the most recent common ancestor of these species.  
     Results showed that for the seven nonsynonymous SNPs [g.107A>G (D36G), 
g.7695T>A (F69Y), g.18237G>A (R238Q), g.19679A>G (E314G), g.19910G>C 
(R391T), g.22060T>G (N413K) and g.23115A>C (N431T)] causing a 
conservative amino-acid change, the non-derived allele was the same in all three 
species, which indicates that FMO2 amino-acid residues at these SNP positions 
are highly conserved among species. 
3.2.9.11.3 Testing for natural selection at radical nonsynonymous and 
nonsense SNP sites 
The same procedure was performed for radical and nonsense nonsynonymous 
SNPs (see above). Results showed that for the three nonsynonymous SNPs 
causing a radical amino acid-change [g.7731T>C (F81S), g.13693T>C (F182S) 
and g.13732C>T (S195L)], only one, g.13732C<T (S195L), had a common allele 
in humans that differed from the allele found in both chimp and mouse. Of the 
three SNPs resulting in a stop-codon (nonsense): g.10951delG (V113fsX), 
g.18269C>T (R249X) and g.23238C<T (Q472X), only the last had a common 
allele in humans different from the one in chimp and mouse (i.e., the allele 
common in humans is the derived allele (T), whereas the non-derived allele (C), is 
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present in chimp and mouse. These results indicate that purifying selection is 
acting on the FMO2 locus and that is why many amino-acid residues are 
conserved among species.  
3.2.9.11.4 Genetic Distance 
A genetic distance is a measure of the differences between populations. 
Genetic distance is measured using a variety of parameters. Genetic distance was 
used to compare the genetic distance between world populations, west- and east-
African populations. A value of 0 indicates that two populations are genetically 
identical, whereas a value of 1 indicates that two populations are different species. 
Pairwise FST was used to estimate genetic distance between two populations 
(Reynolds et al. 1983), whereas hierarchical FST was used to estimate genetic 
distance within and between more than two populations (Excoffier et al. 1992).  
SNPs were classified according to their location and effect on FMO2 function 
into: 1) SNPs in introns, 2) exonic synonymous SNPs, 3) exonic SNPs that cause 
conservative amino-acid changes, 4) exonic SNPs that cause radical amino-acid 
changes and 5) exonic nonsense SNPs causing premature stop-codons. The 
categorization of the nonsynonymous SNPs into conservative and radical was 
based on whether the SNP caused an amino-acid replacement involving two 
amino acids with a pairwise stereochemical difference >3, according to the scale 
of Miyata et al (1979) (Miyata, et al. 1979) (Figure 24). Radical nonsynonymous 
changes included three SNPs (g.7731T>C in exon 2, causing F81S; g.13693T>C, 
causing F182S and g.13732C>T, causing S195L, both in exon 3). The FST values 
between pairs of SNPs were all close to zero (results not shown). 
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Figure24. Stereochemical differences between amino-acid pairs based on  
amino-acid residue and volume 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Miyata`s scale for pairwise stereochemical amino-acid differences. Figure taken 
from Miyata et al. (1979) (Miyata et al. 1979). 
 
3.2.9.12 Testing for selection at intronic sequences 
3.2.9.12.1 Pi (π) ratio comparisons for intronic sequences 
Long-term persistence of both functional and non-functional alleles at the 
Flavin-containing monooxygenase 2 (FMO2) locus suggests that the locus may 
have been subjected to selective forces, i.e., the functional 23238C allele has been 
under purifying selection to remove deleterious SNPs. Balancing and positive 
selection are  other selective forces that might be acting at the FMO2 locus. 
The positive selection hypothesis predicts that the level of polymorphism is 
lower in the selected allele than in the alternative SNP allele, in the proximity of 
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the SNP [g.23238C>T (Q472X)] for example, because of the hitchhiking effect 
(Wang et al. 2006). π, nucleotide diversity per site, associated with the truncated 
and full-length allele, respectively, was used as an indication of the level of 
polymorphism (Wang et al. 2006). 
One hypothesis is that the truncated 23238T alleles (null-alleles) may have 
been positively selected for and that the SNP that caused the truncation, 
g.23238C>T (Q472X), may be moving towards fixation in all human populations 
(pseudogenization). Positive selection of null alleles (i.e., pseudogenes), cannot be 
detected by a comparison of human and chimpanzee sequences. However, human 
population genetic data may retain signatures of selective sweeps for up to 
200,000 years (Przeworski 2003). If pseudogenization is not yet complete, there is 
a good chance of being able to detect the signature of evolutionary forces 
responsible for the pseudogenization. If the nearly complete fixation of a null 
allele has been driven by positive selection there should be signals of recent 
(incomplete) selective sweeps, which could be detected by examining intra-
specific variation of putatively neutral regions (e.g., intronic sequences) 
surrounding the null-allele (Wang et al. 2006). The LRH tests only detect recent 
selection (<30,000 years), which might be the reason Veeramah et al. (2008) did 
not find evidence of positive selection when testing HapMap data for FMO2 
(Veeramah et al. 2008). Analysis of resequencing data from regions close to the 
truncation SNP (within about 15 kb either side) may detect the remnants of a 
much older selective sweep.  
 The following was considered for the analysis:  
Intronic segments situated within about 15 kb either side of the truncation 
SNP (about four upstream and four downstream) were used (see below). The 
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number of SNPs in both the functional 23238C allele and the non-functional 
23238T allele were compared by Fisher`s exact test. There was no significant 
difference between the frequency of SNPs on either a 23238C or a 23238T allele 
background in these intronic sequences, although several SNPs had a higher 
frequency on a 23238T allele background. πT and πC comparisons (by two-tailed Z 
test were also performed, results not shown). Sequence data available for FMO2 
from NIEHS was used for this analysis. Eight heterozygotes for the SNP 
g.23238C<T (Q472X) (C/Ts) (African-American and African) and 100 
homozygote alleles (African, European, Hispanic and Asian) for the truncated 
23238T allele (T/Ts) were used. 
Length of intronic sequences used from (NIEHS) for π ratio comparisons 
were as follows:  
1) Around the truncation SNP 
+20478 to +21977 (located in the intron between exons 7 and 8),                            
1499 nucleotides. 
+22078 to +23130 (located in the intron between exons 8 and 9), 1052 
nucleotides. 
+23479 to +24877 (downstream of exon 9), 1398 nucleotides. 
2) Around exon 7 
+18378 to +19527 (located in the intron between exon 6 and exon 7), 1149 
nucleotides. 
+19927 to +21027 (in the intron between exon 7 and exon 8), 1100 nucleotides. 
3)  Between exons 4, 5 and 6 
+11128 to +13177 (in the intron between exon 4 and exon 5), 2049 
nucleotides. 
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+13778 to +15827 (in the intron between exon 5 and exon 6), 2049 
nucleotides. 
4) Between exons 3 and 4. 
+5528 to +7577 (in the intron between exon 3 and exon 4), 2049 nucleotides. 
+7828 to +9327 (in the intron between exon 4 and exon 5), 1499 nucleotides 
Tajima`s D and Fu and Li`s D* and F* test statistics for these intronic regions 
were calculated for the 23238C and 23238T allele groups. The 23238C allele 
group had a significantly positive Tajima`s D (P<0.05) for the region upstream of 
the g.23238C>T (Q472X) SNP, as well as significantly positive Fu and Li`s D* 
and F* test statistics (P<0.05). All these P values resulted from coalescent 
simulation, with intermediate recombination. These values may indicate 
population subdivision, since the 23238C alleles originated from African-
American and African individuals. Whereas for the 23238T allele regions, in the 
sequence upstream of exon 4, there was a significantly positive Tajima`s D and Fu 
and Li`s D* and F* test statistics (P<0.05), (P<0.05) (from comparison with 
coalescent simulations that had the same sample size and recombination rate as 
the sample). The sequence downstream of exon 4 had a significantly positive Fu 
and Li`s D* (P<0.05). Upstream of the truncation, there was negative Fu and Li`s 
D* and F* test statistics, although not significant. Downstream of the truncation 
SNP, Fu and Li`s D* was significantly positive (P<0.001). Nucleotide diversity 
(π) was estimated for each set of sequences in African-American, European, 
Hispanic and Asian NIEHS individuals (Table 24). 
    The significantly positive values for Tajima`s D and Fu and Li`s D* and F* test 
statistics observed for any intronic sequences in the 23238T alleles may be due to 
population subdivision (FST = 0.20), since the 23238T alleles are from diverse 
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populations (African-American, African, European, Hispanic and Asian 
populations). Comparisons between πC and πT were performed. Ratios of πC/πT 
were calculated across intronic sequences for African-American and African 
individuals from NIEHS (Figure 25). Since the only 23238C alleles came from 
heterozygotes in African-American and African individuals from NIEHS, only 
individuals with complete genotypes were used and haplotypes were inferred 
using Phase.  
 
Table 24. π values for NIEHS populations across intronic sequences 
 
Sequence range 
Population 
Af-Am and Af        European            Asian              23238C 
5.527-7.577 0.00346 0.00203 0.00223 0.00025 
7.828-9.327 0.00243 0.00205 0.00235 0.00001 
11.128-13.177 0.0015 0.00108 0.00108 0.00041 
13.778-15.827 0.00248 0.00158 0.00245 0.00322 
18.378-19527 0.00043 0.00036 0.00075 0.00001 
19.928-21.977 0.00075 0.00075 0.00074 0.00026 
22.078-23.080* 0.00184 0.0018 0.00197 0.00067 
23.479-24.877# 0.00119 0.0011 0.00157 0.00001 
 
Table shows π values for NIEHS populations across eight intronic sequences. Af-Am, African 
American, Af, African, European and Asian 23238T alleles. *Intronic sequence upstream of 
g.23238C<T (Q472X) SNP, #intronic sequence downstream of g.23238C<T (Q472X). 
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Results indicate that πC had lower values compared with πT. This indicates 
lower nucleotide diversity in 23238C alleles compared with 23238T alleles (Table 
24).  Figure 25 displays the πC/πT ratios across intronic sites for African-American 
and African individuals. The lower values of nucleotide diversity in the 23238C 
alleles indicate the possibility than an incomplete selective sweep has been acting 
on the 23238C alleles with the resulting hitchhiking effect leading to a decrease in 
the nucleotide diversity of these alleles (see Figure 25). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. πC/πT for intronic sequences in African-American and African 
individuals. (Arrow indicates the location of the g.23238C>T (Q472X) SNP). 
 
3.2.9.13 Testing for a common origin of African, European, Hispanic and 
Asian 23238T alleles 
To determine whether there is a common origin of the African and the non-
African T alleles, African-American, African NIEHS and combined west- and 
east-African homozygotes for the 23238T allele were combined and phased for 19 
variants. Genotypes of European, Hispanic and Asian individuals from the NIEHS 
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panel were phased for the same variants, in order to check for cosmopolitan 
haplotypes.  
There was a common haplotype among all population groups, haplotype 1, 
which was present at a frequency ranging from 0.33 in Africans to 0.58 in 
Europeans. Africans shared only one haplotype (haplotype 1) with the other 
groups, whereas Europeans shared two haplotypes with Hispanics and, 
interestingly, Asian and Hispanic populations shared three haplotypes (Table 25 
and Figure 26). These results indicate that 23238T alleles of the three old world 
populations may share a common ancestor. 
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Table 25. Haplotypes for the NIEHS populations 
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Frequency 
 
Ancestral           0 A T del T G T C G G C A A G G T A C A del 0 
Population Group  
NIEHS African-Americans, Africans and Africans from the combined resequencing Samples (n=36) 
1                            12  A T del T G T C A G C A A G G T A T A del 0.33* 
2                              2  A T del T G T C A A C A A G G T A C A del 0.05 
3                              7  A T del T G T C A G C A A G G T A C A del 0.19* 
4                              3 A T del T G T C A G C A A C G T A C A del 0.08 
5                              3 A T del T G T C A G C A A C G T A T A del 0.08 
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Haplotypes and their estimated frequencies in the NIEHS Populations and the combined African sample. The nucleotide positions of SNPs are given relative to the A of the ATG translational 
initiation codon. Those that result in amino-acid substitutions, g.107 (D36G), g.7695 (F69Y), g.7700-7702 (71dupD), g.7731 (F81S), g.10951 (V113fsX), g.13693 (F182S), g.13732 (S195L), g.18237 (R238Q), 
g.18269 (R249X), g.19679 (E314G), g.19910 (T391R), g.22026 (E402K),g. 22060 (N413K), g.23238 (Q472X) and g.23353-23354 (F472fsX) are shown in bold. All polymorphisms are shown as derived changes in 
comparison with the human ancestral sequence. Shared haplotypes among populations are colour marked. *Indicates that the haplotype is functional, n=number of alleles in population. Nomenclature of haplotypes is 
the same as in Figure 26. 
6                              1 A T del T G T C A A C A A G G T A T A del 0.03 
7                              3 A T del T G T C A G C A G G G T A T A del 0.08 
8                              1  A T del T G T C A G T A G G G G A T A del 0.03 
9                              1 A T del T G C C G G C A G G G T A T G del 0.03 
10                            1 A T del T G C C G G C A G G G T A T A del 0.03 
11                            1 A T GAC T G T C A G C A A G A T A C A del 0.03 
12                            1 A T GAC T G T C A G T A G G G G A T A del 0.03 
NIEHS European Population (n=26) 
1                            15 A T del T G T C A G C A A G G T A T A del 0.58 
13                            2 A T del T G T C A G C A A G G T A T G del 0.08 
14                            6 A T del T G T T G G C A A G G T A T A del 0.23 
15                            2 A T del T G C C G G C A A G G T A T G del 0.08 
16                            1 A T GAC T G T C A G C A A G G T A T A del 0.04 
NIEHS Hispanic Population (n=24) 
1                        10 A T del T G T C A G C A A G G T A T A del 0.42 
15                        2 A T del T G C C G G C A A G G T A T G del 0.08 
17                        2 A T del T G T T G G C A A G G T A T G del 0.08 
21                        6 A T del T G T T G G C G A G G T A T A T 0.25 
        
 
   
 
     
 
  
NIEHS Asian Population (n=36)  
1                            19 A T del T G T C A G C A A G G T A T A del 0.53 
17                            3 A T del T G T T G G C A A G G T A T G del 0.08 
18                            1 G T del T G T T G G C A A G G T A T A del 0.03 
19                            9 A T del T G T T G G C G A G G T A T A T 0.25 
20                            4 G T del T G T T G G C A A G G T A T A del 0.11 
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Figure 26. Haplotypes and their frequencies in the three old world populations.  
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3.2.10 Time to the most recent common ancestral sequence (TMRCA) 
GeneTree was used to determine the time to the most recent common 
ancestral sequence (TMRCA) as well as the ages of some of the SNPs observed in 
the combined African resequencing sample. Since GeneTree assumes an infinite-
sites model of mutation without recombination, all recombinant haplotypes had to 
be excluded (Table 26). Therefore, of the ten distinct haplotypes present in the 30 
African chromosomes (Table 16), only three could be used for this analysis, since 
an ancestral sequence needed to be included and this caused a reticulation in the 
network (diagram not shown), which indicates possible recombination. A median-
joining network diagram was drawn for the non-recombinant haplotypes (Figure 
27). GeneTree was used to estimate θ (a measure of the average expected per-site 
nucleotide diversity) using a maximum-likelihood (ML) method. θ is needed to 
calculate Ne (effective population size) since GeneTree gives times in units of 2Ne 
(see Sections 2.5.2.6 and  2.5.2.6.1). Ne is calculated from θ = 4 Ne,µ. µ is the 
neutral mutation rate per region per generation and can be calculated from µ  = 
υgL, where υ is the neutral mutation rate per nucleotide per year, g is the 
generation time (20 years) and L is the number of silent sites (intronic + silent 
sites in exons), which was 3442 in the sample. θML = 2.8, which is slightly lower 
than θS, the estimate from the number of segregating sites, which is 3.4. Another 
value required for the calculation of the neutral mutation rate is the net silent-site 
sequence divergence between humans and chimpanzee (i.e, divergence between 
humans and chimpanzee minus the divergence within these two species) and a 
human-chimpanzee divergence time of ~6 million years (Wall 2002). 
The net silent-site sequence divergence was estimated using DnaSP and was 
=  33.3. υ = 8.3 x 10-10/site/year. This value is slightly higher than estimates for 
  140
many other human loci (Tishkoff and Verrelli 2003). So now Ne can be calculated, 
and was estimated to be 9,234 individuals, which is similar to the effective 
population size commonly found from studies of human genes (10,000 
individuals) (Harding et al. 1997; Fullerton et al. 2002; Wooding et al. 2002; 
Tishkoff and Verrelli 2003). GeneTree gave estimates for TMRCA and the ages of 
some of the variants present in the African sample in coalescent units of 2Ne 
generations. Each of the time estimates was converted into years using the 
estimate of Ne and a generation time of 20 years.  
Figure 28 shows the GeneTree for African non-recombinant haplotypes. 
(Times in square brackets are the 95% confidence intervals for the times estimated 
using GeneTree, http://www.dimensionresearch.com). The time to the most-recent 
common ancestral sequence was estimated to be ~0.928 million years (myr) 
[0.843-1.012 myr]. TMRCA (SD = 236 kyr). TMRCA can also be calculated 
independently of GeneTree by using a coalescent model that assumes constant Ne. 
In such a model, the average pairwise divergence is dominated by the time taken 
for the last two lineages to coalesce, which is expected to take 2 Ne generations, or 
half the time to the most recent common ancestor (TMRCA). Therefore, the average 
pairwise age of sequence diversity can be estimated from: human-chimpanzee 
divergence time x the average pairwise difference among human haplotypes/net 
sequence divergence between human and chimpanzee FMO2 genes. This resulted 
in a TMRCA = 1.3 million years (myr), which is slightly higher than the estimate 
from Genetree (0.928 million years). 
GeneTree can also be used to estimate the coalescent times of haplotypes. 
The coalescent time for haplotypes 5, 6 and 9, which corresponds to the point at 
which these lineages coalesce to a common ancestor, is estimated as 732 kyr [662-
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801 kyr] (SD = 193 kyr). Results indicate that 11 of the 12 variants predated the 
out-of-Africa migration. The SNP g.19839A>G (A367A) occurred ~0.83 million 
years ago (myr) [0.750-0.910 myr] (SD = 216 kyr). The only SNP estimated to 
have occurred after the migration of modern Homo sapiens out of Africa ~60,000 
years ago is g.13732C>T (S195SL). The GeneTree time estimate for this SNP 
seems to be underestimated (45 kyr) [31.40-58.60 kyr] (SD = 38 kyr), because if it 
had arisen after modern Homo sapiens migrated out of Africa, it should not be 
present in Africa, but since the SNP is also observed in Africa at high frequency 
(0.53), which indicates that it has arisen in Africa before the migration. This is 
confirmed by the SNP being observed in all three old world populations. The SNP 
is present in the HapMap-CEU and the EGP-CEPH Panels at a frequency of 0.24 
and 0.30, respectively, whereas it occurs at an average frequency of 0.52 in the 
combined HapMap-HCB and HapMap-JPT as well as in the EGP-Asian Panel. 
Five of the 12 SNPs [+7586C>T, +7883T>A, g.13732C>T (S195L), g.13733G>A 
(S195S) and +13952C>A] (Table 26) were also observed in Asian and European 
individuals, whereas another two [g.7731T>C (F81S) and g.18237G>A (R238Q)], 
were observed only in Europeans but not in Asians, which can give valuable 
information as to which haplotypes migrated out of Africa and which did not. 
Alternatively, haplotypes not observed in Asia or Europe might have migrated out 
of Africa, but did not survive in other environments. 
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Table 26. Non-recombinant haplotypes and their frequency 
 
 
Table displays the haplotypes used for GeneTree analysis. Their frequencies are displayed in the 
first column. There were 12 variants. Those resulting in an amino-acid change [g.7731T>C 
(F81S), g.10951delG (V113fsX), g.13732C>T (S195L) and g.18237G>A (R238Q) are shown in 
bold. The number under the SNP nucleotide position is the SNP id number as in the MJ network 
diagram (Figure 27) and in the GeneTree (Figure 28). 
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Frequency 
Ancestral  (1)   0 C T T G C G C C G T A G 0.00 
5                      12 
. . . . . A A T . C . A 0.40 
6                        2 
. . . . . A A T A C . A 0.066 
9                        3 T C A del T . . . . . G . 0.10 
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Figure 27. Median-joining (MJ) network diagram of the non-recombinant haplotypes used for GeneTree. Each of the three unique haplotypes is 
represented by a circle, the size of which is proportional to haplotype frequency. The lines connecting the haplotypes indicate the mutational relationship. Mutational 
differences between haplotypes are indicated on the branches of the network. Amino-acid residue positions on the protein identify mutations. Where multiple mutations occur 
along a branch, their order is arbitrary.  
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Figure 28. GeneTree diagram. The GeneTree diagram displays the times of some of the 
mutations and the coalescence times of haplotype clusters. 
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3.2.11 The evolutionary relationship among FMO2 haplotypes 
      The evolutionary relationship among nine of the ten FMO2 haplotypes for the 
combined African resequencing sample of 30 chromosomes, was visualized by a 
reduced-median (RM) network (Figure 29). Haplotype identities are the ones 
displayed in (Table 16), except for haplotype 10, which was removed from the 
diagram. The diagram displays each of the 9 haplotypes as a circle, the size of 
which is proportional to haplotype frequency.  
These circles are connected by lines (branches). Mutations are indicated on 
these branches. When more than one mutation occurs on a branch, these mutations 
cannot be ordered and, therefore, their order is arbitrary along the branch. Since 
no haplotype corresponds to the ancestral sequence, the chimpanzee sequence is 
used as the root haplotype of the network. The diagram shows that the earliest 
mutation to occur is the g.23238C>T (Q472X) truncation SNP and that all other 
mutations occur on a 23238T allele background, except for g.18237G>A 
(R238Q), which can also occur on a 23238C allele background. The FMO2 
haplotypes fall into four main groups. The first group comprises of the ancestral 
haplotype, the second is made up of haplotypes 2 and 9. These haplotypes are 
connected by a node, and are separated by two c.SNPs: g.22060T>G (N413K) and 
g.23238C>T (Q472X).  
The third group is separated from the second by 12 mutations and is made up 
of four haplotypes: haplotypes 1, 4, 5 and 6. Each of these haplotypes is separated 
by a single mutation: haplotypes 1 and 6, as well as haplotypes 4 and 5, are 
separated by the c.SNP g.23238C>T (Q472X), whereas haplotypes 1 and 4 and 
haplotypes 5 and 6 are separated by the c.SNP g.18237G>A (R238Q). The 
placement of haplotype 1 is ambiguous, as indicated by a reticulation in the 
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network. Reticulations are due to homoplasy (the occurrence of evolutionary 
events leading to the formation of the same allelic state at a variable site more 
than once). This homoplasy is observed for g.18237G>A (R238Q) and 
g.23238C>T (Q472X). Homoplastic sites can be brought about either by recurrent 
mutation or by recombination. Haplotype 1 may have arisen via a recurrent 
mutation of haplotype 5 at position 18237G>A (R238Q). However, this site is not 
part of a CpG dinucleotide and therefore, will not be subjected to a higher 
mutation rate. A more plausible explanation would be that it arose via a single 
recombination event that took place between haplotype 5 and either haplotype 4 
or 6. This is supported by the four-gamete test, which predicted a recombination 
event between sites g.18237G>A (R238Q) and g.23238C>T (Q472X).  Four 
further mutations separate the third group from the fourth group. This group 
consists of three haplotypes, haplotypes 3, 7 and 8. Haplotypes 3 and 7 are 
separated by a single c.SNP g.23238C>t (Q472X), whereas haplotypes 7 and 8 are 
separated by an intronic SNP, +19969G>A. 
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Figure 29. Reduced-median (RM) network of FMO2 haplotypes for the 
combined African group of 30 chromosomes. Each of the nine unique haplotypes is 
represented by a circle, the size of which is proportional to haplotype frequency. The lines 
connecting the haplotypes indicate the mutational relationship. Mutational differences between 
haplotypes are indicated on the branches of the network. Amino-acid residue positions on the 
protein identify mutations. Where multiple mutations occur along a branch, their order is arbitrary. 
Haplotype 10 was removed. 
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4. General Discussion and Conclusion 
4.1 Functional FMO2 is found at high frequency in east and 
west-Africa 
The frequency of full-length 23238C alleles in east and west-Africa ranges 
from 0.18-0.21, with 0.32-0.36 of individuals possessing at least one full-length 
allele. Resequencing analysis of FMO2 of 14 individuals homozygous for full-
length 23238C alleles revealed that at least 0.54 of the full-length alleles encoded 
a functionally active protein and that 0.72 of these individuals possessed at least 
one potentially functional 23238C allele. These results indicate that the frequency 
of functional FMO2 alleles and the proportion of individuals who possess at least 
one functional allele is relatively high in both east and west-Africa (~0.10 and 
~0.18, respectively), which may have important implications for response to 
therapeutic drugs, especially thiourea-containing drugs used for the treatment of 
tuberculosis, which is widespread in Africa. The exact effect of FMO2 on these 
drugs is still unclear. The frequency of individuals in east and west-Africa (0.18 
and 0.20, respectively) that possess potentially functional FMO2 was not 
significantly different (P>0.2).  
      Results show that the presence of full-length 23238C alleles in an individual, 
are not sufficient to indicate potentially functional FMO2, and that haplotypes 
need to be assessed for the absence of other nonsynonymous SNPs, and only then 
can potentially functional FMO2 be identified. 
The results demonstrate that human FMO2 is not a pseudogene, because 
functional FMO2 is still found at relatively high frequency. My results are similar 
to the results of the study by Veeramah et al. (2008) (Veeramah et al. 2008) in 
that the frequency of full-length 23238C alleles is relatively the same across sub-
Saharan Africa but, interestingly, my results show that although there is no 
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significant difference in the frequency of full-length 23238C alleles among nine 
population groups from sub-Saharan Africa, the frequency of potentially 
functional 23238C alleles differed significantly among these populations 
(P<0.05).  
Another advantage of the study performed in this thesis is that in the study by 
Veeramah et al. (2008) samples were only genotyped for the g.23238C>T 
(Q472X) SNP and not for any other nonsynonymous SNPs, which were reported 
by other studies to cause loss of function (e.g., g.10951delG (V113fsX) and 
g.13732C>T (S195L) (Furnes et al 2003; Krueger et al. 2005, see Table 1), 
whereas this thesis considered testing the full-length 23238C alleles for the 
presence of nonsynonymous SNPs. 
Although a recent study of single-strand conformation polymorphism (SSCP) 
of 50 African-Americans reported a number of previously unknown FMO2 
variants, no attempt was made to establish the background on which the SNPs 
occurred (Furnes et al. 2003). To address this point, I initially genotyped 
individuals from nine sub-Saharan African population groups for five SNPs, 
which were reported, by NCBI, to be at high-frequency in Africa. Genotyping 
results indicated that the frequency of full-length 23238C alleles that are 
potentially functional ranged from 0.35 to 1.00. The frequency of potentially 
functional FMO2 alleles, in comparison to the total number of alleles, in the nine 
African population groups ranged from as low as 0.08 in Nuer to 0.35 in 
Mambila.  
In an attempt to confirm these promising results, samples from west- and 
east-Africa were first genotyped for the g.23238C and g.23238T alleles and then 
resequenced to test for the occurrence of any other deleterious SNPs that might 
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occur on a full-length 23238C allele background. Resequencing results confirmed 
that potentially functional FMO2 is at high frequency in sub-Saharan Africa, since 
more than half (0.55) of the full-length 23238C alleles are not associated with a 
nonsynonymous SNP (see Table 17). Resequencing revealed no novel SNPs. 
According to the equation (1-p)n = significance threshold, where n is the number 
of alleles and p is the proportion of the derived allele of a given variant, the 
minimum number of alleles needed to identify the proportion of derived alleles 
with a 95% confidence when the derived allele frequency is 0.03, 0.04 and 0.05 is 
98, 73 and 58 respectively. So the minimum number of individuals needed for the 
identification of derived alleles with 95% confidence at frequencies of 0.03, 0.04 
and 0.05 is 49, 36 and 29, respectively. So the African resequencing samples 
which consist of 96 alleles are large enough to identify derived allele frequencies 
with 95% confidence at frequencies of 0.04 or above.    
4.1.1 Comparison of previously reported FMO2 haplotypes with the ones 
observed in this thesis 
The study by Krueger et al. (2005) compared the derived allele frequency of 
SNPs in Hispanic-Americans (28 23238C/T heterozygotes and one 23238C 
homozygote) with the ones observed for the African-American (50 individuals) 
study by Furnes et al. (2003) (Furnes et al. 2003). Krueger et al. (2005) genotyped 
the Hispanic population for four SNPs, which were the most frequent in the 
population of 50 African-Americans: the duplication at g.7700-7702dupGAC 
(71Ddup), g.10951delG (V113fsX), g.13732C>T (S195L) and g.22060T>G 
(N413K) and haplotypes were inferred. Twenty-one of these Hispanic individuals 
(0.72) possessed a full-length FMO2 allele that had no other SNPs associated with 
it, and, therefore, are predicted to express functional FMO2. In contrast, the 
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remaining eight (0.28) were heterozygotes for g.13732C>T (S195L). About 0.10 
of the latter  were also heterozygous for two more SNPs: g.10951delG (V113fsX) 
and g.22060T>G (N413K).  
In order to compare the results from the Krueger et al. study with the study 
performed in this thesis, 23238C and 23238T homozygotes were phased for the 
four SNPs mentioned above. Of the 24 23238C and 24 23238T homozygotes, 
haplotypes of 17 of each type of homozygote were successfully inferred using 
Phase. The proportion of homozygous 23238C individuals that did not possess 
any of the four SNPs mentioned above was (0.71), 0.12 had g.13732C>T (S195L) 
present, whereas 0.06 had two SNPs present: g.13732C>T (S195L) and 
g.22060T>G (N413K).  Krueger et al. (2005), also genotyped 124 Puerto Rican-
American 23238T homozygote individuals. Of these, 0.31 had none of the other 
SNPs associated, whereas 0.67 had the g.13732C>T (S195L) SNP associated with 
the 23238T allele. Twenty-seven percent were also homozygous for the 
g.13732C>T (S195L) SNP.  
In the study by Krueger et al. (2005), the g.10951delG (V113fsX) SNP was 
found only in individuals who also had g.13732C>T (S195L) present. The same 
individuals also expressed the g.22060T>G (N413K) SNP. The latter SNP was 
also present alone in 0.02 of the individuals. None of the Hispanic individuals 
genotyped possessed the g.7700-7702dupGAC (71Ddup) SNP. In comparison, for 
the 23238C and T homozygote individuals included in this thesis, 0.82 of the 
23238T homozygotes had none of the other four SNPs present and 0.12 possessed 
the g.13732C>T (S195L) SNP. One similarity to the Krueger et al. (2005) study is 
the absence of the duplication SNP from both the 23238C and 23238T alleles. 
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None of the 23238C or the 23238T homozygotes possessed the g.10951delG 
(V113fsX) SNP. 
     The differences in the frequency of non-functional 23238T alleles observed in 
the nine African population groups (see Table 9) may be indicative of either an 
old selective sweep or it may be explained by mutations occurring across different 
regions of the 23238T allele. 
4.2 Homozygote increase in genotyping samples 
Significant deviation from HWE was observed for three of the SNPs 
[g.107A>G (D36G), g.10951delG (V113fsX) and g.23238C>T (Q472X)] in the 
genotyping samples. In Gurage, for g.107A>G (D36G), (P<0.005) and for 
g.10951delG (V113fsX), (P<0.001), in Fulbe, for g. 107 A>G (D36G), (P<0.001), 
in Manjak, for g.10951delG (V113fsX) (P<0.005) and g.23238C>T (Q472X) 
(P<0.05), and in Nuer, for g.23238C>T (Q472X) (P<0.005).  The deviation was 
caused by less than the expected number of heterozygotes. This might be caused 
by the structure of these populations. Inbreeding may be causing the decrease in 
heterozygotes, since inbreeding leads to an observed increase in homozygotes 
(Charlesworth and Charlesworth 1987). 
 
4.3 The evolution of FMO2 
4.2.1 The mutational relationship of FMO2 variants 
4.2.1.1 For the genotyped populations 
The reduced-median network diagram (see figure 13) showed that mutations 
occur on both a full-length 23238C and a truncated 23238T allele background. 
More complicated network diagrams for some populations were observed, due to 
  153
homoplasy, which may be explained by recombination, since the occurrence of 
mutations on a full-length 23238C allele background is very low.  
4.2.1.2 For the combined African resequencing sample 
The reduced-median network diagram (Figure 29) for the combined African 
sample supports the results for the genotyped samples from the nine African 
population groups in that it shows that mutations mainly occur on a truncated 
23238T allele background, except for the SNP g.18237G>A (R238Q), which 
occurs on both a truncated 23238T and a full-length 23238C allele background. 
The occurrence of this SNP on a full-length 23238C allele background can be 
explained by recombination. This is supported by the results of the four-gamete 
test, which predict a recombination event between g.18237G>A (R238Q) and 
g.23238C>T (Q472X). The diagrams (both for the genotyping populations and for 
the combined African sample) indicate that all of the other SNPs occurred after 
the g.23238C>T (Q472X) SNP, which was estimated by maximum-likelihood 
coalescent analysis to have occurred some 500 thousand years ago (kyr) 
(Veeramah et al. 2008).  
4.2.2 Recombination and linkage disequilibrium 
The presence of sites with four-gametes indicates either recombination or 
recurrent mutation. Since the possibility of recurrent mutation at the same site is 
very small, recombination is the more plausible explanation. The four-gamete test 
results predict five recombination events for the combined African resequencing 
sample (see Section 3.2.7). Despite the number of recombination events, strong 
significant LD is observed for both the 23238C and 23238T alleles. Significant 
LD for the 23238T allele group SNPs extends for 23kb, whereas the LD for the 
23238C allele group SNPs extends for 22.6kb along the FMO2 gene. Significant 
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LD was also observed for the NIEHS Asian (22.2kb) and European (22.1kb) 
groups. The significant LD for the NIEHS Asian group was supported by values 
of ZnS and Za that were both lower and higher than expected under a neutral model 
of evolution (P<0.05). The extensive LD observed in the NIEHS Asian group is 
consistent with a recent bottleneck (Becquet 2003), since recent, long bottlenecks 
favour the complete coalescence of most lineages during the bottleneck. 
4.4 Natural selection 
Enzymes that metabolize foreign chemicals are at the interface between an 
organism and its chemical environment and, thus, are likely candidates for natural 
selection (Verrelli et al. 2002) 
4.4.1 Examining FMO2 for evidence of natural selection 
     The LRH test used by Veeramah et al. (2008) (Veeramah et al. 2008) on 
human SNP data from HapMap phases 1 and 2 did not detect positive selection 
for either the 23238C or 23238T FMO2 alleles. However, the LHR test can only 
detect recent positive selection (20,000-30,000 years) and, consequently, would 
have missed a more ancient selection event. Several population genetic methods 
that test DNA sequence variation for signatures of selection indicate that the 
FMO2 locus might have been subjected to selection. Extensive LD is observed for 
both 23238C and T allele groups as well as the NIEHS Asian and European 
groups. The allele-frequency spectrum for all these groups shows an excess of 
intermediate-frequency variants, when compared with a neutral model (Figures 
20a, b, c and d). Significantly positive Tajima`s D for the NIEHS Asian group 
supports the presence of an excess of intermediate-frequency, compared with low-
frequency, variants. 
     Measures of population structure on a global level indicate that only ~0.10-
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0.16 (Wright’s fixation index FST = (0.10-0.16) of observed genetic variation is 
due to differences among populations from Africa, Europe and Asia (Tishkoff and 
Verrelli 2003; International HapMap Consortium 2005; Weir et al. 2005). My 
result is higher than this range, FST = 0.20. The NIEHS Asian group shows an 
increased number of derived alleles present at frequencies reaching 0.27. The 
exposure to new chemical environments out of Africa may have rendered 
expressing the 23238C allele less favourable. This may be the reason that 23238C 
alleles are not found in Asia, although this may be because modern Homo sapiens 
who migrated into Asia did not possess 23238C alleles, or that these alleles were 
eliminated during the bottleneck that occurred after the migration out of Africa.  
4.4.1.1 The McDonald-Kreitman test 
The results of the MK test for the combined African sample as well as for 
both the 23238C and the 23238T allele groups showed an excess of polymorphic 
nonsynonymous SNPs, although the results were only significant for the 
combined (P<0.03) and the 23238T allele groups (P<0.03) and not for the 23238C 
allele group (P>0.05). 
4.4.1.2 Purifying selection and genetic distance between SNP categories 
It is expected that purifying selection acting to eliminate deleterious 
mutations is accompanied by directional selection on a favorable allele, which, in 
turn, results in hitchhiking events on linked neutral polymorphisms. 
Purifying selection eliminates deleterious mutations, resulting in lower levels 
of genetic variation. Using Tajima`s D test statistic and Fay and Wu`s H statistic 
in combination is useful for distinguishing between selective forces and 
demographic events. If, for example, a significantly negative value of the D 
statistic is accompanied by a significant H value, recent population expansion and 
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background selection can be excluded (Kim and Stephan 2000). Although such a 
result is not observed for any of the groups analysed, reduced genetic diversity at 
FMO2 SNP loci and increased genetic distances between populations can 
alternatively, indicate purifying selection.  
4.4.1.3   Testing for selection at intronic sequences 
Putatively neutral regions can be used to detect a selective sweep. It is evident 
due to the presence of potentially functional FMO2, that the pseudogenization of 
FMO2 is not yet complete; therefore intronic sequences were examined to test for 
such a sweep. Several tests (Tajima`s D and Fu and Li`s D* and F* test statistics) 
as well as nucleotide diversity comparisons between 23238C and 23238T alleles 
were applied to intronic sequences in an attempt to detect selection. The 23238C 
alleles had noticeably less nucleotide diversity, in comparison with 23238T 
alleles. These neutrality tests had significantly positive values for various 
sequences (see Section 3.2.9.12.1). These results indicate that the 23238C allele 
might have been the subject of a selective sweep which resulted in a decrease in 
nucleotide diversity. The high Ka/Ks ratio (>1) and low nucleotide diversity for 
intronic 23238C allele sites, extensive LD, as well as the allele-frequency 
spectrum with an excess of intermediate-frequency variants may be indicate of a 
selective sweep acting on the 23238C allele.  
     The results observed for the NIEHS Asian group; extensive LD with a 
significantly lower than expected value for ZnS and a significantly higher than 
expected Za and of various significant neutrality test values (positive Tajima`s D, 
positive Fu and Lis` D and F test statistics, negative Fay and Wu`s H test, as well 
as an allele-frequency spectrum displaying an excess of intermediate-frequency 
variants) indicate that Asians underwent a bottleneck after the out-of-Africa 
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migration, and that the resulting decrease in population size, caused an increase in 
genetic drift which in turn, resulted in an increase in intermediate-frequency 
variants (Rosenberg et al. 2002). 
4.5 A common origin for the 23238T alleles 
My results provide information about the evolutionary relationships of 
mutations and haplotypes of FMO2, and a comparison between the non-functional 
23238T alleles in the three old world populations (Africans, Europeans and 
Asians).   
     It is important to determine whether there is a common origin for the 23238T 
allele in the three old world populations. The presence of a common haplotype 
shared by all three population groups indicate that the 23238T alleles for all 
populations were similar, and that Asian and European 23238T alleles share a 
common ancestor with African 23238T alleles. These findings further support the 
conclusion that the g.23238C>T (Q472X) mutation predated the out-of-Africa 
migration of Homo sapiens, since all out-of-Africa 23238T alleles share 
haplotypes with the more diverse African 23238T alleles.  
4.6 Time to the most recent common ancestral sequence (TMRCA) 
4.6.1  Time depth of FMO2 variation and ages of some mutations 
Both GeneTree and an independent coalescent model were used for the 
estimation of TMRCA. GeneTree gave an estimate of 0.928 million years [0.843-
1.012 myr] (SD = 236 kyr), whereas the coalescent model resulted in a slightly 
higher estimate of 1.3 million years (myr). GeneTree was also used to date some 
of the FMO2 mutations. GeneTree results indicate that 11 out of the 12 variants 
analysed by GeneTree predated the out-of-Africa migration, except for 
g.13732C>T (S195L). The frequency of this SNP in Africa is high, as reported by 
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NCBI in the HapMap-Yoruba Panel (0.53) and the EGP-Yoruba panel (0.58) as 
well as in the combined African resequencing sample (0.11), indicating that the 
age of the mutation estimated by GeneTree (45 kyr) [31.40-58.60 kyr] (SD = 38 
kyr) might be low and that the SNP actually predated the migration of modern 
humans out-of-Africa. The presence of the SNP in all three old world populations 
supports this.  
The information about which SNPs are found both in and out of Africa will 
be used in an attempt to determine which haplotypes left Africa and which did 
not. Of the 12 variants mentioned in Table 26, five were also observed outside 
Africa, in Asian and European individuals [+7586C>T, +7883T>A, g.13732C>T 
(S195L), g.13733G>A (S195S) and +13952C>A], whereas another two 
[g.7731T>C (F81S) and g.18237G>A (R238Q)] were observed only in Europeans 
but not in Asians. These results suggest that all three haplotypes displayed in 
Table 26 have migrated out of Africa, but must have recombined [e.g., haplotype 
9 contains the [g.7731T>C (F81S) and the g.10951delG (V113fsX) SNP]. The 
former is observed only in Europeans, whereas the latter is not observed in 
Europeans and Asians, it is only observed in African-Americans at a frequency of 
0.125  
4.7 Concluding Statement 
It is well documented that enzymes involved in the metabolism of foreign 
compounds exhibit genetic variation (Board et al. 1998; Bertilson et al. 2002) 
The main findings of this Thesis are: 
1) The frequency of full-length functional FMO2 is high in sub-Saharan 
Africa (at least 0.54), which has important implications for therapeutic 
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treatment of sub-Saharan Africans and individuals of recent African 
descent with drugs that are substrates of FMO2. 
2) The frequency of full-length alleles is not significantly different in sub-
Saharan Africa, whereas the frequency of inferred potentially functional 
alleles is significantly different among populations in sub-Saharan Africa 
(P<0.05). 
3) The lower intronic diversity in g.23238C allele intronic sequences and a 
Ka/Ks > 1, indicate a possible selective sweep acting on the g.23239C 
alleles.  
         From the results observed in this thesis, it is possible to gain insights into the 
evolutionary history of the FMO2 gene. The presence of full-length functional 
FMO2 alleles at high frequency in Africa ( ≥54%) and in contrast, the complete 
absence of these functional alleles in European and Asians indicates that there 
might have been selection for the truncated allele in the latter populations 
and/or for the full-length allele in Africa (see finding 3). Alternatively, 
individuals possessing a full-length 23238C allele may not have been part of 
the migration out of Africa or the allele may not have survived the bottleneck 
associated with the migration. It is apparent that the human FMO2 gene has 
been under the influence of complex forces leaving a distinct pattern of 
diversity. 
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5. Future Work 
Sub-Saharan Africa has an important and rich history from which we can gain 
insights into the origin of our species and how genetic variation affects human 
phenotypes, including complex diseases and the response to drugs.  
Future work should include sequencing more intronic sequences of FMO2, 
since positive selection cannot be detected by the comparison of human and 
chimp sequences and if the pseudogenization is not yet complete, there is a good 
chance of being able to detect the remnants of a selective sweep (if any), by 
examining intra-specific variation at putatively neutral regions (e.g., intronic 
sequences) surrounding the null-allele. It would also be useful to sequence a 
number of g.23238C>T (Q472X) homozygotes in an attempt to further investigate 
the background on which other nonsynonymous SNPs occur. More African 
individuals (n=150) should be sequenced for the complete coding region of FMO2 
in order to make sure that even very rare mutations (1%) are picked up at a 
confidence of 95%, in order to completely exclude any other nonsynonymous 
SNPs occurring on a g.23238C background either known or novel. Analysis of 
more independent loci and a larger number of African populations, particularly 
from east Africa, will be necessary to better estimate the number and source of 
migration events out of Africa (Reed and Tishkoff 2006).  
Research is needed to examine the effect of various nonsynonymous SNPs on 
protein function. Another interesting field of research would be to investigate the 
potential correlation between FMO2 genotypes and the metabolism of two 
commonly used second-line antitubercular drugs TAZ and ETA in vivo, as well as 
studying the various responses to these drugs. Knockout mice models are the best 
way to establish genotype to phenotype relations. 
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